$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Single polypeptide chain binding molecules 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • C12N-015/00
  • C12N-015/11
  • C12N-015/03
  • C12P-021/00
출원번호 US-0299617 (1989-01-19)
발명자 / 주소
  • Ladner Robert C. (Ijamsville MD) Bird Robert E. (Rockville MD) Hardman Karl (Chevy Chase MD)
출원인 / 주소
  • Genex Corporation (Gaithersburg MD 02)
인용정보 피인용 횟수 : 1537  인용 특허 : 12

초록

The invention pertains to a single polypeptide chain binding molecule which has binding specificity and affinity substantially similar to the binding specificity and affinity of the light and heavy chain aggregate variable region of an antibody, to genetic sequences coding therefor, and to recombina

대표청구항

A method of producing a single chain polypeptide having binding affinity for an antigen, said polypeptide comprising: (a) a first polypeptide comprising the binding portion of the light chain variable region of an antibody; (b) a second polypeptide comprising the binding portion of the heavy chain v

이 특허에 인용된 특허 (12)

  1. Ehrlich Paul H. (White Plains NY) Matsueda Gary R. (Winchester MA) Margolies Michael N. (Weston MA) Haber Edgar (Weston MA), Antibody fragment compositions and process.
  2. Paulus Henry P. (Boston MA), Bispecific antibody determinants.
  3. Ladner Robert C. (3827 Green Valley Iamsville MD 21754), Computer based system and method for determining and displaying possible chemical structures for converting double- or m.
  4. Moore Kevin W. (San Bruno CA) Zaffaroni Alejandro (Atherton CA), Hybrid DNA prepared binding composition.
  5. Auditore-Hargreaves Karen (Wilmington DE), Immunoglobulin half-molecules and process for producing hybrid antibodies.
  6. Auditore-Hargreaves Karen (Wilmington DE), Immunoglobulin half-molecules and process for producing hybrid antibodies.
  7. Dubois ; Jacques E. ; Miller ; John A., Keyboard operated apparatus for simultaneous coding and display of chemical structure and similar graphical information.
  8. Waite John H. (46 Grove St. Haddonfield NJ 08033), Method and apparatus for making correlations and predictions using a finite field of data of unorganized and/or partiall.
  9. Trowbridge Ian S. (San Diego CA), Monoclonal antibodies specific for the human transferrin receptor glycoprotein.
  10. Boss Michael A. (Slough GBX) Kenten John H. (High Wycombe GBX) Emtage John S. (High Wycombe GBX) Wood Clive R. (Near Fordingbridge GBX), Multichain polypeptides or proteins and processes for their production.
  11. Matherat Philippe (Paris FRX), Processor for a graphic terminal.
  12. Cabilly Shmuel (Monrovia CA) Heyneker Herbert L. (Burlingame CA) Holmes William E. (Pacifica CA) Riggs Arthur D. (La Verne CA) Wetzel Ronald B. (San Francisco CA), Recombinant immunoglobin preparations.

이 특허를 인용한 특허 (1537)

  1. Glick, Gary D., 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties.
  2. Glick, Gary D., 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties.
  3. Glick, Gary D., 1,4-benzodiazepine-2,5-diones with therapeutic properties.
  4. Glick, Gary D., 1,4-benzodiazepine-2,5-diones with therapeutic properties.
  5. Glick, Gary D.; Taylor, Clarke Bentley; Toogood, Peter Laurence; Van Huis, Chad Alan, 1,4-benzodiazepinone compounds and their use in treating cancer.
  6. Glick, Gary D., 1,4-benzodiazepone-2,5-diones and related compounds with therapeutic properties.
  7. Fang Sheng-Ding ; Lankin Michael E. ; Founds Henry W. ; Shih David H., 6-(N-carboxymethylamino)caproate, salts thereof and methods of use therefor.
  8. Heilmann, Ingo H.; Shanklin, John, ADS genes for reducing saturated fatty acid levels in seed oils.
  9. Wain-Hobson, Simon; Vartanian, Jean-Pierre, APOBEC3 mediated DNA editing.
  10. Cao, Deliang, ARL-1 specific antibodies.
  11. Cao, Deliang, ARL-1 specific antibodies and uses thereof.
  12. Barghorn, Stefan; Hillen, Heinz; Striebinger, Andreas R.; Labkovsky, Boris; Ebert, Ulrich; Keller, Patrick, Abeta conformer selective anti-Abeta globulomer monoclonal antibodies.
  13. Calvo, Eric; Marinotti, Osvaldo; Ribeiro, Jose M. C.; Francischetti, Ivo M., Aegyptin and uses thereof.
  14. Calvo, Eric; Marinotti, Osvaldo; Ribeiro, Jose M. C.; Francischetti, Ivo M., Aegyptin and uses thereof.
  15. Calvo, Eric; Marinotti, Osvaldo; Ribeiro, Jose M. C.; Francischetti, Ivo M., Aegyptin and uses thereof.
  16. Ogata, Etsuro; Onuma, Etsuro; Tsunenari, Toshiaki; Saito, Hidemi; Azuma, Yumiko, Agents for ameliorating low vasopressin level.
  17. Adams, Camellia W.; Carter, Paul J.; Fendly, Brian M.; Gurney, Austin L., Agonist antibodies.
  18. Hansen,Hans J.; Qu,Zhengxing; Goldenberg,David M., Alpha-fetoprotein Immu31 antibodies and fusion proteins.
  19. Hansen, Hans J.; Qu, Zhengxing; Goldenberg, David M., Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof.
  20. Hansen, Hans J.; Qu, Zhengxing; Goldenberg, David M., Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof.
  21. Hansen,Hans J.; Qu,Zhengxing; Goldenberg,David M., Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof.
  22. van Eenennaam, Hans; van Elsas, Andrea; Hulsik, David Lutje; Medema, Jan Paul, Altered APRIL binding antibodies.
  23. Abastado Jean-Pierre,FRX ; Mottez Estelle,FRX ; Kourilsky Philippe,FRX ; Casrouge Armanda,FRX ; Ojcius David,FRX ; Lone Yu-Chun,FRX, Altered major histocompatibility complex (MHC) determinant and methods of using the determinant.
  24. Siddiqui-Jain, Adam; Bearss, David J., Alvocidib prodrugs having increased bioavailability.
  25. Hillen, Heinz; Striebinger, Andreas; Krantz, Carsten; Moeller, Achim; Mueller, Reinhold, Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof.
  26. Barghorn, Stefan; Hillen, Heinz; Striebinger, Andreas; Giaisi, Simone; Ebert, Ulrich; Benatuil, Lorenzo, Amyloid-beta binding proteins.
  27. Barghorn, Stefan; Hillen, Heinz; Striebinger, Andreas; Giaisi, Simone; Ebert, Ulrich; Benatuil, Lorenzo, Amyloid-beta binding proteins.
  28. Barghorn, Stefan; Hillen, Heinz; Striebinger, Andreas; Giaisi, Simone; Ebert, Ulrich; Hsieh, Chung-Ming, Amyloid-beta binding proteins.
  29. Barghorn, Stefan; Hillen, Heinz; Striebinger, Andreas; Giaisi, Simone; Ebert, Ulrich; Hsieh, Chung-Ming, Amyloid-beta binding proteins.
  30. Hillen, Heinz; Barghorn, Stefan; Labkovsky, Boris; Ebert, Ulrich; Striebinger, Andreas R.; Keller, Patrick, Amyloid-beta globulomer antibodies.
  31. Markel, Gal; Ortenberg, Rona, Anti CEACAM1 antibodies and methods of using same.
  32. Markel, Gal; Ortenberg, Rona; Schachter, Jacob, Anti CEACAM1 antibodies and methods of using same.
  33. Barghorn, Stefan; Hillen, Heinz; Labkovsky, Boris; Striebinger, Andreas R.; Keller, Patrick; Ebert, Ulrich, Anti-Aβ globulomer 5F7 antibodies.
  34. Barghorn, Stefan; Hillen, Heinz; Labkovsky, Boris; Striebinger, Andreas R.; Keller, Patrick; Ebert, Ulrich, Anti-Aβ globulomer 7C6 antibodies.
  35. Kalled, Susan L.; Hsu, Yen-Ming, Anti-BCMA antibodies.
  36. Fung,Michael S. C.; Sun,Cecily R. Y.; Sun,William N. C., Anti-C2/C2a inhibitors of complement activation.
  37. Zauderer, Maurice; Evans, Elizabeth E., Anti-C35 antibody combination therapies and methods.
  38. Rother, Russell P.; Sheridan, Douglas L.; Tamburini, Paul P.; Zhang, Yuchun, Anti-C5a antibodies.
  39. Rother, Russell P.; Sheridan, Douglas L.; Tamburini, Paul P.; Zhang, Yuchun, Anti-C5a antibodies.
  40. Simons, Petrus Johannes; Boon, Louis, Anti-CD134 (OX40) antibodies and uses thereof.
  41. Super, Michael; Davis, Jonathan; Stein, Pascal André, Anti-CD19 antibodies with reduced immunogenicity.
  42. Super, Michael; Davis, Jonathan; Stein, Pascal André, Anti-CD19 antibodies with reduced immunogenicity.
  43. Hansen, Hans; Qu, Zhengxing; Goldenberg, David M., Anti-CD20 antibodies and fusion proteins thereof and methods of use.
  44. Hansen,Hans; Qu,Zhengxing; Goldenberg,David M., Anti-CD20 antibodies and fusion proteins thereof and methods of use.
  45. Hansen,Hans; Qu,Zhengxing; Goldenberg,David M., Anti-CD20 antibodies and fusion proteins thereof and methods of use.
  46. Park, Peter U.; Bartle, Laura M.; Skaletskaya, Anna; Golmakher, Viktor; Tavares, Daniel; Deckert, Jutta; Mikol, Vincent; Blanc, Veronique, Anti-CD38 antibodies for the treatment of cancer.
  47. Griffiths, Gary L.; Hansen, Hans J.; Goldenberg, David M.; Lundberg, Bo B., Anti-CD74 immunoconjugates and methods.
  48. Griffiths, Gary L.; Hansen, Hans J.; Goldenberg, David M.; Lundberg, Bo B., Anti-CD74 immunoconjugates and methods.
  49. Griffiths, Gary L.; Hansen, Hans J.; Goldenberg, David M.; Lundberg, Bo B., Anti-CD74 immunoconjugates and methods.
  50. Byrd, John C.; Goldenberg, David M.; Hansen, Hans J., Anti-CD74 immunoconjugates and methods of use.
  51. Byrd, John C.; Goldenberg, David M.; Hansen, Hans J., Anti-CD74 immunoconjugates and methods of use.
  52. Byrd, John C.; Goldenberg, David M.; Hansen, Hans J., Anti-CD74 immunoconjugates and methods of use.
  53. Hansen, Hans J.; Goldenberg, David M.; Chang, Chien-Hsing, Anti-CD74 immunoconjugates and methods of use.
  54. Hansen, Hans J.; Goldenberg, David M.; Chang, Chien-Hsing, Anti-CD74 immunoconjugates and methods of use.
  55. Seldon, Therese Ann; Munster, David John; Hart, Derek Nigel John; Jones, Martina Louise; Munro, Trent Phillip; Mahler, Stephen Michael; Zhou, Eunice Yu; Marks, James D., Anti-CD83 antibodies and use thereof.
  56. Pages, Gilles; Grepin, Renaud, Anti-CXCL1, CXCL7 and CXCL8 antibodies and their applications.
  57. Patz, Jr., Edward F.; Campa, Michael J.; Gottlin, Elizabeth; Haynes, Barton F.; Liao, Hua-Xin; Moody, Anthony M., Anti-Complement factor H antibodies.
  58. Gu, Jijie; Ambrosi, Dominic J.; Lappe, Susan E.; Li, Yingchun; Hickson, Jonathan A.; Haasch, Deanna L.; Gupta, Supriya; Chari, Ravi; Zamiri, Camellia; Naumovski, Louie; Cao, Xianhua, Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof.
  59. Gu, Jijie; Ambrosi, Dominic J.; Lappe, Susan E.; Li, Yingchun; Hickson, Jonathan A.; Haasch, Deanna L.; Gupta, Supriya; Chari, Ravi; Zamiri, Camellia; Naumovski, Louie; Cao, Xianhua, Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof.
  60. Gu, Jijie; Ambrosi, Dominic J.; Lappe, Susan E.; Li, Yingchun; Hickson, Jonathan A.; Haasch, Deanna L.; Gupta, Supriya; Chari, Ravi; Zamiri, Camellia; Naumovski, Louie; Cao, Xianhua, Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof.
  61. Cummings, W. Jason; Yabuki, Munehisa; Leppard, John B.; Wood, Christi L.; Maizels, Nancy; Allison, Daniel S.; Tjoelker, Larry W., Anti-FZD10 monoclonal antibodies and methods for their use.
  62. Cummings, W. Jason; Yabuki, Munehisa; Leppard, John B.; Wood, Christi L.; Maizels, Nancy; Allison, Daniel S.; Tjoelker, Larry W., Anti-FZD10 monoclonal antibodies and methods for their use.
  63. Tu, Bailin; Ziemann, Robert N.; Tieman, Bryan C.; Hemken, Philip M.; Ramsay, Carol S.; Strobel, Carolyn J.; Hawksworth, David J.; Birkenmeyer, Larry G.; Zhao, Cheng; Brophy, Susan E.; Dowell, Barry L.; Muerhoff, Anthony S., Anti-GP73 monoclonal antibodies and methods of obtaining the same.
  64. Reyes, Christopher L.; Chu, Peter; Tan, Xiangyang; Yang, Weixing; Graff, Christilyn, Anti-GPR49 monoclonal antibodies.
  65. Burioni, Roberto; Clementi, Massimo, Anti-HCV monoclonal antibody as a medicament for the therapeutic treatment and prevention of HCV infections.
  66. Clarke, Adam William; Doyle, Anthony Gerard; Jennings, Philip Anthony; Poulton, Lynn Dorothy; Wai, Bernadette; Pow, Andrew James; Kopsidas, George, Anti-IL-12/IL-23 antibodies.
  67. Ke, Yaohuang; Lee, Sum Wai Pierre; Zhang, Yongke, Anti-IL-1β antibodies.
  68. Lee, Sum Wai Pierre; Ke, Yaohuang; Zhang, Yongke, Anti-IL-6 receptor antibodies and methods of use.
  69. Lee, Sum Wai Pierre; Ke, Yaohuang; Zhang, Yongke, Anti-IL-6 receptor antibodies and methods of use.
  70. Kim, Sunghoon; Choi, Yon-Sik; Shim, Hyunbo; Lee, Nam Ju; Park, Min Hwa, Anti-KRS monoclonal antibody and use thereof.
  71. Tsunoda, Hiroyuki; Nakano, Kiyotaka; Orita, Tetsuro; Tsuchiya, Masayuki; Hirata, Yuichi, Anti-MPL antibodies.
  72. Tsunoda, Hiroyuki; Nakano, Kiyotaka; Orita, Tetsuro; Tsuchiya, Masayuki; Hirata, Yuichi, Anti-Mpl antibodies.
  73. Lacy, Susan E.; Barbon, Jeffrey A.; Chhaya, Meha; Fung, Emma; Hutchins, Charles W.; Lang, Diane M.; Barlow, Eve H.; Leddy, Mary; Chari, Ravi, Anti-NGF antibodies and their use.
  74. Lacy, Susan E.; Barbon, Jeffrey A.; Chhaya, Meha; Fung, Emma; Hutchins, Charles W.; Lang, Diane M.; Barlow, Eve H.; Leddy, Mary; Chari, Ravi, Anti-NGF antibodies and their use.
  75. Schweighoffer Fabien,FRX ; Tocque Bruno,FRX, Anti-RAS intracellular binding proteins and use thereof.
  76. Govindan, Serengulam V.; Goldenberg, David M., Anti-Trop-2 antibody-drug conjugates and uses thereof.
  77. DeGrado, William F.; Sheppard, Dean; Jo, Hyunil; Reed, Nilgun Isik; Tang, Youzhi, Anti-alphavbeta1 integrin compounds and methods.
  78. DeGrado, William F.; Sheppard, Dean; Jo, Hyunil; Reed, Nilgun Isik; Tang, Youzhi; McIntosh, Joel, Anti-alphavbeta1 integrin inhibitors and methods of use.
  79. Weksler, Marc E.; Szabo, Paul, Anti-amyloid peptide antibody based diagnosis and treatment of a neurological disease or disorder.
  80. Gillies, Stephen D., Anti-cancer antibodies with reduced complement fixation.
  81. Gillies, Stephen D., Anti-cancer antibodies with reduced complement fixation.
  82. Gillies, Stephen D., Anti-cancer antibodies with reduced complement fixation.
  83. Gillies,Stephen D., Anti-cancer antibodies with reduced complement fixation.
  84. King C. Richter (Washington DC) Kasprzyk Philip G. (Washington DC) Bird Robert E. (Rockville MD), Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof.
  85. Mytych, Daniel T.; Chirmule, Narendra; Weeraratne, Dohan K., Anti-erythropoietin antibodies.
  86. Kelley, Robert F; van Lookeren Campagne, Menno; Scheer, Justin M; Hass, Philip E; Tesar, Devin, Anti-factor D antibodies.
  87. Williamson, Robert Anthony; Wadia, Jehangir; Pascual, Gabriel; Keogh, Elissa, Anti-human Respiratory Syncytial Virus (RSV) antibodies and methods of use.
  88. Williamson, Robert Anthony; Wadia, Jehangir; Pascual, Gabriel; Keogh, Elissa, Anti-human respiratory syncytial virus (RSV) antibodies and methods of use.
  89. Williamson, Robert Anthony; Wadia, Jehangir; Pascual, Gabriel; Keogh, Elissa, Anti-human respiratory syncytial virus (RSV) antibodies and methods of use.
  90. Wittrup,K. Dane; Yeung,Yik Andy; Wands,Jack R., Anti-hydroxylase antibodies and uses thereof.
  91. Burioni, Roberto; Clementi, Massimo, Anti-idiotype monoclonal antibodies mimicking the HIV gp120 CD4-binding (CD4bs).
  92. Muller Sybille ; Wang Haitao, Anti-idiotypic antibody and its use in diagnosis and therapy in HIV-related disease.
  93. Ford John ; Pace Ann, Anti-interleukin-1 receptor antagonist antibodies and uses thereof.
  94. Fanslow, III, William Christian; Kozlosky, Carl; Gudas, Jean Marie, Anti-mesothelin binding proteins.
  95. Digiandomenico, Antonio; Warrener, Paul G.; Stover, Charles K.; Sellman, Brett; Guillard, Sandrine; Minter, Ralph; Rust, Steven; Tomich, Mladen, Anti-pseudomonas Psl binding molecules and uses thereof.
  96. Gazit, Ehud; Cherny, Izhack, Antibacterial agents and methods of identifying and utilizing same.
  97. Merril Carl R. (Rockville MD) Carlton Richard M. (Port Washington NY) Adhya Sankar L. (Gaithersburg MD), Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense system.
  98. Carlton,Richard M.; Merril,Carl R.; Adhya,Sankar L., Antibacterial therapy with bacteriophage physico-chemically altered by pegylation to delay inactivation by the host defense system.
  99. Chamorro Pérez, Sonia; Franco Villanueva, Ana; García Sanz, José Alberto; Kremer Barón, Leonor; Martínez Alonso, Carlos; Vela Cuenca, Maria; Carramolino Fitera, Laura, Antibodies against CCR9 and methods of use thereof.
  100. Marasco, Wayne A.; Sui, Jianhua; Xu, Chen, Antibodies against CXCR4 and methods of use thereof.
  101. Sahin, Ugur; Türeci, Özlem; Mitnacht-Kraus, Rita; Wöll, Stefan, Antibodies against Claudin 18.2 useful in cancer diagnosis.
  102. Goddard,Audrey; Godowski,Paul J.; Gurney,Austin L.; Smith,Victoria; Wood,William I., Antibodies against PRO1310.
  103. Goddard,Audrey; Godowski,Paul J.; Gurney,Austin L.; Smith,Victoria; Wood,William I., Antibodies against PRO1879 and the use thereof.
  104. Goddard,Audrey; Godowski,Paul J.; Gurney,Austin L.; Smith,Victoria; Wood,William I., Antibodies against PRO4406.
  105. Marasco, Wayne; Sui, Jianhua, Antibodies against SARS-CoV and methods of use thereof.
  106. Schebye, Xiao Min; Selby, Mark J.; Han, Michelle Minhua; Bee, Christine; Deng, Andy X.; Chuntharapai, Anan; Devaux, Brigitte; Li, Huiming; Sheppard, Paul O.; Korman, Alan J.; Ardourel, Daniel F.; Deyanova, Ekaterina; Huang, Richard; Chen, Guodong; Kuhne, Michelle; Troung, Hong-An, Antibodies against TIM3 and uses thereof.
  107. Schebye, Xiao Min; Selby, Mark J.; Han, Michelle Minhua; Bee, Christine; Deng, Andy X.; Chuntharapai, Anan; Devaux, Brigitte; Li, Huiming; Sheppard, Paul O.; Korman, Alan J.; Ardourel, Daniel F.; Deyanova, Ekaterina; Huang, Richard; Chen, Guodong; Kuhne, Michelle; Troung, Hong-An, Antibodies against TIM3 and uses thereof.
  108. Sahin, Ugur; Tureci, Ozlem; Mitnacht-Kraus, Rita; Woll, Stefan, Antibodies against claudin 18.2 useful in cancer diagnosis.
  109. Sidhu, Sachdev; Gakhal, Amandeep; Pan, Guohua; Moffat, Jason; Robitaille, Melanie; Angers, Stephane, Antibodies against frizzled receptor.
  110. Williamson, Robert Anthony; Wadia, Jehangir; Pascual, Gabriel; Keogh, Elissa, Antibodies against human respiratory syncytial virus (RSV) and methods of use.
  111. Williamson, Robert Anthony; Wadia, Jehangir; Pascual, Gabriel; Keogh, Elissa, Antibodies against human respiratory syncytial virus (RSV) and methods of use.
  112. Marasco, Wayne A.; Sui, Jianhua; Liddington, Robert C., Antibodies against influenza virus and methods of use thereof.
  113. Gu, Jijie; Bowley, Diana; Eaton, Lucia; Dong, Feng; Benatuil, Lorenzo; Ghayur, Tariq; Chari, Ravi; Rieser, Matthew; Clabbers, Anca, Antibodies against platelet-derived growth factor (PDGF).
  114. Desnoyers,Luc; Goddard,Audrey; Godowski,Paul J.; Gurney,Austin L.; Smith,Victoria; Wood,William I., Antibodies against the PRO862 polypeptides.
  115. Mueller, Bernhard K.; Schmidt, Martin; Barlow, Eve; Leddy, Mary; Hsieh, Chung-Ming; Bardwell, Philip, Antibodies against the RGM A protein and uses thereof.
  116. Mueller, Bernhard K.; Schmidt, Martin; Barlow, Eve; Leddy, Mary; Hsieh, Chung-Ming; Bardwell, Philip, Antibodies against the RGM a protein and uses thereof.
  117. Wu, Yan; Bohlen, Peter; Hicklin, Daniel J., Antibodies against vascular endothelial growth factor receptor-1.
  118. Wu, Yan; Hicklin, Danny J.; Bohlen, Peter, Antibodies against vascular endothelial growth factor receptor-1.
  119. Quertermous,Thomas; Hogan,Brigid; Snodgrass,H. Ralph; Zupancic,Thomas Joel, Antibodies binding to polypeptides encoded by developmentally-regulated endothelial cell locus-1.
  120. Yayon, Avner; Rom, Eran, Antibodies blocking fibroblast growth factor receptor activation and methods of use thereof.
  121. Grotendorst, Gary R., Antibodies directed to fragments of connective tissue growth factor (CTGF) polypeptide and methods and uses thereof.
  122. Kroczek, Richard, Antibodies for depletion of ICOS-positive cells in vivo.
  123. Sahin, Ugur; Tureci, Ozlem; Koslowski, Michael; Walter, Korden; Woll, Stefan; Kreuzberg, Maria; Hubner, Bernd; Erdeljan, Michael; Weichel, Michael, Antibodies for treatment of cancer.
  124. Sahin, Ugur; Tureci, Ozlem; Koslowski, Michael; Walter, Korden; Woll, Stefan; Kreuzberg, Maria; Hubner, Bernd; Erdeljan, Michael; Weichel, Michael, Antibodies for treatment of cancer expressing claudin 6.
  125. Gao, Zeren; Hart, Charles E.; Piddington, Christopher S.; Sheppard, Paul O.; Shoemaker, Kimberly E., Antibodies reactive to the c-terminal portion of growth factor homolog zvegf3.
  126. Sahin, Ugur; Tureci, Ozlem; Koslowski, Michael; Walter, Korden; Woll, Stefan; Kreuzberg, Maria; Hubner, Bernd; Erdeljan, Michael, Antibodies specific for claudin 6 (CLDN6).
  127. Sahin, Ugur; Türeci, Özlem; Koslowski, Michael; Walter, Korden; Woll, Stefan; Kreuzberg, Maria; Hubner, Bernd; Erdeljan, Michael, Antibodies specific for claudin 6 (CLDN6).
  128. Pedersen, Jan Torleif; Pedersen, Lars Østergaard; Daechsel, Justus Claus Alfred; Asuni, Ayodeji Abdur-Rasheed; Rosenqvist, Nina Helen; Volbracht, Christiane; Helboe, Lone; Elvang, Anders Brandt; Sotty, Florence; Christensen, Søren; Stavenhagen, Jeffrey B., Antibodies specific for hyperphosphorylated tau and methods of use thereof.
  129. Rao, Ercole; Mikol, Vincent; Li, Danxi; Kruip, Jochen; Davison, Matthew, Antibodies that bind IL-4 and/or IL-13 and their uses.
  130. Rao, Ercole; Mikol, Vincent; Li, Danxi; Kruip, Jochen; Davison, Matthew, Antibodies that bind IL-4 and/or IL-13 and their uses.
  131. Rao, Ercole; Mikol, Vincent; Li, Danxi; Kruip, Jochen; Davison, Matthew, Antibodies that bind IL-4 and/or IL-13 and their uses.
  132. Stennicke, Vibeke Westphal; Read, Christine Brender; Grell, Susanne Nedergaard; Wiberg, Charlotte; Salbo, Rune; Henriksen, Anette; Padkjaer, Soeren, Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1).
  133. Stennicke, Vibeke Westphal; Read, Christine Brender; Grell, Susanne Nedergaard; Wiberg, Charlotte; Salbo, Rune; Henriksen, Anette; Padkjaer, Soeren, Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1).
  134. Stennicke, Vibeke Westphal; Read, Christine Brender; Grell, Susanne Nedergaard; Wiberg, Charlotte; Salbo, Rune; Henriksen, Anette; Padkjaer, Soeren, Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1).
  135. Jaspers, Stephen R.; Presnell, Scott R., Antibodies that bind both IL-17A and IL-17F.
  136. Jaspers, Stephen R.; Presnell, Scott R.; Huber, Monica, Antibodies that bind both IL-17A and IL-17F.
  137. Jaspers, Stephen R.; Presnell, Scott R.; Huber, Monica, Antibodies that bind both IL-17A and IL-17F and methods of using the same.
  138. Keler, Tibor; He, Lizhen; Ramakrishna, Venky; Vitale, Laura A., Antibodies that bind human dendritic and epithelial cell 205 (DEC-205).
  139. Keler, Tibor; He, Lizhen; Ramakrishna, Venky; Vitale, Laura A., Antibodies that bind human dendritic and epithelial cell 205 (DEC-205).
  140. Keler, Tibor; He, Lizhen; Ramakrishna, Venky; Vitale, Laura A., Antibodies that bind human dendritic and epithelial cell 205 (DEC-205).
  141. Keler, Tibor; He, Lizhen; Ramakrishna, Venky; Vitale, Laura A., Antibodies that bind human dendritic and epithelial cell 205 (DEC-205).
  142. Stennicke, Vibeke Westphal; Read, Christine Brender; Kuijper, Joseph Leon; Tang, Xiaoting; Heipel, Mark; Hjorth, Siv Annegrethe, Antibodies that bind peptidoglycan recognition protein 1.
  143. Stennicke, Vibeke Westphal; Read, Christine Brender; Kuijper, Joseph Leon; Tang, Xiaoting; Heipel, Mark; Hjorth, Siv Annegrethe, Antibodies that bind peptidoglycan recognition protein 1.
  144. Siegel, Richard M.; Meylan, Francoise; Song, Yun-Jeong, Antibodies that bind to TL1A and methods of treating inflammatory or autoimmune disease comprising administering such antibodies.
  145. Siegel, Richard M; Meylan, Francoise; Song, Yun-Jeong, Antibodies that bind to TL1A and methods of treating inflammatory or autoimmune disease comprising administering such antibodies.
  146. McCauley, Scott Alan; Rodriguez, Hector; Garcia, Carlos Aurelio; Smith, Victoria, Antibodies that bind to lysyl oxidase-like 2 (LOXL2).
  147. Mueller, Bernhard; Huang, Lili; Bardwell, Philip D.; Kutskova, Yuliya; Memmott, John, Antibodies that bind to repulsive guidance molecule A (RGMA).
  148. Zauderer, Maurice; Evans, Elizabeth E., Antibodies that bind to the C35 polypeptide.
  149. Zauderer, Maurice; Evans, Elizabeth E., Antibodies that bind to the C35 polypeptide.
  150. Yayon, Avner; Rom, Eran; Thomassen-Wolf, Elisabeth; Borges, Eric, Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof.
  151. Yayon,Avner; Rom,Eran; Thomassen Wolf,Elisabeth; Borges,Eric, Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof.
  152. Salcedo,Theodora; Ruben,Steven M.; Rosen,Craig A.; Albert,Vivian R.; Dobson,Claire; Vaughan,Tristan, Antibodies that immunospecifically bind to trail receptors.
  153. Krumlauf, Robb; Ellies, Debra, Antibodies that specifcally bind Sost and Wise peptides.
  154. Bouchard, Herve; Commercon, Alain; Fromond, Claudia; Mikol, Vincent; Parker, Fabienne; Sassoon, Ingrid; Tavares, Daniel, Antibodies that specifically bind to the EphA2 receptor.
  155. Bouchard, Herve; Commercon, Alain; Fromond, Claudia; Mikol, Vincent; Parker, Fabienne; Sassoon, Ingrid; Tavares, Daniel, Antibodies that specifically bind to the EphA2 receptor.
  156. Ashkenazi, Avi J.; Botstein, David; Dodge, Kelly H.; Goddard, Audrey; Gurney, Austin L.; Kim, Kyung Jin; Lawrence, David A.; Pitti, Robert; Roy, Margaret A.; Tumas, Daniel B.; Wood, William I., Antibodies to DcR3 Polypeptide, a TNFR Homolog.
  157. Larsen, Flemming; Wahlers, Ulla, Antibodies to MASP-2.
  158. Larsen, Flemming; Wahlers, Ulla, Antibodies to MASP-2.
  159. Spriggs, David; Thapi, Dharmarao, Antibodies to MUC16 and methods of use thereof.
  160. Spriggs, David; Thapi, Dharmarao, Antibodies to MUC16 and methods of use thereof.
  161. Boyle,William J.; Martin,Francis H.; Corvalan,Jose R.; Davis,C. Geoffrey, Antibodies to OPGL.
  162. Goddard, Audrey; Godowski, Paul J; Gurney, Austin L; Smith, Victoria; Wood, William I, Antibodies to PRO 1120 polypeptide.
  163. Sheppard, Paul O.; Fox, Brian A.; Klucher, Kevin M.; Taft, David W.; Kindsvogel, Wayne, Antibodies to ZCYTO20 (IL-28A) and ZCYTO22 (IL-28B).
  164. Markel, Gal; Ben Moshe, Tehila; Sapir, Yair; Mandel, Ilana; Schachter, Jacob; Ortenberg, Rona, Antibodies to carcinoembryonic antigen-related cell adhesion molecule (CEACAM).
  165. Brigstock, David R.; Harding, Paul A., Antibodies to heparin-binding growth factor (HBGF) polypeptides.
  166. Goddard, Audrey; Godowski, Paul J.; Gurney, Austin L.; Mark, Melanie R.; Yang, Ruey-Bing, Antibodies to human Toll homologues.
  167. Moscow Jeffrey A. ; Cowan Kenneth H. ; Dixon Kathy ; He Rui, Antibodies to human reduced folate carrier protein.
  168. Ni,Jian; Rosen,Craig A.; Gentz,Reiner L., Antibodies to human tumor necrosis factor receptor-like 2.
  169. Ware,Carl E., Antibodies to p30 polypeptides and methods making and using same.
  170. Strakhova, Marina I.; Brederson, Jill-Desiree, Antibodies to receptor for advanced glycation end products (RAGE) and uses thereof.
  171. Strakhova, Marina I.; Brederson, Jill-Desiree, Antibodies to receptor for advanced glycation end products (RAGE) and uses thereof.
  172. Gu, Jijie; Hsieh, Chung-Ming; Wu, Zhen; DiGiammarino, Enrico L.; Luo, Feng; Fox, Gerard B.; Harlan, John E.; Schmidt, Martin; Loebbert, Ralf; Mueller, Reinhold; Ebert, Ulrich; Nimmrich, Volker, Antibodies to receptor of advanced glycation end products (RAGE) and uses thereof.
  173. Gu, Jijie; Hsieh, Chung-Ming; Wu, Zhen; DiGiammarino, Enrico L.; Luo, Feng; Fox, Gerard B.; Harlan, John E.; Schmidt, Martin; Loebbert, Ralf; Mueller, Reinhold; Ebert, Ulrich; Nimmrich, Volker, Antibodies to receptor of advanced glycation end products (RAGE) and uses thereof.
  174. Tully, Sarah E.; Hsieh-Wilson, Linda, Antibodies to sulfated carbohydrates.
  175. Tully, Sarah E.; Hsieh-Wilson, Linda C., Antibodies to sulfated carbohydrates.
  176. Yu, Guo-Liang; Rosen, Craig A.; Fraser, Claire M.; Gocayne, Jeannine D., Antibodies to superoxide dismutase-4.
  177. Carozzi Nadine B. (Raleigh NC) Koziel Michael G. (Cary NC), Antibodies which bind to insect gut proteins and their use.
  178. Carozzi Nadine Barbara ; Koziel Michael Gene, Antibodies which bind to insect gut proteins and their use.
  179. Nesspor, Thomas; Scallon, Bernard, Antibodies with improved half-life in ferrets.
  180. Jensen, Martin Blomberg, Antibodies, compounds and derivatives thereof for use in the treatment of male infertility.
  181. Archer, Robert A.; Beechem, Joseph M.; Hagen, David C.; Haugland, Richard P.; Haugland, Rosaria P., Antibody complexes and methods for immunolabeling.
  182. Archer, Robert; Haugland, Richard; Haugland, Rosaria; Beechem, Joseph; Hagen, David, Antibody complexes and methods for immunolabeling.
  183. Käsermann, Fabian; Rüegsegger, Monika; Miescher, Sylvia; Elkon, Keith, Antibody composition with altered Fab sialylation.
  184. Xiao, Shouhua; Pan, Zheng; Wickramasinghe, Dineli; Kufer, Peter; Hoffmann, Patrick; Raum, Tobias; Lutterbüse, Ralf; Nahrwold, Elisabeth; Blumel, Claudia, Antibody constructs for CDH19 and CD3.
  185. Xu, Liang; Huang, Cheng-Cheng; Alexander, William; Tang, WenHua; Chang, Esther H., Antibody fragment-targeted immunoliposomes for systemic gene delivery.
  186. Xu,Liang; Huang,Cheng Cheng; Alexander,William; Tang,WenHua; Chang,Esther H., Antibody fragment-targeted immunoliposomes for systemic gene delivery.
  187. Panyam, Jayanth; Kalscheuer, Stephen, Antibody fragments for detecting cancer and methods of use.
  188. Umaña, Pablo; Jean-Mairet, Joël; Bailey, James E., Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity.
  189. Umaña, Pablo; Jean-Mairet, Joël; Bailey, James E., Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity.
  190. Umaña, Pablo; Jean-Mairet, Joël; Bailey, James E., Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity.
  191. Umaña, Pablo; Jean-Mairet, Joël; Bailey, James E.; Bailey, legal representative, M. Sean, Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity.
  192. Bremel, Robert D.; Eakle, Kurt; Imboden, Michael, Antibody libraries.
  193. Vasquez, Maximiliano; Sivasubramanian, Arvind; Feldhaus, Michael, Antibody libraries.
  194. Vasquez, Maximiliano; Sivasubramanian, Arvind; Feldhaus, Michael, Antibody libraries.
  195. Adams, Ralph; Baker, Terence Seward; Griffiths Lawson, Alastair David, Antibody molecules which bind IL-17A and IL-17F.
  196. Tureci, Ozlem; Sahin, Ugur; Koslowski, Michael; Fritz, Stephan; Geppert, Harald-Gerhard, Antibody to genetic products differentially expressed in tumors and the use thereof.
  197. Keler, Tibor; Endres, Michael; He, Lizhen; Ramakrishna, Venky, Antibody vaccine conjugates and uses therefor.
  198. Keler, Tibor; Endres, Michael; He, Lizhen; Ramakrishna, Venky, Antibody vaccine conjugates and uses therefor.
  199. Ceriani, Roberto Luis; Peterson, Jerry Arthur; Larocca, David James, Antibody with 46 kdalton HMFG antigen binding specificity, immunoassay kit and diagnostic method.
  200. Govindan, Serengulam V.; Gale, Jonathan B.; Holman, Nicholas J.; Goldenberg, David M., Antibody-SN-38 immunoconjugates with a CL2A linker.
  201. Govindan, Serengulam V.; Gale, Jonathan B.; Holman, Nicholas J.; Goldenberg, David M., Antibody-SN-38 immunoconjugates with a CL2A linker.
  202. Govindan, Serengulam V.; Gale, Jonathan B.; Holman, Nicholas J.; Goldenberg, David M., Antibody-SN-38 immunoconjugates with a CL2A linker.
  203. Govindan, Serengulam V.; Gale, Jonathan B.; Holman, Nicholas J.; Goldenberg, David M., Antibody-SN-38 immunoconjugates with a CL2A linker.
  204. Govindan, Serengulam V.; Gale, Jonathan B.; Holman, Nicholas J.; Goldenberg, David M., Antibody-SN-38 immunoconjugates with a CL2A linker.
  205. Govindan, Serengulam V.; Gale, Jonathan B.; Holman, Nicholas J.; Goldenberg, David M., Antibody-SN-38 immunoconjugates with a CL2A linker.
  206. Govindan, Serengulam V.; Gale, Jonathan B.; Holman, Nicholas J.; Goldenberg, David M., Antibody-SN-38 immunoconjugates with a CL2A linker.
  207. Goldenberg, David M.; Govindan, Serengulam V., Antibody-drug conjugates and uses thereof.
  208. Goldenberg, David M.; Govindan, Serengulam V., Antibody-drug conjugates and uses thereof.
  209. Ho, David T.; Olafsen, Tove; Agahi, Giti; Behrenbruch, Christian P., Antigen binding constructs to CD8.
  210. Guo, Amy Y., Antigen binding proteins.
  211. Hackett, John R.; Yamaguchi, Julie; Golden, Alan M.; Brennan, Catherine A.; Hickman, Robert K.; Devare, Sushil G., Antigen constructs useful in the detection and differentiation of antibodies to HIV.
  212. Hackett, Jr., John R.; Yamaguchi, Julie; Golden, Alan M.; Brennan, Catherine A.; Hickman, Robert K.; Devare, Sushil G., Antigen constructs useful in the detection and differentiation of antibodies to HIV.
  213. Hackett, Jr., John R.; Yamaguchi, Julie; Golden, Alan M.; Brennan, Catherine A.; Hickman, Robert K.; Devare, Sushil G., Antigen constructs useful in the detection and differentiation of antibodies to HIV.
  214. Hackett, Jr., John R.; Yamaguchi, Julie; Golden, Alan M.; Brennan, Catherine A.; Hickman, Robert K.; Devare, Sushil G., Antigen constructs useful in the detection and differentiation of antibodies to HIV.
  215. Hackett, Jr., John R.; Yamaguchi, Julie; Golden, Alan M.; Brennan, Catherine A.; Hickman, Robert K.; Devare, Sushil G., Antigen constructs useful in the detection and differentiation of antibodies to HIV.
  216. Hackett, Jr., John R.; Yamaguchi, Julie; Golden, Alan M.; Brennan, Catherine A.; Hickman, Robert K.; Devare, Sushil G., Antigen constructs useful in the detection and differentiation of antibodies to HIV.
  217. Whitlow Marc ; Filpula David ; Shorr Robert, Antigen-binding fusion proteins.
  218. Ring David B., Antigen-binding sites of antibody molecules specific for cancer antigens.
  219. Ring David B., Antigen-binding sites of antibody molecules specific for cancer antigens.
  220. Fields,Howard A.; Khudyakov,Yury E., Antigenic epitopes and mosaic polypeptides of hepatitis C virus proteins.
  221. Pinkosky, Stephen L.; Filippov, Sergey V.; Hurley, Timothy R.; Srivastava, Rai Ajit K.; Newton, Roger S., Apolipoprotein mixtures.
  222. Ebner, Reinhard; Yu, Guo-Liang; Ruben, Steven M.; Ullrich, Stephen; Zhai, Yifan, Apoptosis inducing molecule II and methods of use.
  223. Penninger, Josef M.; Kroemer, Guido P.; Siderovski, David Peter; Zamzami, Naoufal; Susin, Santos A.; Snow, Bryan E. L., Apoptosis-inducing factor.
  224. Penninger,Josef M.; Kroemer,Guido P.; Siderovski,David Peter; Zamzami,Naoufal; Susin,Santos A.; Snow,Bryan E. L., Apoptosis-inducing factor.
  225. Glick, Gary D.; Toogood, Peter; Ney, Gina, Aryl guanidine F1F0-ATPase inhibitors and related methods.
  226. Foresman Mark D. ; Ghai Jyotsna ; Newman Karel Z., Assay methods and reagents for detecting autoantibodies.
  227. Carney, Walter P.; Hamer, Peter J., Assays for cancer patient monitoring based on levels of analyte components of the plasminogen activator system in body fluid samples.
  228. Carney,Walter P.; Hamer,Peter J.; Lipton,Allan; Leitzel,Kim; Ali,Suhail M., Assays for cancer patient monitoring based on levels of epidermal growth factor receptor (EGFR) extracellular domain (ECD) analyte, alone or in combination with other analytes, in body fluid samples.
  229. Goldstein, Lawrence S. B.; Kamal, Adeela; Stokin, Gorazd, Assays for inhibitors of neuronal transport of Alzheimer's amyloid precursor protein.
  230. John Ford ; Ann Pace, Assays involving an IL-1 receptor antagonist.
  231. Nagaraja, Kakambi; Bennett, Richard; Halvorson, David; Njenga, Moses Kariuki, Avian pneumovirus vaccine.
  232. Barghorn, Stefan; Hillen, Heinz; Striebinger, Andreas R.; Labkovsky, Boris; Ebert, Ulrich; Keller, Patrick, Aβ conformer selective anti-Aβ globulomer monoclonal antibodies.
  233. Barghorn, Stefan; Hillen, Heinz; Striebinger, Andreas R.; Labkovsky, Boris; Ebert, Ulrich; Keller, Patrick, Aβ conformer selective anti-Aβ globulomer monoclonal antibodies.
  234. Barghorn, Stefan; Hillen, Heinz; Striebinger, Andreas R.; Labkovsky, Boris; Ebert, Ulrich; Keller, Patrick, Aβ conformer selective anti-Aβ globulomer monoclonal antibodies.
  235. Barghorn, Stefan; Hillen, Heinz; Striebinger, Andreas R.; Labkovsky, Boris; Ebert, Ulrich; Keller, Patrick, Aβ conformer selective anti-aβ globulomer monoclonal antibodies.
  236. Grosmaire, Laura Sue; Hayden-Ledbetter, Martha Susan; Ledbetter, Jeffrey A.; Thompson, Peter Armstrong; Simon, Sandy Alexander; Brady, William, B-cell reduction using CD37-specific and CD20-specific binding molecules.
  237. Chen, Lieping; Strome, Scott E.; Kwon, Eugene D., B7-H1 and methods of diagnosis, prognosis, and treatment of cancer.
  238. Chen, Lieping, B7-H1 antibodies and method of use.
  239. Langermann, Solomon; Liu, Linda; Podojil, Joseph R.; Miller, Stephen D.; Marshall, Shannon, B7-H4 fusion proteins and methods of use thereof.
  240. Langermann, Solomon; Liu, Linda; Podojil, Joseph R.; Miller, Stephen D.; Marshall, Shannon, B7-H4 fusion proteins and methods of use thereof.
  241. Albitar, Maher, BCR-ABL variants.
  242. Ma, Wanlong, BCR-ABL1 splice variants and uses thereof.
  243. Ma, Wanlong, BCR-ABL1 splice variants and uses thereof.
  244. Ma, Wanlong, BCR-ABL1 splice variants and uses thereof.
  245. Korsmeyer, Stanley J.; Letai, Anthony, BH3 peptides and method of use thereof.
  246. Korsmeyer, Stanley J.; Letai, Anthony, BH3 peptides and method of use thereof.
  247. Korsmeyer, Stanley J.; Letai, Anthony, BH3 peptides and methods of use thereof.
  248. Glick, Gary D., Benzodiazepine compositions for treating epidermal hyperplasia and related disorders.
  249. Glick, Gary D., Benzodiazepine compositions for treating epidermal hyperplasia and related disorders.
  250. Glick, Gary D.; Hurd, Alexander Ross; Van Huis, Chad Alan, Benzodiazepinone compounds and methods of treatment using same.
  251. Glick, Gary D., Benzodiazepinone compounds useful in the treatment of skin conditions.
  252. Glick, Gary D., Benzodiazepinone compounds useful in the treatment of skin conditions.
  253. Glick, Gary D., Benzodiazepinone compounds useful in the treatment of skin conditions.
  254. Kupcho, Kevin R.; Vogel, Kurt; Werner, Elizabeth A.; Beebe, Jane A.; Klink, Tony A.; Lasky, David A.; Kleman Leyer, Karen M.; Somberg, Richard, Bimolecular optical probes.
  255. Ledbetter, Jeffrey A.; Hayden-Ledbetter, Martha, Binding constructs and methods for use thereof.
  256. Ledbetter, Jeffrey A.; Hayden-Ledbetter, Martha Susan, Binding constructs and methods for use thereof.
  257. Ledbetter, Jeffrey A.; Hayden-Ledbetter, Martha, Binding domain-immunoglobulin fusion proteins.
  258. Ledbetter, Jeffrey A.; Hayden-Ledbetter, Martha S., Binding domain-immunoglobulin fusion proteins.
  259. Ledbetter, Jeffrey A.; Hayden-Ledbetter, Martha S., Binding domain-immunoglobulin fusion proteins.
  260. Ledbetter, Jeffrey A.; Hayden-Ledbetter, Martha Susan, Binding domain-immunoglobulin fusion proteins.
  261. Ledbetter, Jeffrey A.; Hayden-Ledbetter, Martha Susan, Binding domain-immunoglobulin fusion proteins.
  262. Ledbetter, Jeffrey A.; Hayden-Ledbetter, Martha Susan, Binding domain-immunoglobulin fusion proteins.
  263. Muller, Bernhard K.; Schaffar, Gregor; Mueller, Reinhold, Binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and their use.
  264. Lieschke Graham J. ; Mulligan Richard C., Bioactive fusion proteins comprising the p35 and p40 subunits of IL-12.
  265. Mascia,Peter N., Biological containment system.
  266. Yang, Haining; Carbone, Michele; Pass, Harvey I., Biomarker of asbestos exposure and mesothelioma.
  267. Rathmann, Wolfgang; Herder, Christian; Illig, Thomas; Adamski, Jerzy; Wang-Sattler, Rui; Yu, Zhongao; Wichmann, H.-Erich; Haring, Hans-Ulrich; Roden, Michael; Peters, Annette; Meisinger, Christine; Hrabe De Angelis, Martin; Meitinger, Thomas, Biomarkers for type 2 diabetes.
  268. Houston,Lou L.; Ring,David B., Biosynthetic binding proteins for immuno-targeting.
  269. Huston James S. ; Houston L. L. ; Ring David B. ; Oppermann Hermann, Biosynthetic binding proteins for immuno-targeting.
  270. May, Chad Michael; Root, Adam Reid; Brady, William A.; Tchistiakova, Lioudmila Gennadievna; Mosyak, Lidia; Bloom, Laird; Moore, Paul A.; Johnson, Leslie S., Bispecific heterodimeric diabodies and uses thereof.
  271. Malter,James S.; Esnault,Stephane; Shen,Zhong Jian, Blockade of Pin1 prevents cytokine production by activated immune cells.
  272. Lundberg, Urban; Meinke, Andreas; Nagy, Eszter; Von Gabain, Alexander; Noiges, Birgit; Gelbmann, Dieter; Poljak, Albina; Triska, Christine, Borrelia antigens.
  273. Lundberg, Urban; Meinke, Andreas; Nagy, Eszter; von Gabain, Alexander; Noiges, Birgit; Gelbmann, Dieter; Poljak, Albina; Triska, Christine, Borrelia antigens.
  274. Cojocaru, Gady S.; Rotman, Galit; Levine, Zurit; Dassa, Liat; Levi, Ofer; Briante, Raffaella; Singh, Shweta; Watson, Susan R.; Pergam, Tania, C10RF32 antibodies, and uses thereof for treatment of cancer.
  275. Johnson, Leslie S.; Huang, Ling; Li, Hua; Tuaillon, Nadine, CD16A binding proteins and use for the treatment of immune disorders.
  276. Johnson, Leslie S.; Huang, Ling; Li, Hua; Tuaillon, Nadine, CD16A binding proteins and use for the treatment of immune disorders.
  277. Johnson,Leslie S.; Huang,Ling; Li,Hua; Tuaillon,Nadine, CD16A binding proteins and use for the treatment of immune disorders.
  278. Tan, Philip; Simon, Sandy A; Cerveny, Charles G; Nilsson, Christy Anne; Brady, William; Ledbetter, Jeffrey A; Hayden-Ledbetter, Martha S; Thompson, Peter A; Morales, Cecile, CD37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof.
  279. Tan, Philip; Simon, Sandy Alexander; Brady, William; Morales, Cecile, CD37 immunotherapeutics and uses thereof.
  280. Thomas, David; De Boer, Mark; Res, Pieter C. J. M.; Simone, Peter J., CD40-binding activating antibodies.
  281. Naor, David; Nedvetzki, Shlomo; Golan, Itshak; Kessel, Irina; Melnik, Lora, CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases.
  282. Naor, David; Nedvetzki, Shlomo; Golan, Itshak; Kessel, Irina; Melnik, Lora, CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases.
  283. Eckelman, Brendan; Timmer, John; Razai, Amir; Deveraux, Quinn; Jones, Kyle; Nguy, Peter L., CD47 antibodies and methods of use thereof.
  284. Eckelman, Brendan; Timmer, John; Razai, Amir; Deveraux, Quinn; Jones, Kyle; Nguy, Peter L., CD47 antibodies and methods of use thereof.
  285. Bicknell, Roy; Zhuang, Xiaodong; Mura, Manuela, CLEC14A inhibitors.
  286. Michael Isaac Lerman ; Farida Latif GB; Ming-Hui Wei ; Fuh-Mei Duh ; John Dorrance Minna ; Yoshitaka Sekido JP; Boning Gao, Calcium channel compositions and methods of use thereof.
  287. Lerman, Michael Isaac; Latif, Farida; Wei, Ming-Hui; Duh, Fuh-Mei; Minna, John Dorrance; Sekido, Yoshitaka; Gao, Boning, Calcium channel proteins.
  288. Govindan, Serengulam V.; Goldenberg, David M., Camptothecin conjugates of anti-CD22 antibodies for treatment of B cell diseases.
  289. White, Thomas F.; Hoth, Dan, Cancer therapy.
  290. White, Thomas F.; Smith, Steven, Cancer therapy.
  291. Sahin, Ugur; Tureci, Ozlem; Koslowski, Michael; Walter, Korden; Kreuzberg, Maria; Luxen, Sylvia, Cancer therapy using CLDN6 target-directed antibodies in vivo.
  292. Sahin, Ugur; Tureci, Ozlem; Koslowski, Michael; Walter, Korden; Kreuzberg, Maria; Luxen, Sylvia, Cancer therapy using CLDN6 target-directed antibodies in vivo.
  293. Gill, Parkash; Krasnoperov, Valery; Keen, Simon William; Jones, Timothy David; Carr, Francis Joseph, Cancer treatment using humanized antibodies that bind to EphB4.
  294. Schneider, Robert J.; Jamal, Sumayah, Cancer treatment with endothelin receptor antagonists.
  295. Schneider, Robert J.; Jamal, Sumayah, Cancer treatment with endothelin receptor antagonists.
  296. Schneider, Robert; Jamal, Sumayah, Cancer treatment with endothelin receptor antagonists.
  297. Schneider, Robert; Jamal, Sumayah, Cancer treatment with endothelin receptor antagonists.
  298. Gillies,Stephen D.; Stein,Pascal A.; Lo,Kin Ming, Cancer treatments including administering IL-2 fusion proteins with modulated selectivity.
  299. Bergeron, Lisa Marie; Bainbridge, Graeme; Dunham, Steven A.; Dai, Minghua, Caninized anti-NGF antibodies and methods thereof.
  300. Bergeron, Lisa Marie; Bainbridge, Graeme; Dunham, Steven; Dai, Minghua, Caninized anti-NGF antibodies and methods thereof.
  301. Lacy, Susan E.; Barbon, Jeffrey A.; Chhaya, Meha; Fung, Emma; Hutchins, Charles W.; Lang, Diane M.; Barlow, Eve H.; Leddy, Mary; Chari, Ravi, Caninized anti-NGF antibodies and their use.
  302. Marasco, Wayne A.; Lo, Agnes; Xu, Chen, Carbonic anhydrase IX (G250) anitbodies.
  303. Carr,Francis J.; Hamilton,Anita A., Carrier molecules.
  304. Carr,Francis J.; Hamilton,Anita A., Carrier molecules.
  305. McCauley, Scott; Smith, Victoria, Catalytic domains from lysyl oxidase and LOXL2.
  306. McCauley, Scott; Smith, Victoria, Catalytic domains from lysyl oxidase and LOXL2.
  307. Koelsch, Gerald; Tang, Jordan J. N.; Hong, Lin; Ghosh, Arun K.; Lin, Xinli, Catalytically active recombinant memapsin and methods of use thereof.
  308. White, Thomas F.; Schnipper, Edward F.; Hoth, Dan, Catecholic butanes and use thereof for cancer therapy.
  309. Ozaki, Shuji; Abe, Masahiro; Tsuchiya, Masayuki; Kimura, Naoki; Kawai, Shigeto, Cell death-inducing agent.
  310. Collins, Daniel P.; Hapke, Joel H.; Buchert, Carol A., Cell separation compositions and methods.
  311. Collins,Daniel P.; Shaut,David M.; Hapke,Joel H., Cell separation compositions and methods.
  312. Collins,Daniel P.; Shaut,David M.; Hapke,Joel H., Cell separation compositions and methods.
  313. Rabinovich, Peter M.; Weissman, Sherman M.; Komarovskaya, Marina E.; Bahceci, Erkut; Katz, Samuel; Golub, Efim, Cells prepared by transient transfection and methods of use thereof.
  314. Smith, Victoria; Holzer, Alison Kay, Chemotherapeutic methods and compositions.
  315. Smith, Victoria; Holzer, Alison Kay, Chemotherapeutic methods and compositions.
  316. Marasco, Wayne A.; Lo, Agnes; Xu, Chen, Chimeric T cell receptor comprising carbonic anhydrase IX (G250) antibody.
  317. Ramakrishnan,Vanitha; Powers,David; Johnson,Dale E.; Jeffry,Ursula; Bhaskar,Vinay, Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis.
  318. Ramakrishnan, Vanitha; Powers, David; Johnson, Dale E.; Jeffry, Ursula, Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis.
  319. Ramakrishnan, Vanitha; Powers, David; Johnson, Dale E.; Jeffry, Ursula; Bhaskar, Vinay, Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis.
  320. Ramakrishnan, Vanitha; Powers, David; Johnson, Dale E.; Jeffry, Ursula; Bhaskar, Vinay, Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis.
  321. Ramakrishnan, Vanitha; Powers, David; Johnson, Dale E.; Jeffry, Ursula; Bhaskar, Vinay, Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis.
  322. Ramakrishnan, Vanitha; Powers, David; Johnson, Dale E.; Jeffry, Ursula; Bhaskar, Vinay, Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis.
  323. Achen, Marc Gregory; Stacker, Steven Alan; Renner, Christoph, Chimeric anti-VEGF-D antibodies and humanized anti-VEGF-D antibodies and methods of using same.
  324. Schreiber, Hans; Idel, Christian; Engels, Boris, Chimeric antigen receptors recognizing cancer-specific TN glycopeptide variants.
  325. Chiu, Daniel T.; Wu, Changfeng; Zhang, Xuanjun; Yu, Jiangbo; Ye, Fangmao, Chromophoric polymer dots.
  326. Chiu, Daniel T.; Wu, Changfeng; Zhang, Xuanjun; Yu, Jiangbo; Ye, Fangmao, Chromophoric polymer dots.
  327. Chiu, Daniel T.; Wu, Changfeng; Rong, Yu; Zhang, Yong; Wu, Yi-Che; Chan, Yang-Hsiang; Zhang, Xuanjun; Yu, Jiangbo; Sun, Wei, Chromophoric polymer dots with narrow-band emission.
  328. Chen Hong ; Freimer Nelson B., Chromosome 18 marker.
  329. Chen Hong ; Freimer Nelson B., Chromosome 18 marker.
  330. Chen Hong ; Freimer Nelson B., Chromosome 18 marker.
  331. Mooney, David J.; Yuen, William W.; Arany, Praveen, Co-delivery of stimulatory and inhibitory factors to create temporally stable and spatially restricted zones.
  332. Norman, Timothy John; De Candole, Benjamin Charles; Ali, Mezher Hussein, Comb polymers.
  333. Zhang, Bo; McDonagh, Charlotte; Huhalov, Alexandra, Combination therapies comprising anti-ERBB3 agents.
  334. Chang, Chien-Hsing; Goldenberg, David M.; Rossi, Edmund A., Combination therapy with anti-CD74 and anti-CD20 antibodies provides enhanced toxicity to B-cell diseases.
  335. Chang, Chien-Hsing; Goldenberg, David M.; Rossi, Edmund A., Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, Autoimmune disease and other diseases.
  336. Chang, Chien-Hsing; Goldenberg, David M.; Rossi, Edmund A., Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, autoimmune disease and other diseases.
  337. Goldenberg, David M.; Cardillo, Thomas M., Combination therapy with anti-HLA-DR antibodies and kinase inhibitors in hematopoietic cancers.
  338. Goldenberg, David M.; Cardillo, Thomas M., Combining anti-HLA-DR or anti-Trop-2 antibodies with microtubule inhibitors, PARP inhibitors, bruton kinase inhibitors or phosphoinositide 3-kinase inhibitors significantly improves therapeutic outcome in cancer.
  339. Fung, Michael S. C.; Sun, Cecily R. Y.; Sun, William N. C., Complement inhibitors and uses thereof.
  340. Fung, Michael S. C.; Sun, Cecily R. Y.; Sun, William N. C., Complement inhibitors and uses thereof.
  341. Allison, Daniel S.; Cummings, W. Jason; Leppard, John B.; Maizels, Nancy; Tjoelker, Larry W.; Wood, Christi L.; Yabuki, Munehisa, Composition and method for diversification of target sequences.
  342. Mueller, Bernhard; Huang, Lili; Bardwell, Philip D.; Kutskova, Yuliya; Memmott, John, Composition and method for the diagnosis and treatment of diseases associated with neurite degeneration.
  343. Beligere, Gangamani S.; Manoj, Shamila; Brate, Elaine M.; Grenier, Frank C.; Hawksworth, David J.; Ziemann, Robert N.; Birkenmeyer, Larry G.; Mueller, Bernhard; Popp, Andreas; Brophy, Susan, Composition and method for the diagnosis and treatment of iron-related disorders.
  344. Mueller, Bernhard; Popp, Andreas; Perez, Jennifer M., Composition and method for the diagnosis and treatment of iron-related disorders.
  345. Mi, Sha; Pepinsky, R. Blake; Graff, Christilyn, Composition comprising antibodies to LINGO or fragments thereof.
  346. Mi, Sha; Pepinsky, R. Blake; Graff, Christilyn, Composition comprising antibodies to LINGO or fragments thereof.
  347. Manucharyan, Karen; Gevorgyan, Gohar, Compositions and methods for alzheimer's disease.
  348. Pardridge, William M.; Boado, Ruben J., Compositions and methods for blood-brain barrier delivery of IgG-decoy receptor fusion proteins.
  349. Scholl, David R.; Jollick, Joseph D.; Gillim-Ross, Laura; Taylor, Jill; Wentworth, David E., Compositions and methods for detecting a non plus-stranded RNA virus.
  350. Chiu, Charles; Lee, Deanna; Berg, Michael; Dawson, George; Coller, Kelly; Cheng, Kevin; Hackett, John; Frankel, Matthew; Forberg, Kenn, Compositions and methods for detecting human Pegivirus 2 (HPgV-2).
  351. Chiu, Charles; Lee, Deanna; Berg, Michael; Dawson, George; Coller, Kelly; Cheng, Kevin; Hackett, Jr., John R.; Frankel, Matthew; Forberg, Kenn, Compositions and methods for detecting human pegivirus 2 (HPgV-2).
  352. Shoemaker, Daniel D.; Scherer, Stewart; Friend, Stephen H., Compositions and methods for exon profiling.
  353. Schurpf, Thomas; Mahanthappa, Nagesh K.; Straub, Michelle Marie, Compositions and methods for growth factor modulation.
  354. Schurpf, Thomas; Mahanthappa, Nagesh K.; Straub, Michelle Marie, Compositions and methods for growth factor modulation.
  355. Schurpf, Thomas; Mahanthappa, Nagesh K.; Straub, Michelle Marie, Compositions and methods for growth factor modulation.
  356. Chang, Paul; Vyas, Sejal, Compositions and methods for identification of PARP function, inhibitors, and activators.
  357. Glick, Gary D.; Opipari, Anthony W., Compositions and methods for inhibiting the proliferation of cells.
  358. Glick, Gary D.; Opipari, Anthony W., Compositions and methods for inhibiting the proliferation of cells.
  359. Singh, Suman Kumar; Tobin, Desmond John, Compositions and methods for modulating skin pigmentation.
  360. Sabbadini, Roger A.; Cavalli, Amy L.; Garland, William A., Compositions and methods for the treatment and prevention of hyperproliferative diseases.
  361. Chang, Paul; Vyas, Sejal K.; Leung, Anthony; Sharp, Phillip A., Compositions and methods for treating cancer and modulating stress granule formation.
  362. Clinton, Gail M., Compositions and methods for treating cancer by modulating HER-2 and EGF receptors.
  363. Clinton,Gail M., Compositions and methods for treating cancer by modulating HER-2 and EGF receptors.
  364. Pelletier,Jerry; Gros,Philippe; DuBow,Mike, Compositions and methods involving an essentialgene and its encoded protein.
  365. Salceda, Susana; Hu, Ping; Recipon, Herve; Cafferkey, Robert, Compositions and methods of diagnosing, monitoring, staging, imaging and treating mammary gland cancer.
  366. Shen, Enyun; Ren, Shiqi, Compositions and methods related to the prevention and treatment of rabies infection.
  367. Glick,Gary D., Compositions and methods relating to F1F0-ATPase inhibitors and targets thereof.
  368. Glick, Gary D., Compositions and methods relating to novel benzodiazepine compounds and derivatives.
  369. Glick, Gary D., Compositions and methods relating to novel compounds and targets thereof.
  370. Glick, Gary D., Compositions and methods relating to novel compounds and targets thereof.
  371. Glick, Gary D., Compositions and methods relating to novel compounds and targets thereof.
  372. Glick, Gary D.; Opipari, Anthony W., Compositions and methods relating to novel compounds and targets thereof.
  373. Gazit, Ehud; Porat, Yair, Compositions and methods using same for treating amyloid-associated diseases.
  374. Ben-Moshe, Tehila; Sapir, Yair; Mandel, Ilana; Meilin, Edna, Compositions comprising anti-CEACAM1 and anti-PD antibodies for cancer therapy.
  375. Mi, Sha; Pepinsky, R. Blake; Graff, Christilyn, Compositions comprising antibodies to LINGO or fragments thereof.
  376. Yaspan, Brian; Graham, Robert Royal; Dressen, Amy; Li, Zhengrong; Strauss, Erich; Bugawan, Teodorica, Compositions for detecting complement factor H (CFH) and complement factor I (CFI) polymorphisms.
  377. Maes,Roger K.; Wise,Annabel G.; Kiupel,Matti, Compositions for the diagnosis and treatment of epizootic catarrhal enteritis in ferrets.
  378. Gazit, Ehud; Cohen, Tomer, Compositions for treating amyloid associated diseases.
  379. Langermann, Solomon; Liu, Linda, Compositions of PD-1 antagonists and methods of use.
  380. Glick,Gary D., Compositions relating to novel compounds and targets thereof.
  381. Mintz, Liat, Compositions, reagents and kits for and methods of diagnosing, monitoring and treating hormonal imbalance.
  382. Reed, Steven G.; Skeiky, Yasir A. W.; Dillon, Davin C.; Campos-Neto, Antonio; Houghton, Raymond; Vedvick, Thomas S.; Twardzik, Daniel R., Compounds and methods for immunotherapy and diagnosis of tuberculosis.
  383. Ben-Ari, Yehezkel; Ferrari, Diana Carolina; Nardou, Romain; LeMonnier, Eric, Compounds for the treatment of autism in a baby child.
  384. Friend,Stephen H.; Stoughton,Roland, Computer systems and computer programs for determining protein activity levels using gene expression profiles.
  385. Chung, Yong-Hoon; Han, Ji-Woong; Lee, Hye-Ja; Choi, Eun-Yong; Kim, Jin-Mi, Concatameric immunoadhesion molecule.
  386. Adler, Michael; Detmers, Jan, Conjugate complexes for analyte detection.
  387. Mooney, David J.; Ali, Omar Abdel-Rahman; Dranoff, Glenn, Continuous cell programming devices.
  388. Ali, Omar Abdel-Rahman; Dranoff, Glenn; Mooney, David J., Controlled delivery of TLR agonists in structural polymeric devices.
  389. Ali, Omar Abdel-Rahman; Dranoff, Glenn; Mooney, David J., Controlled delivery of TLR3 agonists in structural polymeric devices.
  390. Puttaraju, Madaiah; Otto, Edward; Garcia-Blanco, Mariano A.; McGarrity, Gerard J.; Temple, Gary F.; Mitchell, Lloyd G.; Cote, Colette; Mansfield, S. Gary, Correction of alpha-1-antitrypsin genetic defects using spliceosome mediated RNA trans splicing.
  391. Chen, Lieping; Strome, Scott E.; Kwon, Eugene D., Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target.
  392. Chang, Chien-Hsing; Goldenberg, David M., Crosslinking of CD22 by epratuzumab triggers BCR signaling and caspase-dependent apoptosis in hematopoietic cancer cells.
  393. Pandit Jayvardhan ; Jancarik Jarmila ; Kim Sung-Hou ; Koths Kirston ; Halenbeck Robert ; Fear Anna Lisa ; Taylor Eric ; Yamamoto Ralph ; Bohm Andrew, Crystallization of M-CSF.alpha..
  394. Peled, Tony; Steinhardt, Yair, Culturing of mesenchymal stem cells with FGF4 and nicotinamide.
  395. McDonald,John R.; Coggins,Philip J., Cytotoxic conjugates comprising a chemokine receptor targeting agent.
  396. Gurney, Austin L.; Van Der Horst, Edward Thein Htun; Satyal, Sanjeev H., DDR1-binding agents and methods of use thereof.
  397. Gurney, Austin L.; Van Der Horst, Edward Thein Htun; Satyal, Sanjeev H., DDR1-binding agents and methods of use thereof.
  398. Gillies, Stephen D.; Stein, Pascal Andre; Lo, Kin-Ming, DNA encoding IL-2 fusion proteins with modulated selectivity.
  399. Adams, Ralph; Baker, Terence Seward; Lawson, Alastair David Griffiths, DNA encoding antibody molecules which bind IL-17A and IL-17F.
  400. Huston James S. ; Houston L. L. ; Ring David B. ; Oppermann Hermann, DNA encoding biosynthetic binding protein for cancer marker.
  401. Li Ning,CNX ; Wu Changxin,CNX ; Zhao Yaofeng,CNX, DNA markers for pig litter size.
  402. Ni, Jian; Rosen, Craig A.; Pan, James G.; Gentz, Reiner L.; Dixit, Vishva M., Death domain containing receptor 4.
  403. Ni, Jian; Rosen, Craig A.; Pan, James G.; Gentz, Reiner L.; Dixit, Vishva M., Death domain containing receptor 4 antibodies and methods.
  404. Ni,Jian; Rosen,Craig A.; Pan,James G.; Gentz,Reiner L.; Dixit,Vishva M., Death domain containing receptor 4 antibodies and methods.
  405. Ni,Jian; Rosen,Craig A.; Pan,James; Gentz,Reiner L.; Dixit,Vishva M., Death domain containing receptor 4 antibody and methods.
  406. Ni, Jian; Gentz, Reiner L.; Yu, Guo-Liang; Rosen, Craig A., Death domain containing receptor 5.
  407. Ni, Jian; Gentz, Reiner L.; Yu, Guo-Liang; Rosen, Craig A., Death domain containing receptor 5 antibodies.
  408. Jian Ni ; Craig A. Rosen ; James G. Pan ; Reiner L. Gentz ; Vishva M. Dixit, Death domain containing receptor-4.
  409. Tsuchiya, Masayuki; Ohtomo, Toshihiko; Yabuta, Naohiro; Tsunoda, Hiroyuki; Orita, Tetsuro, Degraded TPO agonist antibody.
  410. Tsuchiya, Masayuki; Ohtomo, Toshihiko; Yabuta, Naohiro; Tsunoda, Hiroyuki; Orita, Tetsuro, Degraded TPO agonist antibody.
  411. Baker, Jr., James R.; Huang, Baohua, Dendrimer compositions and methods of synthesis.
  412. Baker, Jr., James R.; Cheng, Xue-min; Thomas, Thommey P.; Huang, Baohua Mark, Dendrimer conjugates.
  413. Baker, Jr., James R.; Cheng, Xue-min; Thomas, Thommey P.; Huang, Baohua Mark, Dendrimer conjugates.
  414. Baker, Jr., James R.; Cheng, Xue-min; Van Der Spek, Abraham F. L.; Huang, Baohua Mark; Thomas, Thommey P., Dendrimer conjugates.
  415. Baker, Jr., James R.; Cheng, Xue-min; Van Der Spek, Abraham F. L.; Huang, Baohua Mark; Thomas, Thommey P., Dendrimer conjugates.
  416. Pardoll, Drew M.; Tsuchiya, Haruo; Gorski, Kevin S.; Tseng, Su-Yi, Dendritic cell co-stimulatory molecules.
  417. Villanueva,Julie M.; Quirk,Stephen, Detecting lipocalin.
  418. Chen, Lieping, Detection and diagnosis of inflammatory disorders.
  419. Chen, Lieping, Detection and diagnosis of inflammatory disorders.
  420. Gudas, Lorraine J., Detection and modulation of cancer stem cells.
  421. Banerjee, Subhasis, Diagnostic and therapeutic applications of soluble LHCGR protein.
  422. Muller Uwe Richard, Diagnostic methods and probes.
  423. Mezes Peter S. ; Richard Ruth A. ; Affholter Joseph A. ; Kotite Nicolas J., Dimer and multimer forms of single chain polypeptides.
  424. Mezes Peter S. ; Richard Ruth A. ; Affholter Joseph A. ; Kotite Nicolas J., Dimer and multimer forms of single chain polypeptides.
  425. Chang, Chien-Hsing; Goldenberg, David M., Dock-and-lock (DNL) complexes for therapeutic and diagnostic use.
  426. Chang, Chien-Hsing; Goldenberg, David M., Dock-and-lock (DNL) complexes for therapeutic and diagnostic use.
  427. Govindan, Serengulam V.; Goldenberg, David M., Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity.
  428. Govindan, Serengulam V.; Goldenberg, David M., Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity.
  429. Govindan, Serengulam V.; Goldenberg, David M., Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity.
  430. Govindan, Serengulam V.; Goldenberg, David M., Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity.
  431. Govindan, Serengulam V.; Goldenberg, David M., Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity.
  432. Govindan, Serengulam V.; Goldenberg, David M., Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity.
  433. Govindan, Serengulam V.; Goldenberg, David M., Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity.
  434. Govindan, Serengulam V.; Goldenberg, David M., Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity.
  435. Govindan, Serengulam V.; Goldenberg, David M., Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity.
  436. Govindan, Serengulam V.; Goldenberg, David M., Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity.
  437. Govindan, Serengulam V.; Goldenberg, David M., Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity.
  438. Ostroff, Gary R., Drug delivery product and methods.
  439. Ostroff, Gary R., Drug delivery product and methods.
  440. Ostroff, Gary R., Drug delivery product and methods.
  441. Ghayur, Tariq; Gu, JiJie; Harris, Maria; Goodreau, Carrie; Saluja, Sonal, Dual specific binding proteins directed against IL-1 and/or IL-17.
  442. Hsieh, Chung-Ming; Ghayur, Tariq; Goodreau, Carrie L., Dual specific binding proteins directed against IL-13 and IL-17.
  443. Ghayur, Tariq; Gu, JiJie; Harris, Maria; Goodreau, Carrie; Saluja, Sonal, Dual specific binding proteins directed against IL-1β and/or IL-17.
  444. Wu, Chengbin; Ghayur, Tariq; Dixon, Richard W.; Salfeld, Jochen G., Dual variable domain immunoglobulin and uses thereof.
  445. Wu, Chengbin; Ghayur, Tariq; Dixon, Richard W.; Salfeld, Jochen G., Dual variable domain immunoglobulin and uses thereof.
  446. Ghayur, Tariq; Hahn, Alfred; Mueller, Bernhard, Dual variable domain immunoglobulins and uses thereof.
  447. Ghayur, Tariq; Isakson, Peter C.; Olson, Lisa M.; Wu, Chengbin; Hugunin, Margaret; Kamath, Rajesh V.; Cuff, Carolyn A.; Allen, Hamish J., Dual variable domain immunoglobulins and uses thereof.
  448. Ghayur, Tariq; Kamath, Rajesh V.; Liu, Junian; Honore, Marie P., Dual variable domain immunoglobulins and uses thereof.
  449. Ghayur, Tariq; Liu, Junjian; Isakson, Peter C., Dual variable domain immunoglobulins and uses thereof.
  450. Ghayur, Tariq; Liu, Junjian; Isakson, Peter C., Dual variable domain immunoglobulins and uses thereof.
  451. Ghayur, Tariq; Liu, Junjian; Manoj, Sharmila; Brophy, Susan E., Dual variable domain immunoglobulins and uses thereof.
  452. Ghayur, Tariq; Morgan-Lappe, Susan E.; Reilly, Edward B.; Kingsbury, Gillian A.; Phillips, Andrew; Wang, Jieyi; Bell, Randy L.; Norvell, Suzanne M.; Li, Yingchun; Liu, Junjian; Ying, Hua, Dual variable domain immunoglobulins and uses thereof.
  453. Ghayur, Tariq; Salfeld, Jochen G.; McPherson, Michael J., Dual variable domain immunoglobulins and uses thereof.
  454. Ghayur, Tariq; Salfeld, Jochen G.; McPherson, Michael J.; Harris, Maria C.; Liu, Junjian; Isakson, Peter C.; Gu, Jijie, Dual variable domain immunoglobulins and uses thereof.
  455. Ferrara,Napoleone; Watanabe,Colin; Wood,William I.; Shek,Theresa, EG-VEGF nucleic acids and polypeptides and method of use.
  456. Ferrara, Napoleone; Watanabe, Colin; Wood, William I., EG-VEGF nucleic acids and polypeptides and methods of use.
  457. Ferrara, Napoleone; Watanabe, Colin; Wood, William I., EG-VEGF nucleic acids and polypeptides and methods of use.
  458. Ferrara,Napoleone; Watanabe,Colin; Wood,William I., EG-VEGF nucleic acids and polypeptides and methods of use.
  459. Blanc, Veronique; Fromond, Claudia; Parker, Fabienne; Han, Jiawen; Tavares, Daniel; Zhang, Chonghui; Li, Min; Zhou, Xiao-Mai; Streuli, Michel, EPHA2 receptor antagonist antibodies.
  460. Blanc, Veronique; Fromond, Claudia; Parker, Fabienne; Han, Jiawen; Tavares, Daniel; Zhang, Chonghui; Li, Min; Zhou, Xiao-Mai; Streuli, Michel, EPHA2 receptor antagonist antibodies.
  461. Govindan, Serengulam V.; Cardillo, Thomas M.; Goldenberg, David M., Efficacy of anti-HLA-DR antiboddy drug conjugate IMMU-140 (hL243-CL2A-SN-38) in HLA-DR positive cancers.
  462. Farooqui, Firdous; Reddy, Parameswara Meda, Efficient synthesis of protein-oligonucleotide conjugates.
  463. Pandey,Ravindra K.; Dougherty,Thomas J.; Pallenberg,Alexander J., Efficient synthesis of pyropheophorbide a and its derivatives.
  464. Czech, Michael P.; Ostroff, Gary R.; Aouadi, Myriam, Encapsulated nanoparticles for nucleic acid delivery.
  465. Wu, Anna M.; Olafsen, Tove; Raubitschek, Andrew A., Engineered anti-CD20 antibody fragments for in vivo targeting and therapeutics.
  466. Kaushik, Azad Kumar; Koti, Madhuri; Nagy, Eva, Engineered scFv against bovine herpes virus type I.
  467. Gillies, Stephen D.; Lan, Yan; Holden, Sylvia, Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents.
  468. Ravetch,Jeffrey V., Enhancement of antibody-mediated immune responses.
  469. Chen, Lieping; Strome, Scott E., Enhancement of immune responses by 4-1 BB-binding agents.
  470. Peled, Tony; Frei, Gabi M., Enhancement of natural killer (NK) cell proliferation and activity.
  471. Mooney, David J.; Borselli, Cristina; Vandenburgh, Herman; Shvartsman, Dimitry; Storrie, Hannah; Lichtman, Jeff, Enhancement of skeletal muscle stem cell engraftment by dual delivery of VEGF and IGF-1.
  472. Gillies, Stephen D.; Burger, Christa; Lo, Kin-Ming, Enhancing the circulating half-life of antibody-based fusion proteins.
  473. Gillies,Stephen D.; Burger,Christa; Lo,Kin Ming, Enhancing the circulating half-life of antibody-based fusion proteins.
  474. Gillies,Stephen D.; Burger,Christa; Lo,Kin Ming, Enhancing the circulating half-life of antibody-based fusion proteins.
  475. Meinke, Andreas; Nagy, Eszter; Hanner, Markus; Gelbmann, Dieter, Enterococcus antigens.
  476. Meinke, Andreas; Nagy, Eszter; Hanner, Markus; Gelbmann, Dieter, Enterococcus antigens.
  477. Yamada,Akiyo; Ozeki,Yoshihiro; Saito,Takeo, Environmental stress resistance gene.
  478. Bacha Patricia A., Epidermal growth factor receptor targeted molecules for treatment of inflammatory arthritis.
  479. Glanville, Jacob E., Epitope focusing by variable effective antigen surface concentration.
  480. Glanville, Jacob E., Epitope focusing by variable effective antigen surface concentration.
  481. Way,Jeffrey, Erythropoietin forms with improved properties.
  482. Fritz, Christian; Youngman, Philip; Guzman, Luz-Maria, Essential bacterial genes and their use.
  483. Fritz, Christian; Youngman, Philip; Guzman, Luz-Maria, Essential bacterial genes and their use.
  484. Wang, Zhao Yi, Estrogen receptors and methods of use.
  485. Renner Wolfgang A.,CHX ; Orberger Georg H.,CHX ; Koller Daniel,CHX ; Bailey James E.,CHX, Expression cloning processes for the discovery characterization, and isolation of genes encoding polypeptides with a predetermined property.
  486. Renner, Wolfgang A.; Orberger, Georg H.; Koller, Daniel; Bailey, James E., Expression cloning processes for the discovery, characterization and isolation of genes encoding polypeptides with a predetermined property.
  487. Andersson, Leif; Marklund, Stefan, Expression constructs expressing Prkag3.
  488. Carter,Paul J., Expression of functional antibody fragments.
  489. Gillies,Stephen D.; Lo,Kin Ming, Expression technology for proteins containing a hybrid isotype antibody moiety.
  490. Bleck,Gregory T., Expression vectors.
  491. Erlanson, Daniel A.; Braisted, Andrew C.; McDowell, Robert; Prescott, John, Extended tethering approach for rapid identification of ligands.
  492. Rahat, Michal A.; Lahat, Nitza; Walter, Miriam; Bitterman, Haim, Extracellular matrix metalloproteinase inducer (EMMPRIN) peptides and binding antibodies.
  493. Harper, Jeffrey Wade; Elledge, Stephen J., F-box genes and proteins.
  494. Kornecki, Elizabeth; Babinska, Anna; Ehrlich, Yigal H., F11 receptor (F11R) antagonists as therapeutic agents.
  495. Kornecki, Elizabeth; Babinska, Anna; Ehrlich, Yigal H.; Salifu, Moro, F11 receptor (F11R) antagonists as therapeutic agents.
  496. Glick, Gary D.; Ney, Gina, F1F0-ATPase inhibitors and related methods.
  497. Greene, Mark I.; Murali, Ramachandran; Hasegawa, Akihiro, Fas peptide mimetics and uses thereof.
  498. Gillies,Stephen D.; Lo,Kin Ming; Wesolowski, Jr.,John S., Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens.
  499. Gillies,Stephen D.; Lauder,Scott, Fc-erythropoietin fusion protein with improved pharmacokinetics.
  500. Sun, Haijun, Fibroblast growth factor receptor-3 (FGFR-3) inhibitors and methods of treatment.
  501. Sun, Haijun; Liu, Ling, Fibroblast growth factor receptor-3 (FGFR-3) inhibitors and methods of treatment.
  502. Sun, Haijun; Liu, Ling, Fibroblast growth factor receptor-3 (FGFR-3) inhibitors and methods of treatment.
  503. Scuderi, Gaetano J.; Hanna, Lewis S.; Bowser, Robert, Fibronectin aggrecan biomarker for the identification of spinal and joint source of pain.
  504. Pandey, Ravindra K.; Potter, William R.; Dougherty, Thomas J., Fluorinated photosensitizers related to chlorins and bacteriochlorins for photodynamic therapy.
  505. Hirsch, Raphael; Wilson, David C., Follistatin-like protein-1 as a biomarker for inflammatory disorders.
  506. Hirsch, Raphael, Follistatin-like protein-1 as a biomarker for sepsis.
  507. Vitalis, Timothy Z.; Gabathuler, Reinhard, Fragments of P97 and uses thereof.
  508. Vitalis, Timothy Z.; Gabathuler, Reinhard, Fragments of p97 and uses thereof.
  509. Chiu, Daniel T.; Wu, Changfeng; McNeill, Jason; Yu, Jiangbo, Functionalized chromophoric polymer dots and bioconjugates thereof.
  510. Naasani, Imad, Functionalized fluorescent nanocrystal compositions and methods for their preparation.
  511. Naasani, Imad, Functionalized fluorescent nanocrystal compositions and methods for their preparation.
  512. Naasani,Imad, Functionalized fluorescent nanocrystals, and methods for their preparation and use.
  513. Pardridge, William M.; Boado, Ruben J., Fusion antibodies that cross the blood-brain barrier in both directions.
  514. Umaña, Pablo; Bruenker, Peter; Ferrara, Claudia; Suter, Tobias, Fusion constructs and use of same to produce antibodies with increased Fc receptor binding affinity and effector function.
  515. Umaña, Pablo; Bruenker, Peter; Ferrara, Claudia; Suter, Tobias, Fusion constructs and use of same to produce antibodies with increased Fc receptor binding affinity and effector function.
  516. Fandl, James P.; Chen, Gang; Papadopoulos, Nicholas J.; Aldrich, Thomas H., Fusion polypeptides capable of activating receptors.
  517. Fandl, James P.; Chen, Gang; Papadopoulos, Nicholas J.; Aldrich, Thomas H., Fusion polypeptides capable of activating receptors.
  518. Fandl, James P.; Chen, Gang; Papadopoulos, Nicholas J.; Aldrich, Thomas H., Fusion polypeptides capable of activating receptors.
  519. Fandl, James P.; Chen, Gang; Papadopoulos, Nicholas J.; Aldrich, Thomas H., Fusion polypeptides capable of activating receptors.
  520. Fandl, James P.; Chen, Gang; Papadopoulos, Nicholas J.; Aldrich, Thomas H., Fusion polypeptides capable of activating receptors.
  521. Barth, Stefan; Fitting, Jenny; Tur, Mehmet Kemal, Fusion protein to target and treat acute myeloid leukemia cells.
  522. Marc D. Better ; Stephen F. Carroll, Fusion proteins and polynucleotides encoding gelonin sequences.
  523. Pardridge, William M.; Boado, Ruben J., Fusion proteins for delivery of GDNF to the CNS.
  524. Skeiky, Yasir; Reed, Steven; Alderson, Mark, Fusion proteins of .
  525. Skeiky, Yasir; Reed, Steven; Houghton, Raymond L.; McNeill, Patricia D.; Dillon, Davin C.; Lodes, Michael J., Fusion proteins of .
  526. Skeiky, Yasir; Reed, Steven; Houghton, Raymond L.; McNeill, Patricia D.; Dillon, Davin C.; Lodes, Michael J., Fusion proteins of .
  527. Skeiky, Yasir; Guderian, Jeff; Reed, Steven, Fusion proteins of Mycobacterium tuberculosis .
  528. Skeiky, Yasir; Guderian, Jeff; Reed, Steven, Fusion proteins of mycobacterium tuberculosis.
  529. Skeiky, Yasir; Reed, Steven; Alderson, Mark, Fusion proteins of mycobacterium tuberculosis.
  530. Reed, Steven G.; Skeiky, Yasir A.; Dillon, Davin C.; Alderson, Mark; Campos-Nero, Antonio, Fusion proteins of mycobacterium tuberculosis antigens and their uses.
  531. Hellerqvist, Carl G.; Fu, Changlin, GBS toxin receptor compositions and methods of use.
  532. Beers, Courtney; O'Neill, Jason C.; Foltz, Ian; Ketchem, Randal R.; Piasecki, Julia C., GITR antigen binding proteins and methods of use thereof.
  533. Filardo, Edward J.; Sabo, Edmond, GPR30 estrogen receptor in breast cancers.
  534. Golan, Itshak; Caspi, Dan; Melnik, Lora, Galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases.
  535. Muntendam, Pieter, Galectin-3 and cardiac resynchronization therapy.
  536. Powers, Scott; Yang, Jianxin, Gene amplification in cancer.
  537. Thomas, David; De Boer, Mark; Res, Pieter C. J. M.; Simons, Peter J., Gene constructs coding for CD40-binding activating antibodies.
  538. Moscow Jeffrey A. ; Cowan Kenneth H. ; Dixon Kathy ; He Rui, Gene encoding a human reduced folate carrier (RFC).
  539. Li Zhu ; Shaobing Benjamin Hua, Generation of highly diverse library of expression vectors via homologous recombination in yeast.
  540. Farnet, Chris M.; Staffa, Alfredo; Zazopoulos, Emmanuel, Genes and proteins involved in the biosynthesis of enediyne ring structures.
  541. Farnet,Chris M.; Staffa,Alfredo; Zazopoulos,Emmanuel, Genes and proteins involved in the biosynthesis of lipopeptides.
  542. Holsboer, Florian; Ising, Marcus; Yehuda, Rachel; Buxbaum, Joseph D., Genes associated with posttraumatic-stress disorder (PTSD).
  543. Wohlgemuth, Jay; Tayama, Darren; Walther, Dirk; Lal, Preeti G., Genes useful for diagnosing and monitoring inflammation related disorders.
  544. Chiang,Wen; Strasburg,Gale; Linz,John, Genetic test for PSE-susceptible turkeys.
  545. Pardridge, William M.; Boado, Ruben J., Genetically encoded multifunctional compositions bidirectionally transported between peripheral blood and the cns.
  546. Chye,Mee Len; Xu,Zeng Fu; Sin,Suk Fong, Genetically modified plants expressing proteinase inhibitors, SaPIN2a or SaPIN2b, and methods of use thereof for the inhibition of trypsin-and chymotrypsin-like activities.
  547. Frey,Perry A.; Ruzicka,Frank J., Glutamate 2,3-aminomutases and methods of use thereof.
  548. Ghaderi, Darius; da Silva, Ana Paula Galvao, Glycan-interacting compounds.
  549. Ghaderi, Darius; da Silva, Ana Paula Galvao, Glycan-interacting compounds.
  550. DeSander, Julie; Behrens, Jeffrey; Lugovskoy, Alexey Alexandrovich, Glycan-interacting compounds and methods of use.
  551. Satomaa, Tero; Saarinen, Juhani; Natunen, Jari; Vilkman, Anja; Virtanen, Heidi; Hiltunen, Jukka, Glycoprotein.
  552. Rawat, Manish; Hsieh-Wilson, Linda, Glycosaminoglycan mimetics.
  553. Sallberg,Matti, Glycosylated ligand/receptor specificity exchangers specific for bacterial adhesion receptors.
  554. Sallberg,Matti, Glycosylated specificity exchangers.
  555. Sällberg, Matti; Vahlne, Anders; Perdomo, Maria, Glycosylated specificity exchangers.
  556. Sällberg, Matti; Vahlne, Anders; Perdomo, Maria, Glycosylated specificity exchangers.
  557. Sällberg, Matti; Vahlne, Anders; Perdomo, Maria, Glycosylated specificity exchangers.
  558. Sällberg, Matti; Vahlne, Anders; Perdomo, Maria, Glycosylated specificity exchangers.
  559. S��llberg,Matti; Vahlne,Anders; Perdomo,Maria, Glycosylated specificity exchangers.
  560. S��llberg,Matti; Vahlne,Anders; Perdomo,Maria, Glycosylated specificity exchangers.
  561. Umana, Pablo; Jean-Mairet, Joel; Bailey, James E., Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity.
  562. Umaña, Pablo; Jean Mairet, Joël; Bailey, legal representative, M. Sean; Bailey, James E, Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity.
  563. Umaña, Pablo; Jean-Mairet, Joël; Bailey, James E., Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity.
  564. Umaña, Pablo; Jean-Mairet, Joël; Bailey, James E., Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity.
  565. Umaña, Pablo; Jean-Mairet, Joël; Bailey, James E., Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity.
  566. Umaña, Pablo; Jean-Mairet, Joël; Bailey, James E., Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity.
  567. Umaña, Pablo; Jean-Mairet, Joël; Bailey, James E., Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity.
  568. Gao, Zeren; Hart, Charles E.; Piddington, Christopher S.; Sheppard, Paul O.; Shoemaker, Kimberty E.; Gilbertson, Debra G.; West, James W., Growth factor homolog ZVEGF3.
  569. Gao, Zeren; Hart, Charles E.; Piddington, Christopher S.; Sheppard, Paul O.; Shoemaker, Kimberly E., Growth factor homolog zvegf3.
  570. Gao,Zeren; Hart,Charles E.; Piddington,Christopher S.; Sheppard,Paul O.; Shoemaker,Kimberly E.; Gilbertson,Debra G.; West,James W., Growth factor homolog zvegf3 polynucleotides.
  571. Muerhoff, A. Scott; Marohnic, Christopher; Birkenmeyer, Larry; Prostko, John; Bogdan, M. Felisha; Gutierrez, Robin, HCV NS3 recombinant antigens and mutants thereof for improved antibody detection.
  572. Dawson, George J.; Desai, Suresh M.; Gutierrez, Robin A.; Muerhoff, A. Scott; Prostko, John; Bogdan, M. Felicia; Marohnic, Christopher C., HCV antigen-antibody combination assay and methods and compositions for use therein.
  573. Ziemann, Robert; Ahlberg, April; Hawksworth, David; Tieman, Bryan; Muerhoff, A. Scott; Marohnic, Christopher; Otis, Kathy, HCV core lipid binding domain monoclonal antibodies.
  574. Ziemann, Robert; Ahlberg, April; Hawksworth, David; Tieman, Bryan; Muerhoff, A. Scott; Marohnic, Christopher; Otis, Kathy, HCV core lipid binding domain monoclonal antibodies.
  575. Clinton, Gail M.; Evans, Adam; Henner, William D., HER-2 binding antagonists.
  576. Huebsch, Nathaniel D.; Mooney, David J., Harnessing cell dynamics to engineer materials.
  577. Sheng, Gloria J.; Hsieh-Wilson, Linda C., Heparan sulfate/heparin mimetics with anti-chemokine and anti-inflammatory activity.
  578. Pecker,Iris; Vlodavsky,Israel; Friedman,Yael; Perets,Tuvia, Heparanase specific antibodies and their use in research and medical applications.
  579. Pecker, Iris; Vlodavsky, Israel; Friedmann, Yael; Peretz, Tuvia, Heparanase specific molecular probes and their use in research and medical applications.
  580. Sallberg, Matti, Hepatitis C virus codon optimized non-structural NS3/4A fusion gene.
  581. Sallberg, Matti, Hepatitis C virus codon optimized non-structural NS3/4A fusion gene.
  582. Sallberg, Matti, Hepatitis C virus codon optimized non-structural NS3/4A fusion gene.
  583. Sallberg, Matti, Hepatitis C virus codon optimized non-structural NS3/4A fusion gene.
  584. Sallberg,Matti, Hepatitis C virus codon optimized non-structural NS3/4A fusion gene.
  585. Sallberg,Matti, Hepatitis C virus codon optimized non-structural NS3/4A fusion gene.
  586. Sallberg,Matti, Hepatitis C virus codon optimized non-structural NS3/4A fusion gene.
  587. S?llberg, Matti, Hepatitis C virus non-structural NS3/4A fusion gene.
  588. Sällberg, Matti, Hepatitis C virus non-structural NS3/4A fusion gene.
  589. S?llberg,Matti, Hepatitis C virus non-structural NS3/4A fusion gene.
  590. S��llberg,Matti, Hepatitis C virus non-structural NS3/4A fusion gene.
  591. Gillies, Stephen D.; Lo, Kin Ming; Lan, Yan, Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation.
  592. Gillies, Stephen D.; Lo, Kin-Ming; Lan, Yan, Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation.
  593. Gillies, Stephen D.; Lo, Kin-Ming; Lan, Yan, Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation.
  594. Gillies,Stephen D.; Lo,Kin Ming; Lan,Yan, Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation.
  595. Kranz, David M.; Wittrup, K. Dane; Holler, Phillip D., High affinity TCR proteins and methods.
  596. Kranz, David M.; Wittrup, K. Dane; Holler, Phillip D., High affinity TCR proteins and methods.
  597. Zhu, Li; Wei, Shuanghong; Hua, Shaobing B., High throughput generation and affinity maturation of humanized antibody.
  598. Haga,Tatsuya; Okuda,Takashi, High-affinity choline transporter.
  599. Haga,Tatsuya; Okuda,Takashi, High-affinity choline transporter.
  600. Dong, Feng; Benatuil, Lorenzo; Gu, Jijie; Hsieh, Chung-Ming, High-throughput antibody humanization.
  601. Li Zhu ; Shaobing Benjamin Hua, Highly diverse library of yeast expression vectors.
  602. Chiu, Daniel T.; Wu, Changfeng; Ye, Fangmao, Highly fluorescent polymer nanoparticle.
  603. Meade, Harry M.; Chen, Li-How, Highly galactosylated anti-TNF-α antibodies and uses thereof.
  604. Naasani,Imad, Highly luminescent functionalized semiconductor nanocrystals for biological and physical applications.
  605. Olsson, Anna Karin; Larsson, Helena; Claesson Welsh, Lena, Histidine-rich glycoprotein.
  606. Olsson,Anna Karin; Larsson,Helena; Claesson Welsh,Lena, Histidine-rich glycoprotein.
  607. Adams, Thomas; Jablonski, Edward, Homogeneous analyte detection.
  608. Adams, Thomas; Jablonski, Edward, Homogeneous analyte detection.
  609. Bremel, Robert D.; Miller, Linda U.; Bleck, Gregory T., Host cells containing multiple integrating vectors.
  610. Bremel,Robert D.; Miller,Linda U.; Bleck,Gregory T., Host cells containing multiple integrating vectors.
  611. Donoho, Gregory; Turner, Jr., C. Alexander; Hilbun, Erin; Nehls, Michael C.; Friedrich, Glenn; Zambrowicz, Brian; Sands, Arthur T., Human ATPase proteins and polynucleotides encoding the same.
  612. Gregory Donoho ; C. Alexander Turner, Jr. ; Erin Hilbun ; Michael C. Nehls DE; Glenn Friedrich ; Brian Zambrowicz ; Arthur T. Sands, Human ATPase proteins and polynucleotides encoding the same.
  613. Heavner, George A.; Knight, David M.; Ghrayeb, John; Scallon, Bernard J.; Nesspor, Thomas C.; Huang, Chichi, Human EPO mimetic hinge core mimetibodies, compositions, methods and uses.
  614. D. Wade Walke ; Nathaniel L. Wilganowski ; C. Alexander Turner, Jr., Human G-coupled protein receptor kinases and polynucleotides encoding the same.
  615. Walke, D. Wade; Wilganowski, Nathaniel L.; Turner, Jr., C. Alexander, Human G-coupled protein receptor kinases and polynucleotides encoding the same.
  616. Li, Yi, Human G-protein chemokine receptor HSATU68.
  617. Turner, Jr., C. Alexander; Mathur, Brian; Friedrich, Glenn; Zambrowicz, Brian; Sands, Arthur T., Human GABA receptor proteins and polynucleotides encoding the same.
  618. Friddle,Carl Johan; Gerhardt,Brenda; Hu,Yi, Human GABA transporter protein and polynucleotides encoding the same.
  619. Towne, Jennifer E.; Cheng, Janet D.; O'Neill, Jason C.; Zhang, Yu; Sun, Yu; Cerne, Heather; Piper, Derek E.; Ketchem, Randal R., Human IL-23 antigen binding proteins.
  620. Towne, Jennifer E.; Cheng, Janet D.; O'Neill, Jason C.; Zhang, Yu; Sun, Yu; Cerne, Heather; Piper, Derek E.; Ketchem, Randal R., Human IL-23 antigen binding proteins.
  621. Towne, Jennifer E.; Cheng, Janet D.; O'neill, Jason C.; Zhang, Yu; Sun, Yu; Cerne, Heather; Piper, Derek E.; Ketchem, Randal R., Human IL-23 antigen binding proteins.
  622. Turner, Jr., C. Alexander; Zambrowicz, Brian; Friedrich, Glenn; Sands, Arthur T., Human LDL receptor encoding polynucleotides.
  623. Yu, Xuanchuan; Miranda, Maricar; Cullinan, Emily B., Human adenylsuccinate synthetase and polynucleotides encoding the same.
  624. Siu, Gerald; Shen, Wenyan; Yoshinaga, Steven K.; Huang, Haichun, Human anti-B7RP1 neutralizing antibodies.
  625. Siu, Gerald; Shen, Wenyan; Yoshinaga, Steven K.; Huang, Haichun, Human anti-B7RP1 neutralizing antibodies.
  626. Siu, Gerald; Shen, Wenyan; Yoshinaga, Steven K.; Huang, Haichun, Human anti-B7RP1 neutralizing antibodies.
  627. Siu, Gerald; Shen, Wenyan; Yoshinaga, Steven Kiyoshi; Huang, Haichun, Human anti-B7RP1 neutralizing antibodies.
  628. Boyle, William J.; Medlock, Eugene; Sullivan, John J.; Elliott, Robin L.; Martin, Frank; Huang, Haichun, Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors.
  629. Boyle, William J.; Medlock, Eugene; Sullivan, John K.; Elliott, Robin L.; Martin, Frank; Huang, Haichun, Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors.
  630. Boyle, William J.; Medlock, Eugene; Sullivan, John K.; Elliott, Robin L.; Martin, Frank; Huang, Haichun, Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors.
  631. Liu, Meilin; Zhu, Zhenping, Human anti-epidermal growth factor receptor antibody.
  632. Thompson,Julia Elizabeth; Vaughan,Tristan John; Williams,Andrew James; Green,Jonathan Alexander; Jackson,Ronald Henry; Bacon,Louise; Johnson,Kevin Stuart; Wilton,Alison Jane; Tempest,Philip Ronald; Field,Raymond Paul; Ruddock,Steven Paul; Winter,Gregory Paul, Human antibodies specific for TGFβ2.
  633. Li, Yang; Stevens, Jennitte; King, Chadwick Terence; Foltz, Ian; Kannan, Gunasekaran; Yie, Junming; Hu, Shaw-Fen Sylvia, Human antigen binding proteins that bind to a complex comprising β-Klotho and an FGF receptor.
  634. Gregory Donoho ; C. Alexander Turner, Jr. ; Michael C. Nehls DE; Glenn Friedrich ; Brian Zambrowicz ; Arthur T. Sands, Human calcium dependent proteases and polynucleotides encoding the same.
  635. Donoho, Gregory; Turner, Jr., C. Alexander; Nehls, Michael C.; Friedrich, Glenn; Zambrowicz, Brian; Sands, Arthur T., Human calcium dependent proteases, polynucleotides encoding the same, and uses thereof.
  636. Donoho, Gregory; Turner, Jr., C. Alexander; Nehls, Michael C.; Friedrich, Glenn; Zambrowicz, Brian; Sands, Arthur T., Human carboxypeptidases and polynucleotides encoding the same.
  637. Gregory Donoho ; C. Alexander Turner, Jr. ; Michael C. Nehls DE; Glenn Friedrich ; Brian Zambrowicz ; Arthur T. Sands, Human carboxypeptidases and polynucleotides encoding the same.
  638. Barth, Stefan; Nachreiner, Thomas; Cremer, Christian, Human cytolytic fusion proteins.
  639. Turner, Jr.,C. Alexander; Mathur,Brian; Cullinan,Emily B., Human dectin proteins and polynucleotides encoding the same.
  640. Donoho, Gregory; Turner, Jr., C. Alexander; Nehls, Michael C.; Friedrich, Glenn; Zambrowicz, Brian; Sands, Arthur T., Human endothelin converting enzyme-like proteins and polynucleotides encoding the same.
  641. Donoho, Gregory; Turner, Jr., C. Alexander; Nehls, Michael C.; Friedrich, Glenn; Zambrowicz, Brian; Sands, Arthur T., Human endothelin converting enzyme-like proteins and polynucleotides encoding the same.
  642. Mirzayans Razmik,CAX ; Paterson Malcolm C.,SAX, Human fibroblast diffusable factors.
  643. Yu, Xuanchuan; Miranda, Maricar; Hu, Yi, Human hydroxylases and polynucleotides encoding the same.
  644. Yu,Xuanchuan; Miranda,Maricar; Hu,Yi, Human hydroxylases and polynucleotides encoding the same.
  645. Hu, Yi; Kieke, James Alvin; Turner, Jr., C. Alexander; Nehls, Michael C.; Friedrich, Glenn; Zambrowicz, Brian; Sands, Arthur T., Human ion channel protein and polynucleotides encoding the same.
  646. Friddle,Carl Johan; Gerhardt,Brenda, Human ion-exchanger proteins.
  647. Yu, Xuanchuan; Scoville, John; Wilganowski, Nathaniel L.; Nguyen, Nghi D., Human kielin-like proteins and polynucleotides encoding the same.
  648. Yu, Xuanchuan; Scoville, John; Wilganowski, Nathaniel L.; Nguyen, Nghi D., Human kielin-like proteins and polynucleotides encoding the same.
  649. Hu, Yi; Kieke, James Alvin; Donoho, Gregory, Human kinase and polynucleotides encoding the same.
  650. Hu, Yi; Kieke, James Alvin; Donoho, Gregory, Human kinase and polynucleotides encoding the same.
  651. Hu, Yi; Nepomnichy, Boris; Gerhardt, Brenda; Walke, D. Wade; Friddle, Carl Johan, Human kinase and polynucleotides encoding the same.
  652. Hu, Yi; Nepomnichy, Boris; Gerhardt, Brenda; Walke, D. Wade; Friddle, Carl Johan, Human kinase and polynucleotides encoding the same.
  653. Hu, Yi; Wilganowski, Nathaniel L.; Friddle, Carl Johan; Walke, D. Wade, Human kinase and polynucleotides encoding the same.
  654. Yu, Xuanchuan; Miranda, Maricar, Human kinase and polynucleotides encoding the same.
  655. Yu, Xuanchuan; Miranda, Maricar; Friddle, Carl Johan, Human kinase and polynucleotides encoding the same.
  656. Yu, Xuanchuan; Miranda, Maricar; Friddle, Carl Johan, Human kinase and polynucleotides encoding the same.
  657. Donoho, Gregory; Hilbun, Erin; Turner, Jr., C. Alexander; Friedrich, Glenn; Zambrowicz, Brian; Sands, Arthur T., Human kinase protein and polynucleotides encoding the same.
  658. Mathur, Brian; Turner, Jr., C. Alexander; Abuin, Alejandro; Friedrich, Glenn; Zambrowicz, Brian; Sands, Arthur T., Human kinase protein and polynucleotides encoding the same.
  659. Donoho, Gregory; Scoville, John; Turner, Jr., C. Alexander; Friedrich, Glenn; Zambrowicz, Brian; Abuin, Alejandro; Sands, Arthur T., Human kinase proteins and polynucleotides encoding the same.
  660. Donoho, Gregory; Scoville, John; Turner, Jr., C. Alexander; Friedrich, Glenn; Zambrowicz, Brian; Abuin, Alejandro; Sands, Arthur T., Human kinase proteins and polynucleotides encoding the same.
  661. Donoho, Gregory; Turner, Jr., C. Alexander; Nehls, Michael C.; Friedrich, Glenn; Zambrowicz, Brian; Sands, Arthur T., Human kinase proteins and polynucleotides encoding the same.
  662. Hu, Yi; Nepomnichy, Boris; Wang, Xiaoming; Donoho, Gregory, Human kinase proteins and polynucleotides encoding the same.
  663. Hu, Yi; Nepomnichy, Boris; Wang, Xiaoming; Donoho, Gregory; Scoville, John; Walke, D. Wade, Human kinase proteins and polynucleotides encoding the same.
  664. Turner, Jr., C. Alexander; Mathur, Brian; Mathur, Daniel; Friddle, Carl Johan, Human kinase proteins and polynucleotides encoding the same.
  665. Walke, D. Wade; Scoville, John; Donoho, Gregory; Turner, Jr., C. Alexander; Mathur, Brian; Mathur, Daniel; Friddle, Carl Johan, Human kinase proteins and polynucleotides encoding the same.
  666. C. Alexander Turner, Jr. ; Brian Mathur, Human kinases and polynucleotides encoding the same.
  667. Friddle, Carl Johan; Hilbun, Erin; Mathur, Brian; Turner, Jr., C. Alexander, Human kinases and polynucleotides encoding the same.
  668. Friddle, Carl Johan; Hilbun, Erin; Mathur, Brian; Turner, Jr., C. Alexander, Human kinases and polynucleotides encoding the same.
  669. Turner, Jr., C. Alexander; Mathur, Brian, Human kinases and polynucleotides encoding the same.
  670. Turner, Jr., C. Alexander; Mathur, Brian, Human kinases and polynucleotides encoding the same.
  671. Turner, Jr., C. Alexander; Mathur, Brian; Friddle, Carl Johan, Human kinases and polynucleotides encoding the same.
  672. Turner, Jr., C. Alexander; Mathur, Brian; Friddle, Carl Johan, Human kinases and polynucleotides encoding the same.
  673. Turner, Jr., C. Alexander; Mathur, Brian; Friddle, Carl Johan, Human kinases and polynucleotides encoding the same.
  674. Walke, D. Wade; Hilbun, Erin; Donoho, Gregory; Turner, Jr., C. Alexander, Human kinases and polynucleotides encoding the same.
  675. Walke, D. Wade; Scoville, John; Friddle, Carl Johan, Human kinases and polynucleotides encoding the same.
  676. Walke, D. Wade; Scoville, John; Friddle, Carl Johan, Human kinases and polynucleotides encoding the same.
  677. Yu, Xuanchuan (Sean); Miranda, Maricar; Friddle, Carl Johan, Human kinases and polynucleotides encoding the same.
  678. Yu, Xuanchuan; Xie, Qiongshu; Abuin, Alejandro; Walke, D. Wade, Human kinases and polynucleotides encoding the same.
  679. Walke, D. Wade; Hilbun, Erin; Donoho, Gregory; Turner, Jr., C. Alexander; Hansen, Gwenn; BeltrandelRio, Hector; Sligtenhorst, Isaac Van, Human kinases and polynucleotides encoding the same, and uses thereof.
  680. Walke,D. Wade; Hilbun,Erin; Donoho,Gregory; Turner, Jr.,C. Alexander; Hansen,Gwenn; BeltrandelRio,Hector; Van Sligtenhorst,Isaac, Human kinases and polynucleotides encoding the same, and uses thereof.
  681. Walke, D. Wade; Scoville, John, Human membrane proteins and polynucleotides encoding the same.
  682. Turner, Jr., C. Alexander; Hilbun, Erin; Potter, David George, Human mitochondrial proteins and polynucleotides encoding the same.
  683. Marasco, Wayne A.; Sui, Jianhua, Human monoclonal anti-PD-L1 antibodies and methods of use.
  684. Garrone Pierre,FRX ; Djossou Odile,FRX ; Fossiez Francois,FRX ; Banchereau Jacques,FRX, Human monoclonal antibodies against human cytokines and methods of making and using such antibodies.
  685. Deo, Yashwant M.; Keler, Tibor; Treml, John, Human monoclonal antibodies to dendritic cells.
  686. Hua, Shaobing; Pauling, Michelle Haynes; Zhu, Li, Human monoclonal antibody against coreceptors for human immunodeficiency virus.
  687. Burioni, Roberto; Clementi, Massimo, Human monoclonal antibody against the VP1 protein of JC virus.
  688. Burton Dennis R. ; Barbas ; III Carlos F. ; Chanock Robert M. ; Murphy Brian R. ; Crowe ; Jr. James E., Human neutralizing monoclonal antibodies to respiratory syncytial virus.
  689. D. Wade Walke ; John Scoville ; C. Alexander Turner, Jr. ; Glenn Friedrich ; Alejandro Abuin ; Brian Zambrowicz ; Arthur T. Sands, Human phosphatases and polynucleotides encoding the same.
  690. Christenson, Erik; Demaggio, Anthony J.; Goldman, Phyllis S.; McElligott, David L., Human poly (ADP-ribose) polymerase 2 materials and methods.
  691. Christenson,Erik; DeMaggio,Anthony J.; Goldman,Phyllis S.; McElligott,David L., Human poly(ADP-ribose) polymerase 2 materials and methods.
  692. Hu, Yi; Nepomnichy, Boris; Walke, D. Wade, Human protease inhibitor and polynucleotides encoding the same.
  693. Hu, Yi; Nepomnichy, Boris; Walke, D. Wade, Human protease inhibitor and polynucleotides encoding the same.
  694. Carl Johan Friddle ; Erin Hilbun, Human proteases and polynucleotides encoding the same.
  695. Donoho, Gregory; Hilbun, Erin; Turner, Jr., C. Alexander; Nehls, Michael C.; Friedrich, Glenn; Zambrowicz, Brian; Sands, Arthur T., Human proteases and polynucleotides encoding the same.
  696. Donoho, Gregory; Scoville, John; Turner, Jr., C. Alexander; Friedrich, Glenn; Abuin, Alejandro; Zambrowicz, Brian; Sands, Arthur T., Human proteases and polynucleotides encoding the same.
  697. Donoho, Gregory; Scoville, John; Turner, Jr., C. Alexander; Friedrich, Glenn; Abuin, Alejandro; Zambrowicz, Brian; Sands, Arthur T., Human proteases and polynucleotides encoding the same.
  698. Donoho, Gregory; Scoville, John; Turner, Jr., C. Alexander; Friedrich, Glenn; Abuin, Alejandro; Zambrowicz, Brian; Sands, Arthur T., Human proteases and polynucleotides encoding the same.
  699. Donoho, Gregory; Turner, Jr., C. Alexander; Friedrich, Glenn; Scoville, John; Zambrowicz, Brian; Sands, Arthur T., Human proteases and polynucleotides encoding the same.
  700. Donoho, Gregory; Turner, Jr., C. Alexander; Friedrich, Glenn; Scoville, John; Zambrowicz, Brian; Sands, Arthur T., Human proteases and polynucleotides encoding the same.
  701. Friddle, Carl Johan; Hilbun, Erin, Human proteases and polynucleotides encoding the same.
  702. Gregory Donoho ; Erin Hilbun ; C. Alexander Turner, Jr. ; Michael C. Nehls DE; Glenn Friedrich ; Brian Zambrowicz ; Arthur T. Sands, Human proteases and polynucleotides encoding the same.
  703. Donoho, Gregory; Turner, Jr., C. Alexander; Nehls, Michael C.; Friedrich, Glenn; Zambrowicz, Brian; Sands, Arthur T., Human proteins and polynucleotides encoding the same.
  704. Yu, Xuanchuan (Sean); Miranda, Maricar; Turner, Jr., C. Alexander, Human protocadherin proteins and polynucleotides encoding the same.
  705. Walke, D. Wade; Wilganowski, Nathaniel L.; Turner, Jr., C. Alexander; Hilbun, Erin; Wang, Xiaoming; Donoho, Gregory; Scoville, John, Human secreted proteins and polynucleotides encoding the same.
  706. Walke, D. Wade; Wang, Xiaoming; Scoville, John; Turner, Jr., C. Alexander, Human semaphorin homologs and polynucleotides encoding the same.
  707. Walke,D. Wade; Wang,Xiaoming; Scoville,John; Turner, Jr.,C. Alexander, Human semaphorin homologs and polynucleotides encoding the same.
  708. Walke,D. Wade; Scoville,John, Human semaphorin proteins and polynucleotides encoding the same.
  709. Buller, Fabian; Wüllner, Ulrich; Zbinden, Irene; Attinger-Toller, Isabella; Von Der Bey, Ulrike; König-Friedrich, Susann; Bertschinger, Julian; Grabulovski, Dragan; Henne, Patricia, Human serum albumin binding compounds and fusion proteins thereof.
  710. McDonagh, Charlotte; Feldhaus, Michael; Huhalov, Alexandra, Human serum albumin linkers and conjugates thereof.
  711. Hu,Yi; Nepomnichy,Boris, Human synaptotagmin and polynucleotides encoding the same.
  712. Mintz, Liat; Xie, Hanqing; Dahary, Dvir; Levanon, Erez; Freilich, Shiri; Beck, Nili; Zhu, Wei-Yong; Wasserman, Alon; Bernstein, Jeanne, Human thrombospondin polypeptide.
  713. Walke, D. Wade; Scoville, John, Human thymosin protein and polynucleotides encoding the same.
  714. Donoho, Gregory; Hilbun, Erin; Turner, Jr., C. Alexander; Friedrich, Glenn; Abuin, Alejandro; Zambrowicz, Brian; Sands, Arthur T.; Walke, D. Wade; Wilganowski, Nathaniel L.; Hu, Yi; Kieke, James Alvi, Human transferase proteins and polynucleotides encoding the same.
  715. Turner, Jr., C. Alexander; Friedrich, Glenn; Abuin, Alejandro; Zambrowicz, Brian; Sands, Arthur T.; Walke, D. Wade; Wilganowski, Nathaniel L., Human transferase proteins and polynucleotides encoding the same.
  716. Hu, Yi; Kieke, James Alvin; Zambrowicz, Brian; Revelli, Jean-Pierre, Human transporter proteins and polynucleotides encoding the same.
  717. C. Alexander Turner, Jr. ; Brian Mathur ; Brian Zambrowicz ; Arthur T. Sands, Human uncoupling proteins and polynucleotides encoding the same.
  718. Turner, Jr.,C. Alexander; Mathur,Brian; Zambrowicz,Brian; Sands,Arthur T., Human uncoupling proteins and polynucleotides encoding the same.
  719. Leonard, Sherry; Freedman, Robert, Human α-7 nicotinic receptor promoter.
  720. Borras, Leonardo Jose; Urech, David, Humanization of rabbit antibodies using a universal antibody framework.
  721. Borras, Leonardo Jose; Urech, David, Humanization of rabbit antibodies using a universal antibody framework.
  722. Borras, Leonardo; Urech, David, Humanization of rabbit antibodies using a universal antibody framework.
  723. Borras, Leonardo; Urech, David, Humanization of rabbit antibodies using a universal antibody framework.
  724. Simons, Petrus Johannes; Boon, Louis; Luo, Jinquan; Brezski, Randall; Goldberg, Monica, Humanized anti-CD134 (OX40) antibodies and uses thereof.
  725. Lee, Renata; Mikol, Vincent; Allen, Elizabeth; Ruetsch, Norman; Cameron, Beatrice; Oligino, Thomas; Baurin, Nicholas, Humanized anti-CXCR5 antibodies, derivatives thereof and their use.
  726. Lee, Renata; Mikol, Vincent; Allen, Elizabeth; Ruetsch, Norman; Cameron, Beatrice; Oligino, Thomas; Baurin, Nicholas, Humanized anti-CXCR5 antibodies, derivatives thereof and their use.
  727. Lee, Renata; Mikol, Vincent; Allen, Elizabeth; Ruetsch, Norman; Cameron, Beatrice; Oligino, Thomas; Baurin, Nicholas, Humanized anti-CXCR5 antibodies, derivatives thereof and their use.
  728. Lee, Renata; Mikol, Vincent; Allen, Elizabeth; Ruetsch, Norman; Cameron, Beatrice; Oligino, Thomas; Baurin, Nicholas, Humanized anti-CXCR5 antibodies, derivatives thereof and their use.
  729. Lee, Renata; Mikol, Vincent; Allen, Elizabeth; Ruetsch, Norman; Cameron, Beatrice; Oligino, Thomas; Baurin, Nicolas, Humanized anti-CXCR5 antibodies, derivatives thereof and their use.
  730. Lee, Renata; Mikol, Vincent; Allen, Elizabeth; Ruetsch, Norman; Cameron, Beatrice; Oligino, Thomas; Baurin, Nicholas, Humanized anti-CXCR5 antibodies, derivatives thereof and their uses.
  731. Huang, Arthur; Kelley, Robert; Lowman, Henry; Van Lookeren Campagne, Menno; Winter, Charles, Humanized anti-factor D antibodies and uses thereof.
  732. Fang, Fang; Kohlstaedt, Lori; Reno, John, Humanized antibodies.
  733. Fang, Fang; Kohlstaedt, Lori; Reno, John, Humanized antibodies.
  734. Smith, Rodger; Kanakaraj, Palanisamy; Cooksey, Bridget A.; Roschke, Viktor; Rosen, Craig, Humanized antibodies against LIGHT and uses thereof.
  735. Reyes, Christopher L.; Chu, Peter; Smith, Kristen M.; Campbell, Lioudmila A.; Shojaei, Farbod; Norton, John Thomas, Humanized antibodies that bind LGR5.
  736. Scott S. Graves ; John M. Reno ; Robert W. Mallett ; Mark D. Hylarides ; Stephen M. J. Searle GB; Andrew H. Henry GB; Jan T. Pedersen DK; Anthony R. Rees GB, Humanized antibodies that bind to the antigen bound by antibody NR-LU-13.
  737. Marasco, Wayne A.; Sui, Jianhua; Avnir, Yuval, Humanized monoclonal antibodies and methods of use.
  738. Dayton, Christopher L. G.; Hitchman, Tim; Kline, Katie; Lyon, Jonathan; Wall, Mark A.; Barton, Nelson R., Hydrolases, nucleic acids encoding them and methods for biocatalytic synthesis of structured lipids.
  739. Dayton, Christopher L. G.; Hitchman, Tim; Kline, Katie; Lyon, Jonathan; Wall, Mark A.; Barton, Nelson R., Hydrolases, nucleic acids encoding them and methods for biocatalytic synthesis of structured lipids.
  740. Dayton, Christopher L. G.; Barton, Nelson; Bueno, Analia; Cuenca, Joslin G.; Hitchman, Tim; Kline, Katie A.; Lyon, Jonathan; Miller, Mark L.; Wall, Mark A., Hydrolases, nucleic acids encoding them and methods for making and using them.
  741. Dayton, Christopher L. G.; Barton, Nelson; Bueno, Analia; Cuenca, Joslin G.; Hitchman, Tim; Kline, Katie A.; Lyon, Jonathan; Miller, Mark L.; Wall, Mark A., Hydrolases, nucleic acids encoding them and methods for making and using them.
  742. Dayton, Christopher L. G.; Hitchman, Tim; Kline, Katie; Lyon, Jonathan; Wall, Mark A.; Barton, Nelson R., Hydrolases, nucleic acids encoding them and methods for making and using them.
  743. Dayton, Christopher L. G.; Hitchman, Tim; Kline, Katie; Lyon, Jonathan; Wall, Mark A.; Barton, Nelson R., Hydrolases, nucleic acids encoding them and methods for making and using them for biocatalytic synthesis of a structured lipid.
  744. Dayton, Christopher L. G.; Hitchman, Tim; Kline, Katie; Lyon, Jonathan; Wall, Mark A.; Barton, Nelson R., Hydrolases, nucleic acids encoding them and methods to produce triglycerides.
  745. Dayton, Christopher L. G.; Hitchman, Tim; Kline, Katie; Lyon, Jonathan; Wall, Mark A.; Barton, Nelson R., Hydrolases, nucleic acids encoding them and methods to produce triglycerides.
  746. Hsieh, Chung-ming; Wu, Chengbin, IL-1 binding proteins.
  747. Lacy, Susan E.; Benatuil, Lorenzo; Chhaya, Meha; Fung, Emma; Miller, Renee; Chari, Ravi; Heighton, Sarah J.; Bixby, Jacqueline G., IL-1 binding proteins.
  748. Wu, Chengbin; Ambrosi, Dominic J.; Hsieh, Chung-ming; Ghayur, Tariq, IL-1 binding proteins.
  749. Wu, Chengbin; Ambrosi, Dominic J.; Hsieh, Chung-ming; Ghayur, Tariq, IL-1 binding proteins.
  750. Wu, Chengbin; Ambrosi, Dominic J.; Hsieh, Chung-ming; Ghayur, Tariq, IL-1 binding proteins.
  751. Wu, Chengbin; Ambrosi, Dominic J.; Hsieh, Chung-ming; Ghayur, Tariq, IL-1 binding proteins.
  752. Wu, Chengbin; Ambrosi, Dominic J.; Hsieh, Chung-ming; Ghayur, Tariq, IL-1 binding proteins.
  753. Wu, Chengbin; Ambrosi, Dominic J.; Hsieh, Chung-ming; Ghayur, Tariq, IL-1 binding proteins.
  754. Lacy, Susan E.; Fung, Emma; Belk, Jonathan P.; Dixon, Richard W.; Roguska, Michael; Hinton, Paul R.; Kumar, Shankar, IL-12/p40 binding proteins.
  755. Lacy, Susan E.; Fung, Emma; Belk, Jonathan P.; Dixon, Richard W.; Roguska, Michael; Hinton, Paul R.; Kumar, Shankar, IL-12/p40 binding proteins.
  756. Caput, Daniel; Ferrara, Pascual; Laurent, Patrick; Vita, Natalio, IL-13 receptor antibodies.
  757. Hsieh, Chung-Ming; Hugunin, Margaret; Kutskova, Yuliya; Memmott, John E.; Perez, Jennifer M.; Zhong, Suju; Tarcsa, Edit; Clabbers, Anca, IL-17 binding proteins.
  758. Hsieh, Chung-Ming; Hugunin, Margaret; Murtaza, Anwar; McRae, Bradford L.; Kutskova, Yuliya; Memmott, John E.; Perez, Jennifer M.; Zhong, Suju; Tarcsa, Edit; Clabbers, Anca; Wallace, Craig; Bryant, Shaughn H.; Leddy, Mary R., IL-17 binding proteins.
  759. Hsieh, Chung-Ming; Hugunin, Margaret; Murtaza, Anwar; McRae, Bradford L.; Kutskova, Yuliya; Memmott, John E.; Perez, Jennifer M.; Zhong, Suju; Tarcsa, Edit; Clabbers, Anca; Wallace, Craig; Bryant, Shaughn H.; Leddy, Mary R., IL-17 binding proteins.
  760. Hsieh, Chung-Ming; Hugunin, Margaret; Murtaza, Anwar; McRae, Bradford L.; Kutskova, Yuliya; Memmott, John E.; Perez, Jennifer M.; Zhong, Suju; Tarcsa, Edit; Clabbers, Anca; Wallace, Craig; Bryant, Shaughn H.; Leddy, Mary R., IL-17 binding proteins.
  761. Hsieh, Chung-Ming; Hugunin, Margaret; Murtaza, Anwar; McRae, Bradford L.; Kutskova, Yuliya; Memmott, John E.; Perez, Jennifer M.; Zhong, Suju; Tarcsa, Edit; Clabbers, Anca; Wallace, Craig; Bryant, Shaughn H.; Leddy, Mary R., IL-17 binding proteins.
  762. Tocker, Joel E.; Peschon, Jacques J.; Fitzpatrick, David; Smothers, James F.; Mehlin, Christopher; Lim, Ai Ching, IL-17 receptor A antigen binding proteins.
  763. Gillies,Stephen D.; Stein,Pascal A.; Lo,Kin Ming, IL-2 fusion proteins with modulated selectivity.
  764. Wu, Chengbin; Ambrosi, Dominic J.; Hsieh, Chung-ming; Ghayur, Tariq, IL-I binding proteins.
  765. Donovan, Kathleen A.; Lust, John A., IL1-β: a new target for myeloma therapy.
  766. Pasternak, Gavril; Pan, Ying-Xian, Identification and characterization of multiple splice variants of the Kappa3-related opioid receptor (KOR-3) gene.
  767. Gavril Pasternak ; Ying-Xian Pan, Identification and characterization of multiple splice variants of the mu-opioid receptor gene.
  768. Arlen,Myron; Tsang,Kwong Y., Identification and development of specific monoclonal antibodies to squamous cell carcinoma.
  769. Stearns, Mark E.; Hu, Youji; Wang, Min, Identification of a pin specific gene and protein (PIN-1) useful as a diagnostic treatment for prostate cancer.
  770. Lu, Xuanyong; Block, Timothy, Identification of modulators of serine protease inhibitor Kazal and their use as anti-cancer and anti-viral agents.
  771. Park, Joon-Hyun; Apuya, Nestor; Bobzin, Steven Craig, Identification of terpenoid-biosynthesis related regulatory protein-regulatory region associations.
  772. Sahin, Ugur; Tureci, Ozlem; Koslowski, Michael; Usener, Dirk, Identification of tumor-associated antigens for diagnosis and therapy.
  773. Sahin, Ugur; Türeci, Özlem; Koslowski, Michael; Usener, Dirk, Identification of tumor-associated antigens for diagnosis and therapy.
  774. Rabinovich, Peter M.; Weissman, Sherman M.; Bahceci, Erkut; Komarovskaya, Marina E., Immune cells modified by transient transfection of RNA.
  775. Vande Woude, George F.; Zhang, Yu-wen; Shinomiya, Nariyoshi, Immune-compromised transgenic mice expressing human hepatocyte growth factor (hHGF).
  776. Barth, Stefan; Wüllner, Ulrich; Neef, Inga, Immuno-RNA-constructs.
  777. Gillies, Stephen D.; Lo, Kin-Ming; Qian, Susan X., Immunocytokine sequences and uses thereof.
  778. Gillies, Stephen D.; Lo, Kin-Ming; Qian, Susan Xiuqi, Immunocytokine sequences and uses thereof.
  779. Gillies,Stephen D.; Lo,Kin Ming; Qian,Susan X., Immunocytokine sequences and uses thereof.
  780. Sällberg, Matti; Soderholm, Jonas; Frelin, Lars, Immunogen platform.
  781. Sällberg, Matti; Soderholm, Jonas; Frelin, Lars, Immunogen platform.
  782. Chen, Swey Shen Alex; Yang, Yong Min; Barankiewicz, Theresa J.; Chen, Zhong, Immunoglobulin E vaccines and methods of use thereof.
  783. Barth, Stefan; Tur, Mehmet Kemal; Stöcker, Michael; Fischer, Rainer, Immunokinases.
  784. Rubin-Bejerano, Ifat; Fink, Gerald R.; Abeijon, Claudia; Kohane, Danial S.; Fuller, Jason E.; Langer, Robert S., Immunomodulating compositions and methods of use.
  785. Rubin-Bejerano, Ifat; Fink, Gerald R.; Abeijon, Claudia; Kohane, Daniel S.; Fuller, Jason E; Langer, Robert S., Immunomodulating compositions and methods of use thereof.
  786. Hirsch, Raphael; Marinov, Anthony D.; Wilson, David C., Immunomodulation of inflammatory conditions utilizing Follistatin-like Protein-1 and agents that bind thereto.
  787. Hirsch, Raphael; Marinov, Anthony D.; Wilson, David C., Immunomodulation of inflammatory conditions utilizing Follistatin-like protein-1 and agents that bind thereto.
  788. Shimamura Toshiro (Kawasaki JPX) Nakazawa Harumi (Kawasaki JPX) Hamuro Junji (Kawasaki JPX), Immunosuppressant.
  789. Goldenberg, David M.; Hansen, Hans J., Immunotherapy of B cell malignancies and autoimmune diseases using unconjugated antibodies and conjugated antibodies and antibody combinations and fusion proteins.
  790. Goldenberg, David M., Immunotherapy of B-cell malignancies using anti-CD22 antibodies.
  791. Pastan Ira ; Kuan Chien-Tsun, Immunotoxin containing a disulfide-stabilized antibody fragment joined to a Pseudomonas exotoxin that does not require.
  792. Better Marc D. (Los Angeles CA) Carroll Stephen F. (Walnut Creek CA) Studnicka Gary M. (Santa Monica CA), Immunotoxins comprising ribosome-inactivating proteins.
  793. Better Marc D. ; Carroll Stephen F. ; Studnicka Gary M., Immunotoxins comprising ribosome-inactivating proteins.
  794. Better Marc D. ; Carroll Stephen F. ; Studnicka Gary M., Immunotoxins comprising ribosome-inactivating proteins.
  795. Better, Marc D.; Carroll, Stephen F.; Studnicka, Gary M., Immunotoxins comprising ribosome-inactivating proteins.
  796. Rosenblum,Michael G., Immunotoxins directed against CD33 related surface antigens.
  797. Kim, Jaeyun; Mooney, David J.; Li, Weiwei Aileen; Arany, Praveen; Gadish, Or, In situ antigen-generating cancer vaccine.
  798. Oh, Youngman; Rosenfeld, Ron; Ingermann, Angela Renae, Induction of apoptosis and cell growth inhibition by protein 4.33.
  799. Thomas,David; de Boer,Mark; Res,Pieter C. J. M.; Simons,Peter J., Induction of cytotoxic T lymphocyte responses using anti-CD40 antibodies.
  800. Kurtzman, Gary J.; Engelman, Edgar G.; Podsakoff, Greg M.; Brockstedt, Dirk G., Induction of immune response to antigens expressed by recombinant adeno-associated virus.
  801. Jove, Richard; Dalton, William; Sebti, Said; Yu, Hua; Heller, Richard; Jaroszeski, Mark; Gilbert, Richard A.; Hamilton, Andrew D., Inhibition of STAT3 signal transduction for human cancer therapy.
  802. Pereira, Daniel; O'Toole, Jennifer, Inhibition of macrophage-stimulating protein receptor (RON) and methods of treatment thereof.
  803. Tang, Jordan J. N.; Ghosh, Arun K., Inhibitors of Memapsin 2 and use thereof.
  804. Nyati, Mukesh K.; Lawrence, Theodore S., Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction.
  805. Gelboin Harry V. ; Gonzalez Frank J., Inhibitory and non-inhibitory antigen binding polypeptides against human P450 enzymes.
  806. Bencherif, Sidi A.; Sands, Roger Warren; Koshy, Sandeep T.; Mooney, David J., Injectable cryogel vaccine devices and methods of use thereof.
  807. Bencherif, Sidi A.; Mooney, David J.; Edwards, David; Sands, Roger Warren, Injectable preformed macroscopic 3-dimensional scaffolds for minimally invasive administration.
  808. Pullen Margaret I., Integrated field modeling system.
  809. Hoffman Allan S. ; Stayton Patrick S., Interactive molecular conjugates.
  810. Autieri Michael V., Interferon responsive transcript (IRT-1).
  811. Ford, John; Ho, Alice Suk-Yue; Pace, Ann, Interleukin--1 receptor antagonist and uses thereof.
  812. John Ford ; Ann Pace, Interleukin-1 receptor antagonist and recombinant production thereof.
  813. Wu, Chengbin; Dixon, Richard W.; Belk, Jonathan P.; Argiriadi, Maria A.; Ying, Hua; Cuff, Carolyn A.; Melim, Terry L.; Kumar, Shankar; Hinton, Paul R.; Chen, Yan, Interleukin-13 binding proteins.
  814. Wu, Chengbin; Dixon, Richard W.; Belk, Jonathan P.; Argiriadi, Maria A.; Ying, Hua; Cuff, Carolyn A.; Melim, Terry L.; Kumar, Shankar; Hinton, Paul R.; Chen, Yan, Interleukin-13 binding proteins.
  815. Wu, Chengbin; Dixon, Richard W.; Belk, Jonathan P.; Ying, Hua; Argiriadi, Maria A.; Cuff, Carolyn A.; Hinton, Paul R.; Kumar, Shankar; Melim, Terry L.; Chen, Yan, Interleukin-13 binding proteins.
  816. Goldenberg,Milton D., Intraoperative, intravascular and endoscopic tumor and lesion detection, biopsy and therapy.
  817. Milton David Goldenberg, Intraoperative, intravascular and endoscopic tumor and lesion detection, biopsy and therapy.
  818. Goldenberg Milton David, Intraoperative, intravascular, and endoscopic tumor and lesion detection, biopsy and therapy.
  819. Grasso, Patricia; Lee, Daniel W.; Leinung, Matthew C., Isolated antibodies against biologically active leptin-related peptides.
  820. Grasso, Patricia; Lee, Daniel W.; Leinung, Matthew C., Isolated antibodies against biologically active leptin-related peptides.
  821. Pease, Larry R.; Van Keulen, Virginia; Ciric, Bogolub, Isolated antibody.
  822. Mueller, Bernhard; Huang, Lili; Bardwell, Philip D.; Kutskova, Yuliya; Memmott, John, Isolated monoclonal anti-repulsive guidance molecule A antibodies and uses thereof.
  823. Ring David B., Isolated nucleic acid molecules encoding antigen binding sites of antibody molecules specific for cancer antigens.
  824. Chen, Yiyou; Chen, Dan; Day, Anthony G.; Estell, David A.; Geng, Wei, Isolating human antibodies.
  825. Altboum, Zeev; Levine, Myron M.; Barry, Eileen M., Isolation and characterization of the csa operon (ETEC-CS4 pili) and methods of using same.
  826. Altboum,Zeev; Levine,Myron M.; Barry,Eileen M., Isolation and characterization of theoperon (ETEC-CS4 pili) and methods of using same.
  827. Goldenberg, David M.; Hansen, Hans J.; Chang, Chien-Hsing, Isolation, detection, diagnosis and/or characterization of circulating Trop-2-positive cancer cells.
  828. Friend,Stephen H.; Stoughton,Roland; Linsley,Peter S.; Burchard,Julja, Iterative probe design and detailed expression profiling with flexible in-situ synthesis arrays.
  829. Blair, Henry; Beck, Thomas; Ladner, Robert C., Kallikrein inhibitors and anti-thrombolytic agents and uses thereof.
  830. Blair, Henry; Beck, Thomas; Ladner, Robert Charles, Kallikrein inhibitors and anti-thrombolytic agents and uses thereof.
  831. Markland, William; Ladner, Robert C., Kallikrein-binding “kunitz domain” proteins and analogues thereof.
  832. Ladner, Robert C.; Ley, Arthur C.; Hirani, Shirish; Williams, Anthony; Grazia De Simoni, Maria; Bergamaschini, Luigi, Kallikrein-inhibitor therapies.
  833. Klink, Tony A.; Beebe, Jane A.; Lasky, David A.; Kleman-Leyer, Karen M.; Somberg, Richard, Kinase and phosphatase assays.
  834. Klink, Tony; Beebe, Jane; Lasky, David; Kleman-Leyer, Karen; Somberg, Richard, Kinase and phosphatase assays.
  835. Werner, Elizabeth A.; Klink, Tony A.; Beebe, Jane A.; Lasky, David A.; Kleman Leyer, Karen M.; Somberg, Richard, Kinase and phosphatase assays.
  836. Idelevich, Pavel; Elkeles, Adi; Terkieltaub, Dov; Eyal, Ami, Kits for and methods of differential staining of cervical cancer cells and/or tissues.
  837. Scuderi, Gaetano J.; Hanna, Lewis S.; Bowser, Robert, Kits for biomarker detection and treatment selection.
  838. Bakshi, Sharmila; Cipps, Thomas; Hanner, Markus; Pikalo, Jutta; Satke, Christina; Nagy, Eszter; Lundberg, Urban; Zierer, Dagmar; Meinke, Andreas; Noiges, Birgit; Stierschneider, Ulrike; Von Gabain, Alexander, Klebsiella antigens.
  839. Bakshi, Sharmila; Cipps, Thomas; Hanner, Markus; Pikalo, Jutta; Satke, Christina; Nagy, Eszter; Lundberg, Urban; Zierer, Dagmar; Meinke, Andreas; Noiges, Birgit; Stierschneider, Ulrike; von Gabain, Alexander, Klebsiella antigens.
  840. Sparks,Mary Jean; Huang,Wenhu, Knockout animals manifesting hyperlipidemia.
  841. Mi, Sha; Pepinsky, R. Blake, LINGO-2 antagonists for treatment of conditions involving motor neurons.
  842. Smith, Victoria; Ogg, Scott; Van Vlasselaer, Peter; Barry, Vivian E.; Marshall, Derek; Holzer, Alison Kay; Rodriguez, Hector; Oyasu, Miho; McCauley, Scott Alan; Garcia, Carlos Aurelio; Biermann, Donna Hiroko Tokuoka, LOX and LOXL2 inhibitors and uses thereof.
  843. Smith, Victoria; Ogg, Scott; Van Vlasselaer, Peter; Barry, Vivian E.; Marshall, Derek; Holzer, Alison Kay; Rodriguez, Hector; Oyasu, Miho; McCauley, Scott Alan; Garcia, Carlos Aurelio; Biermann, Donna Hiroko Tokuoka, LOX and LOXL2 inhibitors and uses thereof.
  844. Benatuil, Lorenzo; Deng, Kangwen; Hanzatian, Denise Karaoglu; Argiriadi, Maria A., LRP-8 binding dual variable domain immunoglobulin proteins.
  845. Tsuchiya, Masayuki; Hirata, Yuichi, Ligand having agonistic activity to mutated receptor.
  846. Sallberg, Matti, Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen.
  847. Berget, Peter B., Linked peptide fluorogenic biosensors.
  848. Whitlow Marc D. ; Filpula David R., Linker and linked fusion polypeptides.
  849. Whitlow Marc D. ; Filpula David R., Linker for linked fusion polypeptides.
  850. Albang, Richard; Fritz, Andreas; Heinrich, Oliver; Ilgenfritz, Hilmar; Maier, Dieter; Wagner, Christian; Folkers, Ulrike; Gerhard, Beatrix; Spreafico, Fabio; De Boer, Lex; Meima, Roelf Bernhard, Lipases and uses thereof.
  851. Albang, Richard; Fritz, Andreas; Heinrich, Oliver; Ilgenfritz, Hilmar; Maier, Dieter; Wagner, Christian; Folkers, Ulrike; Gerhard, Beatrix; Spreafico, Fabio; De Boer, Lex; Meima, Roelf Bernhard, Lipases and uses thereof.
  852. Platt, Adam Samuel; Rapecki, Stephen Edward; Fortunato, Mara; Rainey, David Robert; Rundle, Jon Leigh; Smith, Paul Alfred; Watt, Gillian Sairfull, Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy.
  853. Jensenius, Jens Chr.; Thiel, Steffen, MASP 2, a complement-fixing enzyme, and uses for it.
  854. Jensenius, Jens Chr.; Thiel, Steffen, MASP-2, a complement fixing enzyme, and uses for it.
  855. Thomas Ciossek DE; Axel Ullrich ; Birgit Millauer, MDK1 polypeptides.
  856. Ciossek Thomas,DEX ; Ullrich Axel ; Millauer Birgit, MDKI, a novel receptor tyrosine kinase.
  857. Pardridge, William M.; Boado, Ruben J., Macromolecular compositions that cross the blood-brain barrier and methods of use thereof.
  858. Friedrich, Glenn; Nehls, Michael C., Mammalian cortexin-like proteins and polynucleotides encoding the same.
  859. Hansen,Marc F.; Deshpande,Amit, Mammalian early developmental regulator gene.
  860. Palm, Kaia; Timmusk, Tonis, Mammalian neuralized family transcriptional regulators and uses therefor.
  861. Admon, Arie; Barnea, Eilon; Beer, Ilan; Ziv, Tamar, Markers for cancer detection.
  862. Alitalo, Kari; Petrova, Tatiana; Nykanen, Antti, Materials and methods for colorectal cancer screening, diagnosis and therapy.
  863. Keesee Susan K. ; Obar Robert ; Wu Ying-Jye, Materials and methods for detection of breast cancer.
  864. Keesee Susan K. ; Obar Robert ; Wu Ying-Jye, Materials and methods for detection of breast cancer.
  865. Cao, Lan; Bouhadir, Kamal H.; Mooney, David J., Materials presenting notch signaling molecules to control cell behavior.
  866. Kim, Jaeyun; Li, Weiwei Aileen; Mooney, David J., Mesoporous silica compositions for modulating immune responses.
  867. Fouchier, Ronaldus Adrianus Maria; Van Den Hoogen, Bernadetta Gerarda; Osterhaus, Albertus Dominicus Marcellinus Erasmus; De Jong, Jan Cornelius; Groen, Jan, Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences.
  868. Fouchier, Ronaldus Adrianus Maria; Van Den Hoogen, Bernadetta Gerarda; Osterhaus, Albertus Dominicus Marcellinus Erasmus; De Jong, Jan Cornelius; Groen, Jan, Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences.
  869. Ge, Hui, Method and composition for cancer diagnosis and treatment.
  870. Pentyala, Srinivas N., Method and kits for detecting cerebrospinal fluid in a sample.
  871. Neufeld, Gera; Akiri, Gal; Vadasz, Zahava; Gengrinovitch, Stela, Method for assessing metastatic properties of breast cancer.
  872. Muraoka, Jin; Azuma, Takachika; Murakami, Akikazu, Method for binding a protein consisting of protein A or consisting of at least one domain of the A to E domains of the protein A to the substrate.
  873. Poretz Ronald D. ; Manowitz Paul, Method for detecting a predisposition to susceptibility to toxic effects of drugs and poisons.
  874. Loibner, Hans; Schuster, Manfred; Janzek-Hawlat, Evelyne, Method for determining ACE2 activity.
  875. Sherman, David H.; Smith, Janet L.; Gu, Liangcai; Gehret, Jennifer, Method for enzymatic production of decarboxylated polyketides and fatty acids.
  876. Adair, Charles David, Method for extending pregnancy by reducing intraventricular hemorrhaging in patients exhibiting at least one symptom of preeclampsia and eclampsia.
  877. Hirth Klaus Peter, Method for molecular diagnosis of tumor angiogenesis and metastasis.
  878. Winter Gregory Paul,GBX ; Riechmann Lutz ; Yarranton Geoffrey Thomas,GBX ; Bodmer Mark William,GBX ; Owens Raymond John,GBX, Method for producing Fv fragments in eukaryotic cells.
  879. Yu, Xiao-Fang; Liu, Bindong; Li, Limin, Method for reducing HIV viral budding by administering a VPS28-specfic antibody that disrupts Gag-TSG101-VPS28 binding interactions.
  880. Filpula David R. ; Wang Maoliang ; Whitlow Marc D., Method for targeted delivery of nucleic acids.
  881. Filpula, David R.; Wang, Maoliang; Whitlow, Marc D., Method for targeted delivery of nucleic acids.
  882. Kroczek, Richard, Method for the treatment of T cell mediated conditions by depletion of ICOS-positive cells in vivo.
  883. Nimmrich, Volker; Barghorn, Stefan; Ebert, Ulrich; Hillen, Heinz; Gross, Gerhard; Draguhn, Andreas; Bruhl, Claus; Grimm, Christine; Krantz, Carsten, Method for the treatment of amyloidoses.
  884. O'Neil, Karyn T.; Picha, Kristen; Stojanovic-Susulic, Vedrana, Method for treating insulin sensitivity by long-acting GLP-1 receptor mimetibody agonists.
  885. Harris, Peter C.; Hogan, Marie C.; Ward, Christopher J.; Griffin, Matthew D., Method of detecting endometrial cancer comprising measuring levels of fibrocystin-L.
  886. Macina, Roberto A.; Pillai, Rajeswari, Method of diagnosing, monitoring, staging, imaging and treating colon cancer.
  887. Macina, Roberto A.; Piderit, Alejandra; Sun, Yongmng, Method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancer.
  888. Gazit, Ehud; Reches, Meital, Method of forming a fiber made of peptide nanostructures.
  889. Gazit, Ehud; Reches, Meital, Method of forming a fiber made of peptide nanostructures.
  890. Ranade,Koustubh; Delmonte,Terrye Aigeldinger; Geese,William J., Method of identifying a PPARgamma-agonist compound having a decreased likelihood of inducing dose-dependent peripheral edema.
  891. Gaitanaris, George A.; Bergmann, John E.; Gragerov, Alexander; Hohmann, John; Li, Fusheng; Madisen, Linda; McIlwain, Kellie L.; Pavlova, Maria N.; Vassilatis, Demetri; Zeng, Hongkui, Method of identifying a compound for the treatment or prevention of obesity.
  892. Margolskee,Robert F.; Huang,Liquan; Rong,Minqing; Max,Marianna; Perez,Cristian A., Method of identifying bitter compounds by employing TRP8, a transient receptor potential channel expressed in taste receptor cells.
  893. Gao, Zeren; Hart, Charles E.; Piddington, Christopher S.; Sheppard, Paul O.; Shoemaker, Kimberly E., Method of inhibiting the activity of growth factor homolog ZVEGF3.
  894. Beasley, Matthew; Kiefel, Ben, Method of protein display.
  895. Sexton, Daniel J.; Viswanathan, Malini, Method of treating hereditary angioedema using plasma kallikrein binding antibodies.
  896. Liu, Dingjiang; Huang, Holly Zhuohong; Martin, David Andrew; Russell, Christopher Boyd; Salinger, David H.; Baumgartner, Scott Walter; Endres, Christopher, Method of treating psoriasis using an IL-17 receptor antibody formulation.
  897. Mandelboim, Ofer; Porgador, Angel; Naparstek, Yaakov; Gur, Chamutal, Method of treating type 1 diabetes by administering NKp46 polypeptide.
  898. Bentires-Alj, Mohamed; Aceto, Nicola; Stadler, Michael, Method of treatment of breast cancers over-expressing the SHP2 signature genes.
  899. Dotti, Gianpietro; Ferrone, Soldano; Du, Hongwei; Wang, Xinhui; Ferrone, Cristina, Methods and compositions for chimeric antigen receptor targeting cancer cells.
  900. Unemori, Elaine, Methods and compositions for control of fetal growth via modulation of relaxin.
  901. Unemori, Elaine, Methods and compositions for control of fetal growth via modulation of relaxin.
  902. Bupp, II, Charles Robert; Choi, K. Yeon; Holmes-Davis, Rachel Anne; Izmailov, Alexander; Koshinsky, Heather; Nulf, Christopher Jon; Urdea, Mickey; Wang, Miaomiao; Warner, Brian David; Zwick, Michael, Methods and compositions for detecting polynucleotides.
  903. Wohlgemuth, Jay; Fry, Kirk; Woodward, Robert; Ly, Ngoc, Methods and compositions for diagnosing and monitoring auto immune and chronic inflammatory diseases.
  904. Rosenberg, Steven; Fry, Kirk; Wu, Bin; Dedrick, Russell L., Methods and compositions for diagnosing and monitoring the status of transplant rejection and immune disorders.
  905. Wohlgemuth, Jay; Fry, Kirk E.; Woodward, Robert; Ly, Ngoc; Prentice, James; Morris, Macdonald; Rosenberg, Steven, Methods and compositions for diagnosing and monitoring transplant rejection.
  906. Wohlgemuth, Jay; Fry, Kirk; Woodward, Robert; Ly, Ngoc, Methods and compositions for diagnosing and monitoring transplant rejection.
  907. Wohlgemuth, Jay; Fry, Kirk; Woodward, Robert; Ly, Ngoc; Prentice, James; Morris, MacDonald; Rosenberg, Steven, Methods and compositions for diagnosing and monitoring transplant rejection.
  908. Wohlgemuth, Jay; Fry, Kirk; Woodward, Robert; Ly, Ngoc; Prentice, James; Morris, MacDonald; Rosenberg, Steven, Methods and compositions for diagnosing and monitoring transplant rejection.
  909. Wohlgemuth, Jay; Fry, Kirk; Woodward, Robert; Ly, Ngoc; Prentice, James; Morris, MacDonald; Rosenberg, Steven, Methods and compositions for diagnosing and monitoring transplant rejection.
  910. Hong Chen ; Nelson B. Freimer, Methods and compositions for diagnosing and treating chromosome -18p related disorders.
  911. Hong Chen ; Nelson B. Freimer, Methods and compositions for diagnosing and treating chromosome-18p related disorders.
  912. Tong, Xiao; Sheppard, Michael G., Methods and compositions for diagnosing and treating disorders involving angiogenesis.
  913. Wohlgemuth, Jay; Fry, Kirk; Woodward, Robert; Ly, Ngoc, Methods and compositions for diagnosing or monitoring autoimmune and chronic inflammatory diseases.
  914. Wohlgemuth, Jay; Fry, Kirk; Woodward, Robert; Ly, Ngoc, Methods and compositions for diagnosing or monitoring autoimmune and chronic inflammatory diseases.
  915. Al-Murrani, Samer Waleed Khedheyer; Schoenherr, William David, Methods and compositions for diagnosing osteoarthritis in a feline.
  916. Wohlgemuth, Jay; Fry, Kirk E.; Woodward, Robert; Ly, Ngoc, Methods and compositions for diagnosis and monitoring auto immune and chronic inflammatory diseases.
  917. Sahin, Ugur; Türeci, Özlem; Koslowski, Michael; Helftenbein, Gerd; Walter, Korden; Wöll, Stefan; Oprea, Gabriela-Elena, Methods and compositions for diagnosis and treatment of cancer.
  918. Li, Yue-Ming; Chau, De-Ming; Villa, Jennifer C.; Crump, Christina, Methods and compositions for gamma-secretase assay.
  919. Davis, Noa; Elkeles, Adi; Terkieltaub, Dov; Chausovsky, Alexander, Methods and compositions for identifying a cell phenotype.
  920. Pardridge, William M.; Boado, Ruben J., Methods and compositions for increasing arylsulfatase A activity in the CNS.
  921. Pardridge, William M.; Boado, Ruben J., Methods and compositions for increasing arylsulfatase A activity in the CNS.
  922. Pardridge, William M.; Boado, Ruben J., Methods and compositions for increasing arylsulfatase A activity in the CNS.
  923. Pardridge, William M.; Boado, Ruben J., Methods and compositions for increasing arylsulfatase A activity in the CNS.
  924. Pardridge, William M.; Boado, Ruben J., Methods and compositions for increasing iduronate 2-sulfatase activity in the CNS.
  925. Pardridge, William M.; Boado, Ruben J., Methods and compositions for increasing iduronate 2-sulfatase activity in the CNS.
  926. Chang, Paul; Leung, Anthony; Sharp, Phillip A., Methods and compositions for increasing the activity of inhibitory RNA.
  927. Pardridge, William M.; Boado, Ruben J., Methods and compositions for increasing α-L-iduronidase activity in the CNS.
  928. Pardridge, William M.; Boado, Ruben J., Methods and compositions for increasing α-L-iduronidase activity in the CNS.
  929. Pardridge, William M.; Boado, Ruben J., Methods and compositions for increasing α-L-iduronidase activity in the CNS.
  930. Grusby, Michael J.; Wurster, Andrea; Young, Deborah; Collins, Mary; Whitters, Matthew, Methods and compositions for modulating T helper (T) cell development and function.
  931. Grusby,Michael J.; Wurster,Andrea; Young,Deborah; Collins,Mary; Whitters,Matthew, Methods and compositions for modulating T helper (Th) cell development and function.
  932. Neufeld, Gera; Akiri, Gal; Vadasz, Zahava; Gengrinovitch, Stela, Methods and compositions for modulating angiogenesis.
  933. Qian, Jiahua; Berzofsky, Jay A.; Khleif, Samir N., Methods and compositions for producing an enhanced immune response to a human papillomavirus immunogen.
  934. Holmes-Davis, Rachel Anne; Koshinsky, Heather; Wang, Miaomiao; Warner, Brian David, Methods and compositions for rapid light-activated isolation and detection of analytes.
  935. Chen Hong ; Freimer Nelson B., Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders.
  936. Langermann, Solomon; Liu, Linda, Methods and compositions for the inhibition of transplant rejection.
  937. McDonald,John R.; Coggins,Philip J., Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders.
  938. Smith, Victoria; Ogg, Scott; Van Vlasselaer, Peter; Barry, Vivian E.; Marshall, Derek; Holzer, Alison Kay; Rodriguez, Hector; Oyasu, Miho; McCauley, Scott Alan; Garcia, Carlos Aurelio; Biermann, Donna Hiroko Tokuoka, Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis.
  939. Smith, Victoria; Ogg, Scott; Van Vlasselaer, Peter; Barry, Vivian E.; Marshall, Derek; Holzer, Alison Kay; Rodriguez, Hector; Oyasu, Miho; McCauley, Scott Alan; Garcia, Carlos Aurelio; Biermann, Donna Hiroko Tokuoka, Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis.
  940. Brian Paul Chadwick ; Anna-Maria Frischauf GB, Methods and compositions relating to CD39-like polypeptides and nucleic acids.
  941. Chadwick, Brian Paul; Frischauf, Anna-Maria, Methods and compositions relating to CD39-like polypeptides and nucleic acids.
  942. Chadwick, Brian Paul; Frischauf, Anna-Maria, Methods and compositions relating to CD39-like polypeptides and nucleic acids.
  943. Chadwick, Brian Paul; Frischauf, Anna-Maria, Methods and compositions relating to CD39-like polypeptides and nucleic acids.
  944. Chadwick, Brian Paul; Frischauf, Anna-Maria, Methods and compositions relating to CD39-like polypeptides and nucleic acids.
  945. Chadwick, Brian Paul; Frischauf, Anna-Maria, Methods and compositions relating to CD39-like polypeptides and nucleic acids.
  946. Chadwick, Brian Paul; Frischauf, Anna-Maria, Methods and compositions relating to CD39-like polypeptides and nucleic acids.
  947. Chadwick, Brian Paul; Frischauf, Anna-Maria, Methods and compositions relating to CD39-like polypeptides and nucleic acids.
  948. Chadwick, Brian Paul; Frischauf, Anna-Maria, Methods and compositions relating to CD39-like polypeptides and nucleic acids.
  949. Idelevich, Pavel; Elkeles, Adi; Terkieltaub, Dov; Eyal, Ami; Gelvan, Dan Jacob, Methods and kits for differential staining of abnormal urinary system cells.
  950. Rosario-Jansen, Theresa; Wright, David Erick, Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy.
  951. Dong, Haidong; Kwon, Eugene D.; Markovic, Svetomir N.; Krco, Christopher J., Methods and materials for treating cancer.
  952. John Ford ; Julio J. Mulero ; George Yeung, Methods and materials relating to CD39-like polypeptides.
  953. John Ford ; Julio J. Mulero ; George Yeung, Methods and materials relating to CD39-like polypeptides.
  954. Ford, John; Mulero, Julio J., Methods and materials relating to novel CD39-like polypeptides.
  955. John Ford ; Julio J. Mulero, Methods and materials relating to novel CD39-like polypeptides.
  956. John Ford ; Julio J. Mulero ; George Yeung, Methods and materials relating to novel CD39-like polypeptides.
  957. Radhakrishnan,Suresh; Pease,Larry R.; Kita,Hirohito; Iijima,Koji, Methods and molecules for modulating an immune response.
  958. Chang, Tse Wen, Methods and substances for recruiting therapeutic agents to solid tumors.
  959. Stoughton, Roland; Hughes, Timothy, Methods and systems for characterizing a cellular constituent using response profiles.
  960. Stoughton, Roland; Hughes, Timothy R., Methods and systems for determining the biological function of cell constituents using response profiles.
  961. Sabbadini, Roger A., Methods for decreasing immune response and treating immune conditions.
  962. Sherwood, Steven W., Methods for detecting targets.
  963. Francois J.-M. Iris FR; Jean-Louis Pourny FR, Methods for detection of nucleic acid polymorphisms using peptide-labeled oligonucleotides and antibody arrays.
  964. Burchard,Julja, Methods for determining the specificity and sensitivity of oligonucleo tides for hybridization.
  965. Marton Matthew ; Stoughton Roland, Methods for determining therapeutic index from gene expression profiles.
  966. Marton, Matthew; Stoughton, Roland, Methods for determining therapeutic index from gene expression profiles.
  967. Marton,Matthew; Stoughton,Roland, Methods for determining therapeutic index from gene expression profiles.
  968. Pardridge, William M.; Boado, Ruben J., Methods for diagnosing CNS disorders with fusion antibodies that cross the blood-brain barrier in both directions.
  969. Lederkremer, Gerardo Zelmar, Methods for diagnosing and monitoring liver diseases.
  970. Lal, Preeti G.; Williams, Gavin E.; Fry, Kirk E.; Sun, Jingtao; Dedrick, Russell L., Methods for diagnosing and monitoring the status of systemic lupus erythematosus.
  971. Pardridge, William M.; Boado, Ruben J., Methods for diagnosing and treating CNS disorders by trans-blood-brain barrier delivery of protein compositions.
  972. Ciossek,Thomas; Ullrich,Axel; Millauer,Birgit, Methods for diagnosis and treatment of MDK1 signal transduction disorders.
  973. Roland Stoughton ; Sergey Stepaniants, Methods for drug interaction prediction using biological response profiles.
  974. Lam, David; Weiner, David; Hitchman, Timothy; Barton, Nelson; Burk, Mark, Methods for enzymatic decolorization of chlorophyll.
  975. Simon, Jaime; King, A. Gaylord; Moreno Bermudez, Josue Manuel, Methods for generating radioimmunoconjugates.
  976. Gurney, Austin L.; Lazetic, Alexandra L. L.; Bond, Christopher J., Methods for identifying and isolating cells expressing a polypeptide.
  977. Gurney, Austin L.; Lazetic, Alexandra L. L.; Bond, Christopher J., Methods for identifying and isolating cells expressing a polypeptide.
  978. Gurney, Austin L.; Lazetic, Alexandra L. L.; Bond, Christopher J., Methods for identifying and isolating cells expressing a polypeptide.
  979. Gurney, Austin L.; Lazetic, Alexandra L. L.; Bond, Christopher J., Methods for identifying and isolating cells expressing a polypeptide.
  980. Gurney, Austin L.; Lazetic, Alexandra L. L.; Bond, Christopher J., Methods for identifying and isolating cells expressing a polypeptide.
  981. Karin, Michael; Kapahi, Pankaj, Methods for identifying and using IKK inhibitors.
  982. Karin,Michael; Kapahi,Pankaj, Methods for identifying and using IKK inhibitors.
  983. Gross, Jane A., Methods for inhibiting B lymphocyte proliferation with soluble ztnf4 receptor.
  984. Wells,Jim; Erlanson,Dan; Braisted,Andrew C., Methods for ligand discovery.
  985. Co, Man Sung; Vasquez, Maximiliano; Carreno, Beatriz; Celniker, Abbie Cheryl; Collins, Mary; Goldman, Samuel; Gray, Gary S.; Knight, Andrea; O'Hara, Denise; Rup, Bonita; Veldman, Geertruida M., Methods for modulation of immune responses using humanized immunoglobulins reactive with B7-1 molecules.
  986. Ausiello, Anthony; Salinas, Ruben; Thompson, Michael; Mackey, Daniel J.; Nardozzi, Kaitlyn; Friedman, Michael, Methods for predicting time-to-delivery in pregnant women.
  987. Cicardi, Marco; Bergamaschini, Luigi, Methods for preserving organs and tissues.
  988. Ghebrehiwet, Berhane, Methods for preventing and treating angioedema.
  989. Andrew David Griffiths GB; Samuel Cameron Williams GB; Peter Michael Waterhouse AU; Ahuva Nissim GB; Gregory Paul Winter GB; Kevin Stuart Johnson GB; Andrew John Hammond Smith GB, Methods for producing members of specific binding pairs.
  990. Johnson Kevin Stuart,GBX ; Winter Gregory Paul,GBX ; Griffiths Andrew David,GBX ; Smith Andrew John Hammond,GBX ; Waterhouse Peter Michael,AUX, Methods for producing members of specific binding pairs.
  991. McCafferty John,GBX ; Pope Anthony Richard,GBX ; Johnson Kevin Stuart,GBX ; Hoogenboom Henricus Renerus Jacobus Mattheus,GBX ; Griffiths Andrew David,GBX ; Jackson Ronald Henry,GBX ; Holliger Kaspar , Methods for producing members of specific binding pairs.
  992. McCafferty John,GBX ; Pope Anthony Richard,GBX ; Johnson Kevin Stuart,GBX ; Hoogenboom Henricus Renerus Jacobus Mattheus,GBX ; Griffiths Andrew David,GBX ; Jackson Ronald Henry,GBX ; Holliger Kaspar , Methods for producing members of specific binding pairs.
  993. McCafferty, John; Pope, Anthony Richard; Johnson, Kevin Stuart; Hoogenboom, Hendricus Renerus Jacobus Mattheus; Griffiths, Andrew David; Jackson, Ronald Henry; Holliger, Kaspar Philipp; Marks, James , Methods for producing members of specific binding pairs.
  994. McCafferty, John; Pope, Anthony Richard; Johnson, Kevin Stuart; Hoogenboom, Hendricus Reneus Jacobus Mattheus; Griffiths, Andrew David; Jackson, Ronald Henry; Holliger, Kaspar Philipp; Marks, James David; Clackson, Timothy Piers; Chiswell, David John; Winter, Gregory Paul; Bonnert, Timothy Peter, Methods for producing members of specific binding pairs.
  995. McCafferty, John; Pope, Anthony Richard; Johnson, Kevin Stuart; Hoogenboom, Henricus Renerus Jacobus Mattheus; Griffiths, Andrew David; Jackson, Ronald Henry; Holliger, Kaspar Philipp; Marks, James D, Methods for producing members of specific binding pairs.
  996. McCafferty, John; Pope, Anthony Richard; Johnson, Kevin Stuart; Hoogenboom, Henricus Renerus Jacobus Mattheus; Griffiths, Andrew David; Jackson, Ronald Henry; Holliger, Kaspar Philipp; Marks, James David; Clackson, Timothy Piers; Chiswell, David John; Winter, Gregory Paul; Bonnert, Timothy Peter, Methods for producing members of specific binding pairs.
  997. McCafferty, John; Pope, Anthony Richard; Johnson, Kevin Stuart; Hoogenboom, Henricus Renerus Jacobus Mattheus; Griffiths, Andrew David; Jackson, Ronald Henry; Holliger, Kaspar Philipp; Marks, James David; Clackson, Timothy Piers; Chiswell, David John; Winter, Gregory Paul; Bonnert, Timothy Peter, Methods for producing members of specific binding pairs.
  998. McCafferty, John; Pope, Anthony Richard; Johnson, Kevin Stuart; Hoogenboom, Henricus Renerus Jacobus Mattheus; Griffiths, Andrew David; Jackson, Ronald Henry; Holliger, Kasper Philipp; Marks, James David; Clackson, Timothy Piers; Chiswell, David John; Winter, Gregory Paul; Bonnert, Timothy Peter, Methods for producing members of specific binding pairs.
  999. McCafferty,John; Pope,Anthony Richard; Johnson,Kevin Stuart; Hoogenboom,Henricus Renerus Jacobus Mattheus; Griffiths,Andrew David; Jackson,Ronald Henry; Holliger,Kaspar Philipp; Marks,James David; Cl, Methods for producing members of specific binding pairs.
  1000. Winter Gregory Paul,GBX ; Johnson Kevin Stuart,GBX ; Griffiths Andrew David,GBX ; Smith Andrew John Hammond,GBX, Methods for producing members of specific binding pairs.
  1001. Winter Gregory Paul,GBX ; Johnson Kevin Stuart,GBX ; Griffiths Andrew David,GBX ; Smith Andrew John Hammond,GBX, Methods for producing members of specific binding pairs.
  1002. Winter Gregory Paul,GBX ; Johnson Kevin Stuart,GBX ; Griffiths Andrew David,GBX ; Smith Andrew John Hammond,GBX, Methods for producing members of specific binding pairs.
  1003. Winter Gregory Paul,GBX ; Johnson Kevin Stuart,GBX ; Griffiths Andrew David,GBX ; Smith Andrew John Hammond,GBX, Methods for producing members of specific binding pairs.
  1004. Whitlow Marc D. ; Wood James F. ; Hardman Karl D. ; Bird Robert E. ; Filpula David ; Rollence Michele, Methods for producing multivalent antigen-binding proteins.
  1005. Griffiths Andrew David,GBX ; Williams Samuel Cameron,GBX ; Waterhouse Peter Michael,AUX ; Nissim Ahuva,GBX ; Winter Gregory Paul,GBX ; Johnson Kevin Stuart,GBX ; Smith Andrew John Hammond,GBX, Methods for producing recombinant vectors.
  1006. Friend, Stephen H.; Stoughton, Roland; He, Yudong, Methods for removing artifact from biological profiles.
  1007. Weir, Malcolm Peter; Henderson, Richard; Tate, Christopher Gordon; Magnani, Francesca; Serrano-Vega, Maria Josefa; Shibata, Yoko; Warne, Antony Johannes, Methods for screening for binding partners of G-protein coupled receptors.
  1008. Weir, Malcolm Peter; Marshall, Fiona Hamilton, Methods for screening for binding partners of G-protein coupled receptors.
  1009. Broly, Herve; Ythier, Arnaud; Sievers, Eric, Methods for the treatment and prevention of abnormal cell proliferation using TACI-fusion molecules.
  1010. Flajolet, Marc; Greengard, Paul, Methods for the treatment of A-β related disorders and compositions therefor.
  1011. Broly, Herve; Ythier, Arnaud; Sievers, Eric; Busby, Sharon J.; Öhrström, Jan; Nestorov, Ivan; Ansell, Stephen M., Methods for treating B-cell malignancies using a TACI-Ig fusion molecule.
  1012. Broly, Herve; Visich, Jennifer; Nestorov, Ivan; Busby, Sharon; Gross, Jane, Methods for treating autoimmune diseases using a TACI-Ig fusion molecule.
  1013. Dong, Haidong; Harrington, Susan M.; Kwon, Eugene D.; Krco, Christopher J.; Liu, Xin, Methods for treating cancer in patients with elevated levels of BIM.
  1014. Demopulos, Gregory A.; Dudler, Thomas; Schwaeble, Hans-Wilhelm, Methods for treating conditions associated with MASP-2 dependent complement activation.
  1015. Demopulos, Gregory A.; Dudler, Thomas; Schwaeble, Hans-Wilhelm, Methods for treating conditions associated with MASP-2 dependent complement activation.
  1016. Demopulos, Gregory A.; Dudler, Thomas; Schwaeble, Hans-Wilhelm, Methods for treating conditions associated with MASP-2 dependent complement activation.
  1017. Demopulos, Gregory A.; Dudler, Thomas; Schwaeble, Hans-Wilhelm, Methods for treating conditions associated with MASP-2 dependent complement activation.
  1018. Schwaeble, Hans-Wilhelm; Tedford, Clark E.; Parent, James B.; Dudler, Thomas; Demopulos, Gregory A., Methods for treating conditions associated with MASP-2 dependent complement activation.
  1019. Schwaeble, Hans-Wilhelm; Dudler, Thomas; Tedford, Clark E.; Parent, James B.; Demopulos, Gregory A., Methods for treating disseminated intravascular coagulation by inhibiting MASP-2 dependent complement activation.
  1020. Friend Stephen H. ; Stoughton Roland, Methods for using co-regulated genesets to enhance detection and classification of gene expression patterns.
  1021. Friend, Stephen H.; Stoughton, Roland; He, Yudong, Methods for using co-regulated genesets to enhance detection and classification of gene expression patterns.
  1022. Stephen H. Friend ; Roland Stoughton ; Yudong He, Methods for using-co-regulated genesets to enhance detection and classification of gene expression patterns.
  1023. Ellies, Debra L., Methods of altering bone growth by administration of sost or wise antagonist or agonist.
  1024. Ellies, Debra L., Methods of altering bone growth by administration of sost or wise antagonist or agonist.
  1025. de Boer Mark,NLX ; Conroy Leah B., Methods of blocking T-cell activation using anti-B7 monoclonal antibodies.
  1026. Friend, Stephen H.; Stoughton, Roland; He, Yudong, Methods of characterizing drug activities using consensus profiles.
  1027. Peled, Tony; Fibach, Eitan; Treves, Avi, Methods of controlling proliferation and differentiation of stem and progenitor cells.
  1028. Peled, Tony; Fibach, Eitan; Treves, Avi, Methods of controlling proliferation and differentiation of stem and progenitor cells.
  1029. Peled,Tony; Fibach,Eitan; Treves,Avi, Methods of controlling proliferation and differentiation of stem and progenitor cells.
  1030. Peled,Tony; Fibach,Eitan; Treves,Avi, Methods of controlling proliferation and differentiation of stem and progenitor cells.
  1031. Peled, Tony; Steinhardt, Yair, Methods of culturing and expanding mesenchymal stem cells.
  1032. Letai, Anthony G., Methods of determining cellular chemosensitivity.
  1033. Friend Stephen H. ; Stoughton Roland, Methods of determining protein activity levels using gene expression profiles.
  1034. Peled, Tony; Treves, Avi; Rosen, Oren, Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby.
  1035. Peled,Tony; Treves,Avi; Rosen,Oren, Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby.
  1036. Nudelman, Edward, Methods of identifying glycopeptides recognized by disease-associated auto-antibodies.
  1037. Peled, Tony, Methods of improving stem cell homing and engraftment.
  1038. Bishop, Gail; Vanden Bush, Tony, Methods of improving vaccine immunogenicity.
  1039. Reyes, Christopher L.; Chu, Peter; Tan, Xiangyang; Graff, Christilyn; Yang, Weixing, Methods of inhibiting growth of a colon cancer tumor in a subject by administering monoclonal antibodies to G protein-coupled receptor 49 (GPR49).
  1040. Greene, Mark I.; Murali, Ramachandran; Kinosaki, Masahiko, Methods of inhibiting osteoclast activity.
  1041. Greene, Mark I.; Murali, Ramachandran; Kinosaki, Masahiko, Methods of inhibiting osteoclast activity.
  1042. Greene, Mark I; Murali, Ramachandran; Kinosaki, Masahiko, Methods of inhibiting osteoclast activity.
  1043. Greene, Mark I.; Murali, Ramachandran; Aoki, Kazuhiro; Horne, William Carle; Baron, Roland, Methods of inhibiting osteoclastogenesis.
  1044. Reyes, Christopher L.; Chu, Peter; Tan, Xiangyang; Graff, Christilyn; Yang, Weixing, Methods of inhibiting solid tumor growth by administering GPR49 antibodies.
  1045. Muller, William A.; Schenkel, Alan R., Methods of inhibiting transendothelial migration of neutrophils and monocytes with anti-CD99L2 antibodies.
  1046. Pastan, Ira H.; Lee, Byungkook; Jung, Sun-Hee; Brinkmann, Ulrich, Methods of making recombinant disulfide-stabilized polypeptide fragments having binding specificity.
  1047. Rother, Russell P.; Sheridan, Douglas L.; Tamburini, Paul P.; Zhang, Yuchun, Methods of producing anti-C5a antibodies.
  1048. Gillies, Stephen D.; Lo, Kin Ming, Methods of targeting multiple cytokines.
  1049. Baker, Jr., James R.; Sternson, Larry A.; Repp, David; Ladenheim, Deborah, Methods of treating autoimmune disorders and/or inflammatory disorders.
  1050. Reyes, Christopher L.; Chu, Peter; Tan, Xiangyang; Yang, Weixing; Graff, Christilyn, Methods of treating cancer by administering anti-GPR49 antibodies.
  1051. Salcedo,Theodora W.; Ruben,Steven M.; Rosen,Craig A.; Albert,Vivian R.; Dobson,Claire; Vaughan,Tristan, Methods of treating cancer using antibodies that immunospecifically bind to TRAIL receptors.
  1052. Salcedo,Theodora W.; Ruben,Steven M.; Rosen,Craig A.; Albert,Vivian R.; Dobson,Claire; Vaughan,Tristan, Methods of treating cancer using antibodies that immunospecifically bind to trail receptors.
  1053. Rother, Russell P.; Sheridan, Douglas L.; Tamburini, Paul P.; Zhang, Yuchun, Methods of treating complement-associated disorders with anti-C5a antibodies.
  1054. Rother, Russell P.; Sheridan, Douglas L.; Tamburini, Paul P.; Zhang, Yuchun, Methods of treating complement-associated disorders with anti-C5a antibodies.
  1055. Kornecki, Elizabeth; Babinska, Anna; Ehrlich, Yigal H., Methods of treating disorders by administration of F11 receptor antagonists.
  1056. Jaspers, Stephen R.; Presnell, Scott R., Methods of treating inflammation using IL-17A and IL-17F cross-reactive monoclonal antibodies.
  1057. Jaspers, Stephen R.; Presnell, Scott R.; Huber, Monica J., Methods of treating inflammatory diseases using antibodies that bind both IL-17A and IL-17F.
  1058. Okuse, Kenji; Pristera, Alessandro; Rice, Andrew, Methods of treating pain by inhibition of VGF activity.
  1059. Kudaravalli, Sridhar; Polymeropoulos, Mihael Hristos, Methods of treating psychosis and schizophrenia based on polymorphisms in the CNTF gene.
  1060. Mueller, Bernhard K., Methods of treating retinal nerve fiber layer degeneration with monoclonal antibodies against a retinal guidance molecule (RGM) protein.
  1061. Co, Man Sung; Vasquez, Maximiliano; Carreno, Beatriz; Celniker, Abbie Cheryl; Collins, Mary; Goldman, Samuel; Gray, Gary S.; Knight, Andrea; O'Hara, Denise; Rup, Bonita; Veldman, Geertruida M., Methods of treatment of autoimmune diseases using humanized immunoglobulin reactive with B7-2.
  1062. Adams, Ralph; Baker, Terence Seward; Lawson, Alastair David Griffiths, Methods of treatment using antibodies which bind IL-17A and IL-17F.
  1063. Wei,Ying Fei; Ni,Jian; Gentz,Reiner L.; Ruben,Steven M., Methods of treatment with TNFR5.
  1064. Super, Michael; Davis, Jonathan; Stein, Pascal Andre, Methods of use of anti-CD19 antibodies with reduced immunogenicity.
  1065. Gillies, Stephen D.; Lo, Kin-Ming; Wesolowski, Jr., John S., Methods of using Fc-cytokine fusion proteins.
  1066. Deo, Yashwant M.; Keler, Tibor; Treml, John; Endres, Michael, Methods of using molecular conjugates comprising monoclonal antibodies to dendritic cells.
  1067. Kung Sutherland, Mary S.; Geoghegan, James Charles; Latham, John; Yu, Changpu, Methods to increase or decrease bone density.
  1068. Kung Sutherland, May S.; Geoghegan, James Charles; Latham, John; Yu, Changpu, Methods to increase or decrease bone density.
  1069. Pentyala, Srinivas N., Methods, antibodies and kits for detecting cerebrospinal fluid in a sample.
  1070. Jablonski, Edward; Adams, Thomas, Microbubbles for affinity separation.
  1071. Jablonski, Edward; Adams, Thomas, Microbubbles for affinity separation.
  1072. Barth, Stefan; Thepen, Theopilus; Hristodorov, Dmitrij; Mladenov, Radoslav, Microtubule-modifying compound.
  1073. Studnicka Gary M., Modified antibody variable domains.
  1074. Studnicka Gary M., Modified antibody variable domains.
  1075. Studnicka Gary M., Modified antibody variable domains and therapeutic uses thereof.
  1076. Jankun, Jerzy; Skrzypczak-Jankun, Ewa; Selman, Steven H., Modified plasminogen activator inhibitor type-1 molecule and methods based thereon.
  1077. Rosenblum, Michael G.; Cheung, Lawrence, Modified proteins, designer toxins, and methods of making thereof.
  1078. Rosenblum, Michael G.; Cheung, Lawrence, Modified proteins, designer toxins, and methods of making thereof.
  1079. Rosenblum,Michael G.; Cheung,Lawrence, Modified proteins, designer toxins, and methods of making thereof.
  1080. Rosenblum,Michael G.; Cheung,Lawrence, Modified proteins, designer toxins, and methods of making thereof.
  1081. Apuya, Nestor; Bobzin, Steven Craig; Park, Joon-Hyun, Modulating plant alkaloids.
  1082. Bobzin, Steven Craig; Apuya, Nestor; Chiang, Karen; Doukhanina, Elena; Feldmann, Kenneth; Jankowski, Boris; Margolles-Clark, Emilio; Mumenthaler, Daniel; Okamuro, Jack; Park, Joon-Hyun; Ragab, Amr Saad; Rarang, Joel Cruz; Schneeberger, Richard; Van Fleet, Jennifer E.; Zhang, Ke, Modulating the level of components within plants.
  1083. Strittmatter, Stephen; Mueller, Bernhard; Deitinghoff, Lutz, Modulators and modulation of the interaction between RGM and Neogenin.
  1084. Friedman, Jeffrey M.; Zhang, Yiying; Proenca, Ricardo, Modulators of body weight, corresponding nucleic acids and proteins.
  1085. Friedman Jeffrey M. ; Zhang Yiying ; Proenca Ricardo, Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof.
  1086. Cancedda, Laura; Ben-Ari, Yehezkel; Constestabile, Andrea, Modulators of intracellular chloride concentration for treating down syndrome.
  1087. Deo, Yashwant M.; Keler, Tibor; Treml, John; Endres, Michael, Molecular conjugates comprising human monoclonal antibodies to dendritic cells.
  1088. Chaplin, Jay; Hayden-Ledbetter, Martha; Ledbetter, Jeffrey; Clark, Edward A., Molecules that bind CD180, compositions and methods of use.
  1089. Hayden-Ledbetter, Martha; Ledbetter, Jeffrey, Molecules that bind CD180, compositions and methods of use.
  1090. Amir, Abraham, Monitoring skin metabolism products for evaluating burn injury.
  1091. Hillen, Heinz; Barghorn, Stefan; Labkovsky, Boris; Ebert, Ulrich; Striebinger, Andreas R.; Keller, Patrick, Monoclonal antibodies against amyloid beta protein and uses thereof.
  1092. Sahin, Ugur; Tureci, Ozlem; Usener, Dirk; Fritz, Stefan; Uherek, Christoph; Brandenburg, Gunda; Geppert, Harald-Gerhard; Schroder, Anja Kristina; Thiel, Phillippe, Monoclonal antibodies against claudin-18 for treatment of cancer.
  1093. Sahin, Ugur; Türeci, Özlem; Usener, Dirk; Fritz, Stefan; Uherek, Christoph; Brandenburg, Gunda; Geppert, Harald-Gerhard; Schröder, Anja Kristina; Thiel, Phillippe, Monoclonal antibodies against claudin-18 for treatment of cancer.
  1094. Sahin, Ugur; Türeci, Özlem; Usener, Dirk; Fritz, Stefan; Uherek, Christoph; Brandenburg, Gunda; Geppert, Harald-Gerhard; Schröder, Anja Kristina; Thiel, Phillippe, Monoclonal antibodies against claudin-18 for treatment of cancer.
  1095. Sahin, Ugur; Türeci, Özlem; Usener, Dirk; Fritz, Stefan; Uherek, Christoph; Brandenburg, Gunda; Geppert, Harald-Gerhard; Schröder, Anja Kristina; Thiel, Phillippe, Monoclonal antibodies against claudin-18 for treatment of cancer.
  1096. Sahin, Ugur; Türeci, Özlem; Usener, Dirk; Fritz, Stefan; Uherek, Christoph; Brandenburg, Gunda; Geppert, Harald-Gerhard; Schröder, Anja Kristina; Thiel, Phillippe, Monoclonal antibodies against claudin-18 for treatment of cancer.
  1097. Burioni, Roberto; Clementi, Massimo, Monoclonal antibodies as a medicament for the therapeutic and/or prophylactic treatment of swine-origin influenza A (H1N1) virus (S-OIV) infections.
  1098. Burioni, Roberto; Clementi, Massimo, Monoclonal antibodies capable of reacting with a plurality of influenza virus A subtypes.
  1099. Burioni, Roberto; Clementi, Massimo, Monoclonal antibodies capable of reacting with a plurality of influenza virus A subtypes.
  1100. Sahin, Ugar; Koslowski, Michael; Tureci, Ozlem, Monoclonal antibodies for treatment of cancer.
  1101. Sahin, Ugur; Koslowski, Michael; Tureci, Ozlem, Monoclonal antibodies for treatment of cancer.
  1102. Sahin, Ugur; Koslowski, Michael; Türeci, Özlem, Monoclonal antibodies for treatment of cancer.
  1103. Sahin, Ugur; Koslowski, Michael; Türeci, Özlem, Monoclonal antibodies for treatment of cancer.
  1104. Sahin, Ugur; Tureci, Ozlem; Koslowski, Michael; Mitnacht-Kraus, Rita, Monoclonal antibodies for treatment of cancer.
  1105. Sahin, Ugur; Tureci, Ozlem; Koslowski, Michael; Mitnachtkraus, Rita, Monoclonal antibodies for treatment of cancer.
  1106. Burioni, Roberto; Clementi, Massimo, Monoclonal antibodies having homosubtype cross-neutralization properties against influenza A viruses subtype H1.
  1107. Jaspers, Stephen R.; Presnell, Scott R.; Huber, Monica J., Monoclonal antibodies that bind both IL-17A and IL-17F.
  1108. Deo, Yashwant M.; Keler, Tibor; Treml, John; Endres, Michael, Monoclonal antibodies to dendritic cells.
  1109. Lundgren Åkerlund,Evy, Monoclonal antibody capable of binding integrin alpha 10 beta 1.
  1110. Lundgren-Akerlund, Evy, Monoclonal antibody capable of binding integrin alpha 10 beta 1.
  1111. Lundgren-Ãkerlund, Evy, Monoclonal antibody capable of binding integrin alpha 10 beta 1.
  1112. Lundgren-Äkerlund, Evy, Monoclonal antibody capable of binding integrin alpha 10 beta 1.
  1113. Lundgren-Åkerlund, Evy, Monoclonal antibody capable of binding integrin alpha 10 beta 1.
  1114. Arlen, Myron; Tsang, Kwong, Monoclonal antibody therapy for pancreas cancer.
  1115. Arlen, Myron; Tsang, Kwong, Monoclonal antibody therapy for pancreas cancer.
  1116. Metchetner Eugene ; Roninson Igor B., Monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses.
  1117. Hnatowich, Donald J.; Rusckowski, Mary; Liu, Guozheng, Morpholino imaging and therapy.
  1118. Pasternak,Gavril W.; Pan,Ying Xian, Mu-Opiod receptor splice variant polypeptides.
  1119. Pandey, Ravindra K.; Goswami, Lalit; Spernyak, Joseph; Kanter, Peter; Mazurchuk, Richard, Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents.
  1120. Hufton, Simon E.; Hoogenboom, Hendricus R. J. M., Multi-chain eukaryotic display vectors and uses thereof.
  1121. Hufton, Simon E.; Hoogenboom, Hendricus R. J. M., Multi-chain eukaryotic display vectors and uses thereof.
  1122. Hufton, Simon E.; Hoogenboom, Hendricus R. J. M., Multi-chain eukaryotic display vectors and uses thereof.
  1123. Hufton, Simon E.; Hoogenboom, Hendricus R. J. M., Multi-chain eukaryotic display vectors and uses thereof.
  1124. Brogan,John Bucknam, Multifunctional cross-bridged tetraaza macrocyclic compounds and methods of making and using.
  1125. James R. Baker, Jr. ; Donald A. Tomalia, Multifunctional nanodevice platform.
  1126. Baker, Jr., James R.; Huang, Baohua M.; Thomas, Thommey P., Multifunctional small molecules.
  1127. Baker, Jr., James R.; Zong, Hong; Thomas, Thommey P., Multifunctional small molecules.
  1128. Schmidt, Karsten, Multimer glycosylated nucleic acid binding protein conjugates and uses thereof.
  1129. Fang, Fang; Luo, Guang-Xiang; Kohlstaedt, Lori Allison; Charles, Catherine Helen, Multimeric proteins and methods of making and using same.
  1130. Gillies, Stephen D.; Lo, Kin-Ming, Multiple cytokine protein complexes.
  1131. Gillies,Stephen D.; Lo,Kin Ming, Multiple cytokine protein complexes.
  1132. Chang, Chien-Hsing; Goldenberg, David M.; Rossi, Edmund A., Multiple signaling pathways induced by hexavalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases.
  1133. Chang, Chien-Hsing; Goldenberg, David M.; Rossi, Edmund A., Multiple signaling pathways induced by hexavalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases.
  1134. Chang, Chien-Hsing; Goldenberg, David M.; Rossi, Edmund A., Multiple signaling pathways induced by hexvalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases.
  1135. Davis Paul J.,GBX ; Logt van der Cornelis P.,GBX ; Verhoeyen Martine E.,GBX, Multivalent and multispecific antigen-binding protein.
  1136. Kaspar-Philip Holliger GB; Andrew David Griffiths GB; Hendricus Renerus Jacobus Matheus Hoogenboom BE; Magnus Malmqvist SE; James David Marks ; Brian Timothy McGuinness GB; Anthony Richard Pope, Multivalent and multispecific binding proteins and their use.
  1137. Holliger Kaspar-Philipp,GBX ; Griffiths Andrew David,GBX ; Hoogenboom Hendricus Renerus Jacobus Matheus,BEX ; Malmqvist Magnus,SEX ; Marks James David ; McGuinness Brian Timothy,GBX ; Pope Anthony Ri, Multivalent and multispecific binding proteins, their manufacture and use.
  1138. Holliger,Kaspar Philipp; Griffiths,Andrew David; Hoogenboom,Hendricus Renerus Jacobus Matheus; Malmqvist,Magnus; Marks,James David; McGuinness,Brian Timothy; Pope,Anthony Richard; Prospero,Terence De, Multivalent and multispecific binding proteins, their manufacture and use.
  1139. Whitlow Marc D. ; Wood James F. ; Hardman Karl D. ; Bird Robert E. ; Filpula David ; Rollence Michele, Multivalent antigen-binding proteins.
  1140. Whitlow Marc D. ; Wood James F. ; Hardman Karl D. ; Bird Robert E. ; Filpula David ; Rollence Michele, Multivalent antigen-binding proteins.
  1141. Whitlow Marc D. ; Wood James F. ; Hardman Karl D. ; Bird Robert E. ; Filpula David ; Rollence Michele, Multivalent antigen-binding proteins.
  1142. Whitlow, Marc D.; Wood, James F.; Hardman, Karl D.; Bird, Robert E.; Filpula, David; Rollence, Michele, Multivalent antigen-binding proteins.
  1143. Dixit, Surjit Bhimarao; D'Angelo, Igor Edmondo Paolo; Poon, David Kai Yuen, Multivalent heteromultimer scaffold design and constructs.
  1144. Dixit, Surjit Bhimarao; D'Angelo, Igor Edmondo Paolo; Sanches, Mario; Ng, Gordon Yiu Kon, Multivalent heteromultimer scaffold design and constructs.
  1145. Dixit, Surjit Bhimarao; D'Angelo, Igor Edmundo Paolo; Poon, David Kai Yuen, Multivalent heteromultimer scaffold design and constructs.
  1146. Mezes Peter S. ; Gourlie Brian B., Multivalent single chain antibodies.
  1147. Mezes Peter S. ; Gourlie Brian B., Multivalent single chain antibodies.
  1148. Henderson, Richard; Tate, Christopher Gordon; Magnani, Francesca; Serrano-Vega, Maria Josefa; Shibata, Yoko; Warne, Antony Johannes; Weir, Malcolm Peter, Mutant G-protein coupled receptors and methods for selecting them.
  1149. Oh, Youngman; Rosenfeld, Ron G.; Buckway, Caroline K., Mutant IGFBP-3 molecules that do not bind to IGFs, but retain their ability to functionally bind IGFBP-3 receptor.
  1150. Heal, Jonathan Richard; Henderson, Richard; Tate, Christopher Gordon; Weir, Malcolm Peter, Mutant proteins and methods for producing them.
  1151. Jazayeri-Dezfuly, Seyed Ali; Lebon, Guillaume Pierre; Marshall, Fiona Hamilton; Tate, Christopher Gordon; Robertson, Nathan, Mutant proteins and methods for producing them.
  1152. Weir, Malcolm Peter; Henderson, Richard; Tate, Christopher Gordon; Hulme, Edward Christopher, Mutant proteins and methods for selecting them.
  1153. Barry E. Rothenberg ; Ritsuko Sawada-Hirai ; James C. Barton, Mutations associated with iron disorders.
  1154. Rothenberg, Barry E.; Sawada-Hirai, Ritsuko; Barton, James C., Mutations associated with iron disorders.
  1155. Rothenberg, Barry E.; Sawada-Hirai, Ritsuko; Barton, James C., Mutations associated with iron disorders.
  1156. Iadonato, Shawn P.; Magness, Charles L.; Fellin, P. Campion; Scherer, Christina A.; Hagen, Tory; Olson, Amy, Mutations in OAS1 genes.
  1157. Iadonato, Shawn P; Magness, Charles L; Fellin, P Campion; Scherer, Christina A; Hagen, Tory; Olson, Amy, Mutations in OAS1 genes.
  1158. Mi, Sha; McCoy, John; Pepinsky, R. Blake; Lee, Daniel H. S., NOGO receptor binding protein.
  1159. Mi, Sha; McCoy, John; Pepinsky, R. Blake; Lee, Daniel H. S., NOGO receptor binding protein.
  1160. Naasani, Imad, Nanocrystals.
  1161. Naasani,Imad, Nanocrystals.
  1162. Golomb, Gershon; Sacks, Haigt; Najareh, Yousef; Fishbein, Elia; Chorny, Michael, Nanoparticles containing polymeric nucleic acid homologs.
  1163. Noda, Masaharu; Watanabe, Eiji, Nav2 channel gene-deficient mice.
  1164. Chakraborty, Subhasish K.; Zhang, Mingrui; Waggoner, Alan S., Near infrared fluorogen and fluorescent activating proteins for in vivo imaging and live-cell biosensing.
  1165. Tainsky, Michael A.; Draghici, Sorin; Lin, Ho-Sheng, Neoepitope detection of disease using protein arrays.
  1166. Zhou, Mingdong, Neukinase, a downstream protein of neuregulin.
  1167. Zhou, Mingdong, Neukinase, a downstream protein of neuregulin.
  1168. Berezin, Vladimir; Bock, Elisabeth, Neuritogenic peptides.
  1169. Berezin, Vladimir; Bock, Elisabeth, Neuritogenic peptides.
  1170. Imai, Toshio; Kline, Brad; Kawano, Tetsu; Grasso, Luigi; Sakamoto, Yoshimasa; Spidel, Jared; Nishimura, Miyuki; Muramoto, Kenzo; Horizoe, Tatsuo, Neutralizing anti-CCL20 antibodies.
  1171. Imai, Toshio; Kline, James Bradford; Kawano, Tetsu; Grasso, Luigi; Sakamoto, Yoshimasa; Spidel, Jared; Nishimura, Miyuki; Muramoto, Kenzo; Horizoe, Tatsuo, Neutralizing anti-CCL20 antibodies.
  1172. Pilkington, Glenn R.; Gilmour, Page S.; Chanock, Robert M.; Crowe, Jr., James E.; Murphy, Brian R., Neutralizing monoclonal antibodies to respiratory syncytial virus.
  1173. Pilkington,Glenn R.; Gilmour,Page S.; Chanock,Robert M.; Crowe, Jr.,James E.; Murphy,Brian R., Neutralizing monoclonal antibodies to respiratory syncytial virus.
  1174. Mi, Sha; McCoy, John; Pepinsky, R. Blake; Lee, Daniel H. S., Nogo receptor binding protein.
  1175. Lederkremer, Gerardo Z.; Kondratyev, Maria, Non-invasive marker for liver function and disease.
  1176. Lederkremer, Gerardo Zelmar; Kondratyev, Maria, Non-invasive marker for liver function and disease.
  1177. Ildstad Suzanne T. ; Bergheim Olav B., Non-lethal conditioning methods for the treatment of acquired immunodeficiency syndrome.
  1178. Farnet,Chirs M.; Staffa,Alfredo, Nucleic acid fragment encoding an NRPS for the biosynthesis of anthramycin.
  1179. Farnet,Chris M.; Staffa,Alfredo, Nucleic acid fragment encoding an NRPS for the biosynthesis of anthramycin.
  1180. Madison,Edwin L.; Yeh,Jiunn Chern, Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon.
  1181. Madison,Edwin L.; Ong,Edgar O., Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon.
  1182. Madison,Edwin L.; Ong,Edgar O., Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon.
  1183. McDonald,John R.; Coggins,Philip J., Nucleic acid molecules encoding cytotoxic conjugates that contain a chemokine receptor targeting agent.
  1184. Madison,Edwin L.; Yeh,Jiunn Chern, Nucleic acid molecules encoding serine protease CVSP14, the encoded polypeptides and methods based thereon.
  1185. Whitlow Marc D. ; Hardman Karl D. ; Bird Robert E. ; Filpula David, Nucleic acid molecules encoding single-chain antigen-binding proteins.
  1186. Madison, Edwin L.; Ong, Edgar O.; Yeh, Jiunn-Chern, Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon.
  1187. Madison, Edwin L.; Ong, Edgar O.; Yeh, Jiunn-Chern, Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon.
  1188. Friedman Jeffrey M. ; Zhang Yiying ; Proenca Ricardo ; Maffei Margherita, Nucleic acid primers and probes for the mammalian OB gene.
  1189. Farnet,Chris M.; Staffa,Alfredo; Zazopoulos,Emmanuel, Nucleic acids encoding an enediyne polyketide synthase complex.
  1190. Rother, Russell P.; Sheridan, Douglas L.; Tamburini, Paul P.; Zhang, Yuchun, Nucleic acids encoding anti-C5a antibodies.
  1191. Ring David B., Nucleic acids encoding antigen-binding sites specific for cancer antigens.
  1192. Sadelain,Michel; Brentjens,Renier; Maher,John, Nucleic acids encoding chimeric T cell receptors.
  1193. Madison,Edwin L.; Ong,Edgar O., Nucleic acids encoding endotheliases, endotheliases and uses thereof.
  1194. Pastan Ira ; Kuan Chien-Tsun, Nucleic acids encoding immunotoxins containing a disulfide-stabilized antibody fragment replacing half or more of domain IB of pseudomonas exotoxin, and methods of use of the encoded immunotoxins.
  1195. Friedman, Jeffrey M.; Zhang, Yiying; Proenca, Ricardo; Maffei, Margherita; Halaas, Jeffrey L.; Gajiwala, Ketan; Burley, Stephen K., Nucleic acids encoding modulators of body weight.
  1196. Imai, Toshio; Kline, James Bradford; Kawano, Tetsu; Grasso, Luigi; Sakamoto, Yoshimasa; Spidel, Jared; Nishimura, Miyuki; Muramoto, Kenzo; Horizoe, Tatsuo, Nucleic acids encoding neutralizing anti-CCL20 antibodies.
  1197. Rossi, Edmund A.; Chang, Chien Hsing; McBride, William John, Nucleic acids encoding polyvalent protein complexes.
  1198. Rother, Russell P.; Sheridan, Douglas L.; Tamburini, Paul P.; Zhang, Yuchun, Nucleic acids encodng anti-C5A antibodies.
  1199. Friedman Jeffrey M. ; Zhang Yiying ; Proenca Ricardo, OB polypeptide antibodies and method of making.
  1200. Jeffrey M. Friedman ; Yiying Zhang ; Ricardo Proenca, OB polypeptides and modified forms as modulators of body weight.
  1201. Friedman Jeffrey M. ; Zhang Yiying ; Proenca Ricardo, OB polypeptides as modulators of body weight.
  1202. Friedman Jeffrey M. ; Zhang Yiying ; Proenca Ricardo, OB polypeptides, modified forms and compositions.
  1203. Choi, Yongwon, OCL-2A3 compositions and uses thereof.
  1204. Choi, Yongwon, OCL-2A3 compositions and uses thereof.
  1205. Jeffrey M. Friedman ; Yiying Zhang ; Ricardo Proenca, Ob polypeptides, modified forms and compositions thereto.
  1206. Dayton, Christopher L. G.; Galhardo, Flavio Da Silva; Barton, Nelson; Hitchman, Tim; Lyon, Jonathan; O'Donoghue, Eileen; Wall, Mark A., Oil degumming methods.
  1207. Dayton, Christopher L. G.; Galhardo, Flavio Da Silva; Barton, Nelson; Hitchman, Tim; Lyon, Jonathan; O'Donoghue, Eileen; Wall, Mark A., Oil degumming methods.
  1208. Szalay, Aladar A.; Cappello, Joseph; Chen, Nanhai G.; Minev, Boris, Oncolytic virus adjunct therapy with agents that increase virus infectivity.
  1209. Harper, James Douglas; Mathews, Richard Hart; Johnson, Bernadette; Petrovick, Martha Susan; Rundell, Ann; Nargi, Frances Ellen; Stephens, Timothy; Mendenhall, Linda Marie; Hollis, Mark Alexander; Young, Albert M.; Rider, Todd H.; Schwoebel, Eric David; Vian, Trina Rae, Optoelectronic detection system.
  1210. Harper,James Douglas; Mathews,Richard Hart; Johnson,Bernadette; Petrovick,Martha Susan; Rundell,Ann; Nargi,Frances Ellen; Stephens,Timothy; Mendenhall,Linda Marie; Hollis,Mark Alexander; Young,Albert, Optoelectronic detection system.
  1211. Schwoebel, Eric D.; Harper, James D.; Petrovick, Martha S.; Nargi, Frances E.; Rider, Todd H.; Hogan, Kristine E.; Mathews, Richard H.; Lacirignola, Joseph; Hennessy, Mark; Vian, Trina R.; Joseph, Rose M.; Uttaro, Raymond S.; Berry, Shaun; Johnson, Bernadette; Hollis, Mark A., Optoelectronic detection system.
  1212. Schwoebel, Eric D.; Harper, James D.; Petrovick, Martha S.; Nargi, Frances E.; Rider, Todd H.; Hogan, Kristine E.; Mathews, Richard H.; Lacirignola, Joseph; Hennessy, Mark; Vian, Trina R.; Joseph, Rose M.; Uttaro, Raymond S.; Berry, Shaun; Johnson, Bernadette; Hollis, Mark A., Optoelectronic detection system.
  1213. Schwoebel, Eric D.; Harper, James D.; Petrovick, Martha S.; Nargi, Frances E.; Rider, Todd H.; Hogan, Kristine E.; Mathews, Richard H.; Lacirignola, Joseph; Hennessy, Mark; Vian, Trina R.; Joseph, Rose M.; Uttaro, Raymond S.; Berry, Shaun; Johnson, Bernadette; Hollis, Mark A., Optoelectronic detection system.
  1214. Schwoebel,Eric D.; Harper,James D.; Petrovick,Martha S.; Nargi,Frances E.; Rider,Todd H.; Hogan,Kristine E.; Mathews,Richard H.; Lacirignola,Joseph; Hennessy,Mark; Vian,Trina R.; Joseph,Rose M.; Uttaro,Raymond S.; Berry,Shaun; Johnson,Bernadette; Hollis,Mark A., Optoelectronic detection system.
  1215. Rider, Todd H.; Bortolin, Laura, Optoelectronic sensor.
  1216. Zhang, Qiang; Peng, Youyi; Li, Peng; Beard, J. David; Wennogle, Lawrence P.; Tomesch, John, Organic compounds.
  1217. Owyang, Chung, Orphanin FQ receptor nucleic acids.
  1218. Karsenty, Gerard; Oury, Franck, Osteocalcin as a treatment for cognitive disorders.
  1219. Karsenty, Gerard; Ducy, Patricia F., Osteocalcin as a treatment for male reproductive disorders.
  1220. Choi,Yongwon, Osteoclast-specific genes and proteins and uses thereof.
  1221. Thiele, Michael; Kerschbaumer, Randolf J.; Voelkel, Dirk; Douillard, Patrice; Scheiflinger, Friedrich, OxMIF as a diagnostic marker.
  1222. Smith, Jonathan D.; Hazen, Stanley L., Oxidant resistant apolipoprotein A-1 and mimetic peptides.
  1223. Smith, Jonathan D.; Hazen, Stanley L., Oxidant resistant apolipoprotein A-1 and mimetic peptides.
  1224. Smith, Jonathan D.; Hazen, Stanley L., Oxidant resistant apolipoprotein A-1 and mimetic peptides.
  1225. Jefferies, Wilfred; Tian, Mei Mei; Vitalis, Timothy, P97 fragments with transfer activity.
  1226. Jefferies, Wilfred; Tian, Mei Mei; Vitalis, Timothy, P97 fragments with transfer activity.
  1227. Jefferies, Wilfred; Vitalis, Timothy Z.; Gabathuler, Reinhard, P97-antibody conjugates and methods of use.
  1228. Vitalis, Timothy Z.; Gabathuler, Reinhard, P97-antibody conjugates and methods of use.
  1229. Jefferies, Wilfred; Gabathuler, Reinhard, P97-polynucleotide conjugates.
  1230. Vergnolle, Nathalie; Riteau, Beatrice, PAR2 agonists for use in the treatment or prevention of influenza virus type A infections.
  1231. Hoff, Kirsten Damgaard; Gjørret, Jakob O.; Pii, Kurt; Jensen, Sussie Steen; Winther, Henrik, PAX 5 monoclonal antibody.
  1232. La Du, Bert N.; Draganov, Dragomir I.; Stetson, Phillip L.; Watson, Catherine E., PON3 and uses thereof.
  1233. La Du, Bert N.; Draganov, Dragomir I.; Stetson, Phillip L.; Watson, Catherine E., PON3 and uses thereof.
  1234. Goddard, Audrey; Godowski, Paul J; Gurney, Austin L; Smith, Victoria; Wood, William I, PRO1120 polypeptides.
  1235. Schlessinger, Joseph; Okigaki, Mitsuhiko; Gishizky, Mikhail, PYK2 and inflammation.
  1236. Schlessinger Joseph ; Lev Sima, PYK2 related polynucleotide products.
  1237. Schwoebel, Eric; Harper, James; Petrovick, Martha S.; Nargi, Frances; Hollis, Mark; Johnson, Bernadette; Lacirignola, Joseph; Mathews, Richard; Hogan, Kristine; Vian, Trina; Heff, Allan; Hennessy, Mark; Palchaudhuri, Songeeta; Rider, Todd, Pathogen detection biosensor.
  1238. Schwoebel, Eric; Harper, James; Petrovick, Martha S.; Nargi, Frances; Hollis, Mark; Johnson, Bernadette; Lacirignola, Joseph; Mathews, Richard; Hogan, Kristine; Vian, Trina; Heff, Allan; Hennessy, Mark; Palchaudhuri, Songeeta; Rider, Todd, Pathogen detection biosensor.
  1239. Doronina,Svetlana; Senter,Peter D.; Toki,Brian E., Pentapeptide compounds and uses related thereto.
  1240. Doronina,Svetlana; Senter,Peter D.; Toki,Brian E., Pentapeptide compounds and uses related thereto.
  1241. Herkel, Johannes; Cohen, Irun R.; Rotter, Varda; Lohse, Ansgar W.; Erez, Neta; Mimran, Avishai; Kam, Na'aman, Peptide inhibitors for mediating stress responses.
  1242. Herkel, Johannes; Cohen, Irun R.; Rotter, Varda; Lohse, Ansgar W.; Erez, Neta; Mimran, Avishai; Kam, Na'aman, Peptide inhibitors for mediating stress responses.
  1243. Yemini, Miri; Reches, Meital; Rishpon, Judith; Gazit, Ehud, Peptide nanostructure-coated electrodes.
  1244. Reches, Meital; Gazit, Ehud, Peptide nanostructures and methods of generating and using the same.
  1245. Reches, Meital; Gazit, Ehud, Peptide nanostructures and methods of generating and using the same.
  1246. Reches, Meital; Gazit, Ehud, Peptide nanostructures and methods of generating and using the same.
  1247. Reches,Meital; Gazit,Ehud, Peptide nanostructures and methods of generating and using the same.
  1248. Reches, Meital; Gazit, Ehud, Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same.
  1249. Reches, Meital; Gazit, Ehud, Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same.
  1250. Gazit, Ehud; Reches, Meital, Peptide nanostructures encapsulating a foreign material and method of manufacturing same.
  1251. Gazit, Ehud; Reches, Meital, Peptide nanostructures encapsulating a foreign material and method of manufacturing same.
  1252. Gazit, Ehud; Reches, Meital, Peptide nanostructures encapsulating a foreign material and method of manufacturing same.
  1253. Gopal,T. Venkat, Peptide-mediated gene transfer.
  1254. Anantharamaiah, Gattadahalli M.; Fogelman, Alan M.; Navab, Mohamad; Rudolf, Martin, Peptides and peptide mimetics to treat pathologies associated with eye disease.
  1255. Porgador, Angel, Peptides derived from cytotoxicity receptor natural killer protein 44 NKP44.
  1256. Gazit, Ehud, Peptides directed for diagnosis and treatment of amyloid-associated disease.
  1257. Gazit, Ehud, Peptides directed for diagnosis and treatment of amyloid-associated diseases.
  1258. Meinke, Andreas; Teubenbacher, Astrid; Senn, Beatrice; Zerbs, Manuel; Hanner, Markus; Pikalo, Jutta; Nagy, Eszter; Giefing-Krōll, Carmen; Von Gabain, Alexander, Peptides protective against S. pneumoniae and compositions, methods and uses relating thereto.
  1259. Meinke, Andreas; Teubenbacher, Astrid; Tschanun, Beatrice; Zerbs, Manuel; Hanner, Markus; Pikalo, Jutta; Nagy, Eszter; Giefing, Carmen; Von Gabain, Alexander, Peptides protective against S. pneumoniae and compositions, methods and uses relating thereto.
  1260. Neufeld, Gera; Akiri, Gal; Vadasz, Zahava; Gengrinovitch, Stela, Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors.
  1261. Igawa, Tomoyuki, Pharmaceutical compositions containing sc(Fv)2.
  1262. Igawa, Tomoyuki, Pharmaceutical compositions containing sc(Fv)2.
  1263. Albermann, Kaj; Kemmner, Wolfram; Maier, Dieter; Spreafico, Fabio; Stock, Alexander; Wagner, Christian; De Boer, Lex; Meima, Roelf Bernhard, Phospholipases and uses thereof.
  1264. Albermann, Kaj; Kemmner, Wolfram; Maier, Dieter; Spreafico, Fabio; Stock, Alexander; Wagner, Christian; De Boer, Lex; Meima, Roelf Bernhard, Phospholipases and uses thereof.
  1265. Gygi, Steven P.; Villen, Judit; Beausoleil, Sean, Phosphopeptide compositions and anti-phosphopeptide antibody compositions and methods of detecting phosphorylated peptides.
  1266. Lipkin, W. Ian; Palacios, Gustavo; Kongtorp, Ruth Toril; Brun, Edgar, Piscine reovirus diagnostic compositions.
  1267. Lipkin, W. Ian; Palacios, Gustavo; Kongtorp, Ruth T.; Brun, Edgar, Piscine reovirus immunogenic compositions.
  1268. Sexton, Daniel J.; Viswanathan, Malini, Plasma kallikrein binding proteins.
  1269. Sexton, Daniel J.; Viswanathan, Malini, Plasma kallikrein binding proteins.
  1270. Whitlow, Marc; Shorr, Robert G. L.; Filpula, David R.; Lee, Lihsyng Standford, Polyalkylene oxide-modified single chain polypeptides.
  1271. Whitlow, Marc; Shorr, Robert G. L.; Filpula, David R.; Lee, Lihsyng Standford, Polyalkylene oxide-modified single chain polypeptides.
  1272. Whitlow, Marc; Shorr, Robert G. L.; Filpula, David R.; Lee, Lihsyng Stanford, Polyalkylene oxide-modified single chain polypeptides.
  1273. Whitlow,Marc; Shorr,Robert G. L.; Filpula,David R.; Lee,Lihsyng Standford, Polyalkylene oxide-modified single chain polypeptides.
  1274. Chiu, Daniel T.; Jin, Yuhui; Ye, Fangmao; Wu, Changfeng; Chan, Yang-Hsiang, Polyelectrolyte-coated polymer dots and related methods.
  1275. Bachmann,Brian O.; McAlpine,James B.; Zazopoulos,Emmanuel; Farnet,Chris M., Polyene polyketides, processes for their production and their use as a pharmaceutical.
  1276. Zazopoulos,Emmanuel; Farnet,Chris M., Polyene polyketides, processes for their production and their use as a pharmaceutical.
  1277. Klaerner, Gerrit; Nielsen, Ralph B.; Mansky, Paul; Benoit, Didier; Charmot, Dominique; Jandeleit, Bernd; Mazzola, Laura T., Polymer brushes for immobilizing molecules to a surface and having water-soluble or water-dispersible segments therein and probes bonded thereto.
  1278. Klaerner,Gerrit; Benoit,Didier; Charmot,Dominique; Nomula,Srinivas; Piotti,Marcelo Eduardo; Mazzola,Laura T., Polymer brushes for immobilizing molecules to a surface or substrate having improved stability.
  1279. Klaerner, Gerrit; Nielsen, Ralph B.; Mansky, Paul; Benoit, Didier; Charmot, Dominique; Jandeleit, Bernd; Mazzola, Laura T., Polymer brushes for immobilizing molecules to a surface or substrate, where the polymers have water-soluble or water-dispersible segments and probes bonded thereto.
  1280. Martinez, Alexa L; Sherman, Merry R; Saifer, Mark G. P.; Williams, L. David, Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof.
  1281. Feder,John N.; Nelson,Thomas C.; Chen,Jian; Meegalla,Rupalie; Ramaker,Michael; Cheng,Dong, Polynucleotide encoding a novel acyl coenzyme A, monoacylglycerol acyltransferase-3 (MGAT3), and uses thereof.
  1282. Jaspers, Stephen R.; Presnell, Scott R.; Huber, Monica J., Polynucleotides encoding antibodies that bind both IL-17A and IL-17F.
  1283. Jaspers, Stephen R.; Presnell, Scott R.; Huber, Monica J., Polynucleotides encoding antibodies that bind both IL-17A and IL-17F.
  1284. Jaspers, Stephen R.; Presnell, Scott R.; Huber, Monica J., Polynucleotides encoding antibodies that bind both IL-17A and IL-17F.
  1285. Zauderer, Maurice; Evans, Elizabeth E., Polynucleotides encoding antibodies that bind to the C35 polypeptide.
  1286. Zauderer, Maurice; Evans, Elizabeth E., Polynucleotides encoding antibodies that bind to the C35 polypeptide.
  1287. Reenan,Robert A.; Rogina,Blanka; Helfand,Stephen L., Polynucleotides encoding cellular transporters and methods of use thereof.
  1288. Chung, Yong-Hoon; Han, Ji-Woong; Lee, Hye-Ja; Choi, Eun-Yong; Kim, Jin-Mi, Polynucleotides encoding concatameric immunoadhesion molecules.
  1289. Better Marc D. ; Carroll Stephen F. ; Studnicka Gary M., Polynucleotides encoding gelonin sequences.
  1290. Walke,D. Wade; Friddle,Carl Johan; Mathur,Brian; Turner, Jr.,C. Alexander, Polynucleotides encoding human GABA receptors.
  1291. Friddle, Carl Johan; Gerhardt, Brenda, Polynucleotides encoding human ion-exchanger proteins.
  1292. Harras,Marie; Donoho,Gregory; Turner, Jr.,C. Alexander; Nehls,Michael C.; Friedrich,Glenn; Zambrowicz,Brian; Sands,Arthur T., Polynucleotides encoding human transporter proteins.
  1293. Alexandrov,Nickolai; Brover,Vyacheslav; Feldmann,Kenneth, Polynucleotides having a nucleotide sequence that encodes a polypeptide having MOV34 family activity.
  1294. Pecker, Iris; Vlodavsky, Israel; Feinstein, Elena, Polypeptide having heparanase activity.
  1295. Fukushima, Naoshi; Tsuchiya, Masayuki; Oh-Eda, Masayoshi; Uno, Shinsuke; Kikuchi, Yasufumi, Polypeptide inducing apoptosis.
  1296. Cohen-Dayag, Anat; Beiman, Merav; Dassa, Liat; Bubis, Marina; Greenwald, Shirley Sameach-; Landesman-Milo, Dalit; Koifman, Cynthia; Levy, Ofer; Nemzer, Sergey; Pergam, Tania; Kinar, Yaron; Levine, Zurit; Rosenberg, Avi; Rotman, Galit; Montia, Eve; Novik, Amit; Toporik, Amir; Walach, Shira, Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics.
  1297. Levine, Zurit; Pergam, Tania; Landesman-Milo, Dalit; Cohen-Dayag, Anat; Toporik, Amir; Kinar, Yaron; Nemzer, Sergey; Rosenberg, Avi; Rotman, Galit; Novik, Amit; Koifman, Cynthia; Beiman, Merav; Dassa, Liat; Walach, Shira; Montia, Eve; Sameach-Greenwald, Shirley; Levy, Ofer; Bubis, Marina, Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics.
  1298. Levine, Zurit; Toporik, Amir; Novik, Amit; Cohen-Dayag, Anat; Rosenberg, Avi; Koifman, Cynthia; Landesman-Milo, Dalit; Montia, Eve; Rotman, Galit; Dassa, Liat; Bubis, Marina; Beiman, Merav; Levy, Ofer; Nemzer, Sergey; Walach, Shira; Greenwald, Shirley Sameach-; Pergam, Tania; Kinar, Yaron, Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics.
  1299. Toporik, Amir; Novik, Amit; Cohen-Dayag, Anat; Rosenberg, Avi Yeshah; Koifman, Cynthia; Landesman-Milo, Dalit; Montia, Eve; Rotman, Galit; Dassa, Liat; Bubis, Marina; Beiman, Merav; Levi, Ofer; Nemzer, Sergey; Pergam, Tania; Kinar, Yaron; Greenwald, Shirley Sameach-; Levine, Zurit; Walach, Shira, Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics.
  1300. Toporik, Amir; Novik, Amit; Cohen-Dayag, Anat; Rosenberg, Avi Yeshah; Koifman, Cynthia; Landesman-Milo, Dalit; Montia, Eve; Rotman, Galit; Dassa, Liat; Bubis, Marina; Beiman, Merav; Levy, Ofer; Nemzer, Sergey; Pergam, Tania; Kinar, Yaron; Sameach-Greenwald, Shirley; Levine, Zurit; Walach, Shira, Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics.
  1301. Toporik, Amir; Rosenberg, Avi Yeshah; Rotman, Galit; Hecht, Iris; Levine, Zurit, Polypeptides and uses thereof for treatment of autoimmune disorders and infection.
  1302. Chang, Esther H.; Pirollo, Kathleen F., Preparation of antibody or an antibody fragment targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof.
  1303. Chang, Esther H.; Pirollo, Kathleen F., Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof.
  1304. Chang, Esther H.; Pirollo, Kathleen F., Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof.
  1305. Ladner, Robert C.; Ley, Arthur C.; Hirani, Shirish; Williams, Anthony, Prevention and reduction of blood loss.
  1306. Ladner, Robert Charles; Ley, Arthur Charles; Hirani, Shirish; Williams, Anthony, Prevention and reduction of blood loss.
  1307. Solomon Beka (Herzlya ILX), Prevention of protein aggregation.
  1308. Schlom Jeffrey ; Kashmiri Syed V. S. ; Shu Liming, Production of a single-gene-encoded immunoglobulin.
  1309. Griffiths Andrew David,GBX ; Hoogenboom Hendricus Renerus Jacobus Mattheus,GBX ; Marks James David ; McCafferty John,GBX ; Winter Gregory Paul,GBX ; Grigg Geoffrey Walter,AUX, Production of anti-self antibodies from antibody segment repertoires and displayed on phage.
  1310. Griffiths, Andrew David; Hoogenboom, Hendricus Renerus Jacobus Mattheus; Marks, James David; McCafferty, John; Winter, Gregory Paul; Grigg, Geoffrey Walter, Production of anti-self antibodies from antibody segment repertoires and displayed on phage.
  1311. Griffiths, Andrew David; Hoogenboom, Hendricus Renerus Jacobus Mattheus; Marks, James David; McCafferty, John; Winter, Gregory Paul; Grigg, Geoffrey Walter, Production of anti-self antibodies from antibody segment repertoires and displayed on phage.
  1312. Griffiths, Andrew David; Hoogenboom, Hendricus Renerus Jacobus Mattheus; Marks, James David; McCafferty, John; Winter, Gregory Paul; Grigg, Geoffrey Walter, Production of anti-self antibodies from antibody segment repertoires and displayed on phage.
  1313. Griffiths,Andrew David; Hoogenboom,Hendricus Renerus Jacobus Mattheus; Marks,James David; McCafferty,John; Winter,Gregory Paul; Grigg,Geoffrey Walter, Production of anti-self antibodies from antibody segment repertoires and displayed on phage.
  1314. Griffiths, Andrew David; Hoogenboom, Hendricus Renerus Jacobus Mattheus; Marks, James David; McCafferty, John; Winter, Gregory Paul; Grigg, Geoffrey Walter, Production of anti-self antibodies from antibody segment repertories and displayed on phage.
  1315. Griffiths, Andrew David; Hoogenboom, Hendricus Renerus Jacobus Mattheus; Marks, James David; McCafferty, John; Winter, Gregory Paul; Grigg, Geoffrey Walter, Production of anti-self bodies from antibody segment repertories and displayed on phage.
  1316. Bearss, David J.; Siddiqui-Jain, Adam; Whatcott, Clifford J.; Peterson, Peter W.; Warner, Steven L.; Mouritsen, Lars, Profiling peptides and methods for sensitivity profiling.
  1317. Sands, Roger Warren; Barros E Silva, Eduardo Alexandre; Kawai, Toshihisa; Mooney, David J., Programming of cells for tolerogenic therapies.
  1318. Sands, Roger Warren; Barros e Silva, Eduardo Alexandre; Kawai, Toshihisa; Mooney, David J., Programming of cells for tolerogenic therapies.
  1319. Leonard, Sherry; Freedman, Robert, Promoter variants of the alpha-7 nicotinic acetylcholine receptor.
  1320. Ghayur, Tariq; Gu, Jijie; Isakson, Peter C., Prostaglandin E2 dual variable domain immunoglobulins and uses thereof.
  1321. Senn, Beatrice; Nagy, Eszter; Meinke, Andreas; Von Gabain, Alexander; Maierhofer, Barbara; Stierschneider, Ulrike; Berger, Manfred; Neubauer, Christina; Cohen, Katherine, Protective proteins of S. agalactiae, combinations thereof and methods of using the same.
  1322. Tschanun, Beatrice; Nagy, Eszter; Meinke, Andreas; Von Gabain, Alexander; Maierhofer, Barbara; Stierschneider, Ulrike; Berger, Manfred; Neubauer, Christina; Cohen, Katherine, Protective proteins of S. agalactiae, combinations thereof and methods of using the same.
  1323. Beasley, Matthew; Kiefel, Ben, Protein display.
  1324. You, Liang; Xu, Zhidong; He, Biao; Jablons, David, Protein kinase ck2 gene mutations, amplifications and polymorphisms in human cancers and methods of use.
  1325. Mezes,Peter; Rastelli,Luca; Herrmann,John; MacDougall,John; Zhong,Haihong; Casman,Stacie; Boldog,Ferenc; Shimkets,Richard; Gorman,Linda; Eisen,Andrew; Spaderna,Steven; Vernet,Corine; Berghs,Constance, Proteins and nucleic acids encoding same.
  1326. Rastelli, Luca; Herrmann, John L.; MacDougall, John R.; Zhong, Haihong, Proteins and nucleic acids encoding same.
  1327. Gillies, Stephen D.; Way, Jeffrey; Lo, Kin-Ming, Proteins comprising an IgG2 domain.
  1328. Better Marc D. ; Carroll Stephen F., Proteins encoding gelonin sequences.
  1329. Chen, Li-How; Meade, Harry M., Proteins with modified glycosylation and methods of production thereof.
  1330. Fischer, Meir; Harosh, Eliyahu, Purification of proteins with cationic surfactant.
  1331. Gu Trent ; Orita Satoshi ; Han Min, Ras suppressor SUR-5.
  1332. Han, Min; Sieburth, Derek, Ras suppressor SUR-8 and related compositions and methods.
  1333. Vasquez, Maximiliano; Feldhaus, Michael; Gerngross, Tillman U.; Wittrup, K. Dane, Rationally designed, synthetic antibody libraries and uses therefor.
  1334. Vasquez, Maximiliano; Feldhaus, Michael; Gerngross, Tillman U.; Wittrup, K. Dane, Rationally designed, synthetic antibody libraries and uses therefor.
  1335. Vasquez, Maximiliano; Feldhaus, Michael; Gerngross, Tillman U.; Wittrup, K. Dane, Rationally designed, synthetic antibody libraries and uses therefor.
  1336. Vasquez, Maximiliano; Feldhaus, Michael; Gerngross, Tillman U.; Wittrup, K. Dane, Rationally designed, synthetic antibody libraries and uses therefor.
  1337. Billing Medel,Patricia A.; Cohen,Maurice; Colpitts,Tracey L.; Friedman,Paula N.; Gordon,Julian; Granados,Edward N.; Hodges,Steven C.; Klass,Michael R.; Kratochvil,Jon D.; Roberts Rapp,Lisa; Russell,John C.; Stroupe,Stephen D., Reagents and methods useful for detecting diseases of the breast.
  1338. Guo, Ailan; Lee, Kimberly; Rikova, Klarisa; Farnsworth, Charles; Moritz, Albrecht; Li, Yu; Polakiewicz, Robert, Reagents for the detection of protein phosphorylation in EGFR-signaling pathways.
  1339. Moritz, Albrecht; Lee, Kimberly; Rush, John; Polakiewicz, Roberto, Reagents for the detection of protein phosphorylation in anaplastic large cell lymphoma signaling pathways.
  1340. Polakiewicz, Roberto; Goss, Valerie; Moritz, Albrecht; Gu, Ting-Lei; Lee, Kimberly, Reagents for the detection of protein phosphorylation in leukemia signaling pathways.
  1341. Colonna, Marco; Bouchon, Axel; Salbo, Rune; Wiberg, Charlotte; Stennicke, Vibeke W.; Henriksen, Anette; Andersen, Mette D., Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof.
  1342. Colonna, Marco; Bouchon, Axel, Receptor trem (triggering receptor expressed on myeloid cells) and uses thereof.
  1343. Alain Colige BE; Charles M. Lapiere BE; Darwin J. Prockop, Recombinant N-proteinase and methods and uses thereof.
  1344. Marzari, Roberto; Sblattero, Daniele; Tedesco, Francesco, Recombinant antibodies against CD55 and CD59 and uses thereof.
  1345. Wels Winfried Stephan,CHX ; Hynes Nancy E.,CHX ; Harwerth Ina-Maria,DEX ; Groner Bernd,CHX ; Hardman Norman,CHX ; Zwickl Markus,CHX, Recombinant antibodies specific for a growth factor receptor.
  1346. Gillies Stephen D. (245 Leavitt St. Hingham MA 02043), Recombinant antibody cytokine fusion proteins.
  1347. Pastan Ira H. ; Lee Byungkook ; Jung Sun-Hee ; Brinkmann Ulrich, Recombinant disulfide-stabilized polypeptide fragments having binding specificity.
  1348. Pastan Ira H. ; Lee Byungkook ; Jung Sun-Hee ; Brinkmann Ulrich, Recombinant disulfide-stabilized polypeptide fragments having binding specificity.
  1349. Gillies, Stephen D.; Lo, Kin-Ming; Qian, Susan X., Recombinant tumor specific antibody and use thereof.
  1350. Gillies, Stephen D.; Lo, Kin-Ming; Qian, Susan Xiuqi, Recombinant tumor specific antibody and use thereof.
  1351. Gillies,Stephen D.; Lo,Kin Ming; Qian,Susan Xiuqi, Recombinant tumor specific antibody and use thereof.
  1352. Pease, Larry R.; Van Keulen, Virginia; Ciric, Bogoljub, Recombinantly produced antibody.
  1353. Pease, Larry R; Van Keulen, Virginia; Ciric, Bogoljub, Recombinantly produced antibody.
  1354. Brian Seed ; Charles Romeo ; Waldemar Kolanus, Redirection of cellular immunity by protein tyrosine kinase chimeras.
  1355. Seed Brian ; Romeo Charles ; Kolanus Waldemar, Redirection of cellular immunity by protein tyrosine kinase chimeras.
  1356. Seed,Brian; Romeo,Charles; Kolanus,Waldemar, Redirection of cellular immunity by protein tyrosine kinase chimeras.
  1357. Brian Seed ; Charles Romeo ; Waldemar Kolanus, Redirection of cellular immunity by protein-tyrosine kinase chimeras.
  1358. Seed Brian ; Romeo Charles ; Kolanus Waldemar, Redirection of cellular immunity by protein-tyrosine kinase chimeras.
  1359. Seed,Brian; Romeo,Charles; Kolanus,Waldemar, Redirection of cellular immunity by receptor chimeras.
  1360. Gillies, Stephen D.; Way, Jeffrey; Hamilton, Anita A., Reducing the immunogenicity of fusion proteins.
  1361. Gillies, Stephen D.; Way, Jeffrey; Hamilton, Anita A., Reducing the immunogenicity of fusion proteins.
  1362. Gillies, Stephen D.; Way, Jeffrey; Hamilton, Anita A., Reducing the immunogenicity of fusion proteins.
  1363. Gillies,Stephen D.; Hamilton,Anita A., Reducing the immunogenicity of fusion proteins.
  1364. Wu, Chun; Mountzouris, John A.; Hu, Bingren; Liu, Chunli, Regulation of autophagy pathway phosphorylation and uses thereof.
  1365. Apuya,Nestor; Lu,Yuping, Regulatory regions from.
  1366. Winter, Gregory Paul; Holliger, Kaspar Philipp, Retargetting antibodies.
  1367. Bremel,Robert D.; Bleck,Gregory T.; Imboden,Michael; Eakle,Kurt, Retrovirus-based genomic screening.
  1368. Meinke, Andreas; Nagy, Eszter; Hanner, Markus; Dewasthaly, Shailesh; Stierschneider, Ulrike, S. pneumoniae antigens.
  1369. Kho, Kiang Wei; Malini, Olivo, SERS-based analyte detection.
  1370. Mi, Sha; Pepinsky, R. Blake; Shao, Zhaohui; Graff, Christilyn, SP35 antibodies and uses thereof.
  1371. Mooney, David J.; Ali, Omar Abdel-Rahman, Scaffolds for cell collection or elimination.
  1372. Mooney, David J.; Ali, Omar Abdel-Rahman; Barros E Silva, Eduardo Alexandre; Kong, Hyun Joon; Hill, Jr., Elliot Earl; Boontheekul, Tanyarut, Scaffolds for cell transplantation.
  1373. Mooney, David J.; Ali, Omar Abdel-Rahman; Barros E Silva, Eduardo Alexandre; Kong, Hyun Joon; Hill, Jr., Elliot Earl; Boontheekul, Tanyarut, Scaffolds for cell transplantation.
  1374. Mooney, David J.; Ali, Omar Abdel-Rahman; Barros E Silva, Eduardo Alexandre; Kong, Hyun Joon; Hill, Jr., Elliot Earl; Boontheekul, Tanyarut, Scaffolds for cell transplantation.
  1375. Mooney, David J.; Ali, Omar Abdel-Rahman; Barros E Silva, Eduardo Alexandre; Kong, Hyun Joon; Hill, Jr., Elliot Earl; Boontheekul, Tanyarut, Scaffolds for cell transplantation.
  1376. Weir, Malcolm Peter; Marshall, Fiona Hamilton, Screening.
  1377. Hirth Klaus Peter ; App Harald ; Tsai Jianming, Screening assays for compounds.
  1378. Mi, Sha; Pepinsky, R. Blake; McCoy, John, Screening methods for identifying Sp35 antagonists.
  1379. Smith, Ernest S.; Croy, Leslie A.; Scrivens, Maria G. M., Selection of human TNFα specific antibodies.
  1380. Oxvig, Claus; Mikkelsen, Jakob Hauge; Nielsen, Claus Gyrup, Selective exosite inhibition of PAPP-A activity against IGFBP-4.
  1381. Gazit, Ehud; Mahler, Assaf; Reches, Meital, Self-assembled Fmoc-ff hydrogels.
  1382. Alexandrov,Nickolai; Brover,Vyacheslav; Feldmann,Kenneth, Sequence-determined DNA encoding AP2 domain polypeptides.
  1383. Hudson,Peter L.; He,Wei Wu; Ruben,Steven M., Serum paraoxonase.
  1384. Kavanaugh W. Michael ; Pot David ; Williams Lewis T., Signaling inositol polyphosphate 5-phosphatases (SIPs).
  1385. Chang, Esther H.; Pirollo, Kathleen F., Simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome for systemic administration of a therapeutic or diagnostic agent.
  1386. Chang, Esther H.; Pirollo, Kathleen F., Simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome for systemic administration of a therapeutic or diagnostic agent.
  1387. Nai-Kong V. Cheung ; Steven M. Larson ; Hong-Fen Guo ; Ken Rivlin ; Michel Sadelain, Single chain FV polynucleotide or peptide constructs of anti-ganglioside GD2 antibodies, cells expressing same and related methods.
  1388. Thompson, Peter Armstrong; Ledbetter, Jeffrey A.; Hayden-Ledbetter, Martha Susan; Grosmaire, Laura Sue; Bader, Robert; Brady, William, Single chain multivalent binding proteins with effector function.
  1389. Shi Qinwei,CAX ; Tobias Rowel,CAX, Single-chain polypeptides comprising creatine kinase M and creatine kinase B.
  1390. Qinwei Shi CA; Shigui Liu CA; Mingfu Ling CA, Single-chain polypeptides comprising troponin I N-terminal fragments and troponin C.
  1391. Shi,Qinwei; Song,Qian Li, Single-chain polypeptides comprising troponin I and troponin C.
  1392. Henriksen, Anette; Kjærgaard, Kristian; Stennicke, Vibeke Westphal; Wiberg, Charlotte, Site directed mutagenesis of TREM-1 antibodies for decreasing viscosity.
  1393. Rabinkov,Aharon; Miron,Talia; Mirelman,David; Wilchek,Meir, Site-specific in situ generation of allicin using a targeted alliinase delivery system for the treatment of cancers, tumors, infectious diseases and other allicin-sensitive diseases.
  1394. Meinke, Andreas; Nagy, Eszter; von Gabain, Alexander; Berger, Manfred; Senn, Beatrice; Schunn, Michael, Small Streptococcus pyogenes antigens and their use.
  1395. Durrani, Manzer; Geiss, William B.; Fairfax, David J.; Tymoshenko, Dmytro O.; Le, Van-Duc; Peterson, Lisa Helen, Soluble 1,4 benzodiazepine compounds and stable salts thereof.
  1396. Maihle, Nita J.; Lee, Hakjoo, Soluble ErbB3 and treatment of cancer.
  1397. Maihle, Nita J.; Lee, Hakjoo, Soluble ErbB3 methods of detection and antibodies.
  1398. Wu, Jennifer, Soluble MIC neutralizing monoclonal antibody for treating cancer.
  1399. Douglas T. Fearon ; Thomas Hebell DE, Soluble complement regulatory molecules.
  1400. Maihle, Nita J.; Baron, Andre; Reiter, Jill, Soluble epidermal growth factor receptor isoforms.
  1401. Koths Kirston ; Taylor Eric, Soluble extracellular domain of human M-CSF receptor.
  1402. Gross, Jane A.; Xu, Wenfeng; Madden, Karen L.; Yee, David P., Soluble receptor BR43x2.
  1403. Ellis L. Reinherz ; Jiri Novotny ; Stephen T. Smiley ; Ping Li ; Ramesh Ganju, Soluble single chain T cell receptors.
  1404. Mi, Sha; Pepinsky, R. Blake; Shao, Zhaohui; Garber, Ellen A.; Miklasz, Steven D.; Graff, Christilyn, Sp35 antibodies and uses thereof.
  1405. Mi, Sha; Pepinsky, R. Blake; Shao, Zhaohui; Garber, Ellen A.; Miklasz, Steven D.; Graff, Christilyn, Sp35 antibodies and uses thereof.
  1406. Mi, Sha; Pepinsky, R. Blake; Shao, Zhaohui; Graff, Christilyn, Sp35 antibodies and uses thereof.
  1407. Thompson,Julia Elizabeth; Lennard,Simon Nicholas; Wilton,Alison Jane; Braddock,Peta Sally Helena; Du Fou,Sarah Leila; McCafferty,John Gerald; Conroy,Louise Anne; Tempest,Philip Ronald, Specific binding members for TGFβ.
  1408. Davis Paul James,GBX ; Verhoeyen Martine Elisa,GBX ; De Winter Ronald Frank Jacobus,GBX, Specific binding reagent comprising a variable domain protein linked to a support or tracer.
  1409. Sallberg, Matti; Flock, Jan-Ingmar, Specificity exchangers that redirect antibodies to bacterial adhesion receptors.
  1410. Sutovsky, Peter, Sperm quality assay.
  1411. Lee Lihsyng Stanford, Stabilized monomeric protein compositions.
  1412. Igawa, Tomoyuki; Kameoka, Daisuke, Stabilizer for protein preparation comprising meglumine and use thereof.
  1413. Lu, Wenyuan; Leith, Katherine M.; Chan, Stephen P.; Walton, Courtney E., Stabilizing agents and capture ligands for use in assays measuring analyte concentrations.
  1414. Schnieders, Julia; Usener, Dirk; Ruggeberg, Sabrina; Youssef, Ahmed; Kirsch, Martina; Hagendorf, Annika, Stable IgG4 based binding agent formulations.
  1415. Borras, Leonardo Jose; Urech, David, Stable and soluble antibodies.
  1416. Borras, Leonardo Jose; Urech, David, Stable and soluble antibodies.
  1417. Borras, Leonardo; Gunde, Tea; Urech, David, Stable and soluble antibodies inhibiting TNF alpha.
  1418. Borras, Leonardo; Gunde, Tea; Urech, David, Stable and soluble antibodies inhibiting TNF alpha.
  1419. Borras, Leonardo; Gunde, Tea; Urech, David, Stable and soluble antibodies inhibiting TNFα.
  1420. Borras, Leonardo; Urech, David; Gunde, Tea, Stable and soluble antibodies inhibiting VEGF.
  1421. Borras, Leonardo; Urech, David; Gunde, Tea, Stable and soluble antibodies inhibiting VEGF.
  1422. Borras, Leonardo; Urech, David; Gunde, Tea, Stable and soluble antibodies inhibiting VEGF.
  1423. 800 ; Loerzer et al., Stable troponin subunits and complexes.
  1424. Liu Shigui,CAX ; Shi Qinwei,CAX, Stable troponin subunits and complexes.
  1425. Lukacs, Nicholas W.; Dolgachev, Vladislav A.; Kunkel, Steven L.; Hogaboam, Cory M.; Phan, Sem H., Stem cell factor inhibitor.
  1426. Lukacs, Nicholas W.; Dolgachev, Vladislav A.; Kunkel, Steven L.; Hogaboam, Cory M.; Phan, Sem H., Stem cell factor inhibitor.
  1427. Lukacs, Nicholas W.; Dolgachev, Vladislav; Kunkel, Steven L.; Hogaboam, Cory M.; Phan, Sem H., Stem cell factor inhibitor.
  1428. Stayton, Patrick S.; Lai, Jriuan; Nehilla, Barrett J.; Srinivasan, Selvi, Stimuli-responsive polymer diagnostic assay comprising magnetic nanoparticles and capture conjugates.
  1429. Meinke, Andreas; Nagy, Eszter; Winkler, Birgit; Gelbmann, Dieter, Streptococcus pyogene antigens.
  1430. Igawa, Tomoyuki; Tsunoda, Hiroyuki; Koga, Akiko; Kikuchi, Yasufumi, Structural isomers of sc(Fv)2.
  1431. Goldenberg, David M.; Chang, Chien-Hsing; Hansen, Hans J., Structural variants of antibodies for improved therapeutic characteristics.
  1432. Bonnefoy,Jean Yves; Gauchat,Jean Fran��ois, Substances and their uses.
  1433. Ekker, Stephen C.; Chen, Eleanor Y., Syndecans and angiogenesis.
  1434. Goldenberg, David M.; Cardillo, Thomas M., Synergistic effect of anti-Trop-2 antibody-drug conjugate in combination therapy for triple-negative breast cancer when used with microtubule inhibitors or PARP inhibitors.
  1435. Naasani, Imad, Synthesis of highly luminescent colloidal particles.
  1436. Anantharamaiah, Gattadahalli M.; Garber, David W.; Datta, Geeta; Handattu, Sheila P.; Mishra, Vinod K., Synthetic apolipoprotein E mimicking polypeptides and methods of use.
  1437. Anantharamaiah, Gattadahalli M.; White, C. Roger; Gupta, Himanshu, Synthetic apolipoprotein E mimicking polypeptides and methods of use.
  1438. Fischer, Nicolas; Kosco-Vilbois, Marie; Ravn, Ulla; Gueneau, Franck; Venet-Bonnot, Sophie, Synthetic polypeptide libraries and methods for generating naturally diversified polypeptide variants.
  1439. Anantharamiah, Gattadahalli M.; Garber, David W.; Datta, Geeta, Synthetic single domain polypeptides mimicking apolipoprotein E.
  1440. Chen, Margaret Sällberg, T cell receptors specific for immunodominant CTL epitopes of HCV.
  1441. Margolskee, Robert; Rong, Minqing; Damak, Sami, T1R3 transgenic animals, cells and related methods.
  1442. Margolskee,Robert F.; Huang,Liquan; Rong,Minqing; Max,Marianna; Perez,Cristian A., TRP8, a transient receptor potential channel expressed in taste receptor cells.
  1443. Oh, Young In; Hsieh-Wilson, Linda C., Tailored glycopolymers as anticoagulant heparin mimetics.
  1444. Blume Arthur J., Target specific screens and their use for discovering small organic molecular pharmacophores.
  1445. Seed Brian ; Banapour Babak ; Romeo Charles ; Kolanus Waldemar, Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells.
  1446. Seed Brian ; Banapour Babak ; Romeo Charles ; Kolanus Waldemar, Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells.
  1447. Seed,Brian; Banapour,Babak; Romeo,Charles; Kolanus,Waldemar, Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells.
  1448. Liu, Cheng; Edgington, Thomas S., Targeted delivery to legumain-expressing cells.
  1449. Waggoner, Alan; Bruchez, Marcel P.; Schmidt, Brigitte F.; Chakraborty, Subhasish K., Targeted probes of cellular physiology.
  1450. Allemann, Eric; Bettinger, Thierry; Bussat, Philippe; Hauwel, Mathieu; Yan, Feng, Targeting construct comprising anti-polymer antibody and contrast/therapeutic agents binding to the same.
  1451. Lim, Bing; Zhang, Wencai, Targeting metabolic enzymes in human cancer.
  1452. Chung,Yong Hoon; Han,Ji Woong; Lee,Hye Ja; Choi,Eun Yong; Kim,Jin Mi, Tetravalent etanercept.
  1453. Benatuil, Lorenzo; Boghaert, Erwin R.; Gu, Jijie; Harris, Maria; Hickson, Jonathan A.; Hsieh, Chung-Ming; Kutskova, Yuliya; Li, Yingchun; Liu, Zhihong; Morgan-Lappe, Susan, Therapeutic DLL4 binding proteins.
  1454. Benatuil, Lorenzo; Boghaert, Erwin R.; Gu, Jijie; Harris, Maria; Hickson, Jonathan A.; Hsieh, Chung-Ming; Kutskova, Yuliya; Li, Yingchun; Liu, Zhihong; Morgan-Lappe, Susan, Therapeutic DLL4 binding proteins.
  1455. Benatuil, Lorenzo; Boghaert, Erwin R.; Gu, Jijie; Harris, Maria; Hickson, Jonathan A.; Hsieh, Chung-Ming; Kutskova, Yuliya; Li, Yingchun; Liu, Zhihong; Morgan-Lappe, Susan, Therapeutic DLL4 binding proteins.
  1456. Chen, Ming-Jiu; Hsieh, Chung-Ming; Gu, Jijie; Morgan-Lappe, Susan E.; Li, Yingchun, Therapeutic DLL4 binding proteins.
  1457. Chen, Ming-Jiu; Hsieh, Chung-Ming; Gu, Jijie; Morgan-Lappe, Susan E.; Li, Yingchun, Therapeutic DLL4 binding proteins.
  1458. Faure, Gilbert; Gibot, Sebastien; Panina, Paola; Passini, Nadia, Therapeutic TREM-1 peptides.
  1459. Rosenblum, Michael G.; Liu, Yuying, Therapeutic agents comprising pro-apoptotic proteins.
  1460. Rosenblum, Michael G.; Liu, Yuying, Therapeutic agents comprising pro-apoptotic proteins.
  1461. Rosenblum, Michael G.; Liu, Yuying, Therapeutic agents comprising pro-apoptotic proteins.
  1462. Rosenblum,Michael G.; Liu,Yuying, Therapeutic agents comprising pro-apoptotic proteins.
  1463. Rosenblum,Michael G.; Liu,Yuying, Therapeutic agents comprising pro-apoptotic proteins.
  1464. Glick, Gary D.; Opipari, Jr., Anthony W., Therapeutic applications of pro-apoptotic benzodiazepines.
  1465. Olin, Michael Raymond; Low, Walter; Ohlfest, John R., Therapeutic composition for treatment of glioblastoma.
  1466. Olin, Michael Raymond; Ohlfest, John R.; Low, Walter, Therapeutic composition for treatment of glioblastoma.
  1467. Kerbel, Robert, Therapeutic method for reducing angiogenesis.
  1468. Anderson, David W.; Alsobrook II, John P.; Boldog, Ferenc L.; Burgess, Catherine E.; Casman, Stacie J.; Edinger, Shlomit R.; Gangolli, Esha A.; Gorman, Linda; Guo, Xiaojia Sasha; Khramtsov, Nikolai; , Therapeutic polypeptides, nucleic acids encoding same, and methods of use.
  1469. Chang, Chien-Hsing; Goldenberg, David M.; Hansen, Hans J.; Rossi, Edmund A., Therapeutic use of anti-CD22 antibodies for inducing trogocytosis.
  1470. Chang, Chien-Hsing; Goldenberg, David M.; Hansen, Hans J.; Rossi, Edmund A., Therapeutic use of anti-CD22 antibodies for inducing trogocytosis.
  1471. Chang, Chien-Hsing; Goldenberg, David M.; Hansen, Hans J.; Rossi, Edmund A., Therapeutic use of anti-CD22 antibodies for inducing trogocytosis.
  1472. Chang, Chien-Hsing; Goldenberg, David M.; Hansen, Hans J.; Rossi, Edmund A., Therapeutic use of anti-CD22 antibodies for inducing trogocytosis.
  1473. Ginns, Edward I.; Ostroff, Gary R., Therapy for lysosomal enzyme deficiencies.
  1474. Ginns, Edward I.; Ostroff, Gary R., Therapy for lysosomal enzyme deficiencies.
  1475. Santin, Alessandro D., Therapy with Clostridium perfringens enterotoxin to treat ovarian and uterine cancer.
  1476. Santin, Alessandro D., Therapy with Clostridium perfringens enterotoxin to treat ovarian and uterine cancer.
  1477. Santin, Alessandro D.; Comper, Fabrizio, Therapy with Clostridium perfringens enterotoxin to treat ovarian and uterine cancer.
  1478. Janjic, Nebojsa; Bullard, James M.; McHenry, Charles S.; Kery, Vladimir, Thermophilic polymerase III holoenzyme.
  1479. McHenry Charles S. ; Seville Mark ; Cull Millard G., Thermophilic polymerase III holoenzyme.
  1480. Ambati, Jayakrishna, Toll like receptor (TLR) stimulation for ocular angiogenesis and macular degeneration.
  1481. Andersson,Leif; Marklund,Stefan, Transgenic mouse expressing Prkag3.
  1482. Akira,Shizuo; Hemmi,Hiroaki, Transgenic toll-like receptor 9 (TLR9) mice.
  1483. Rabinovich, Peter M.; Weissman, Sherman M.; Komarovskaya, Marina E.; Bahceci, Erkut, Transient transfection with RNA.
  1484. Faustman Denise L., Transport associated protein splice variants.
  1485. Yang, Haining; Carbone, Michele; Bianchi, Marco E., Treatment and prevention of cancer with HMGB1 antagonists.
  1486. Poduslo, Joseph F.; Curran, Geoffry L., Treatment for central nervous system disorders.
  1487. Hammerberg, Bruce, Treatment of allergic diseases with recombinant antibodies.
  1488. Gajewski, Thomas F.; Sivan, Ayelet; Corrales, Leticia, Treatment of cancer by manipulation of commensal microflora.
  1489. Andre, Fabrice; Zitvogel, Laurence; Sabourin, Jean-Christophe, Treatment of cancer using TLR3 agonists.
  1490. Andre,Fabrice; Zitvogel,Laurence; Sabourin,Jean Christophe, Treatment of cancer using TLR3 agonists.
  1491. Mi, Sha; Pepinsky, R. Blake; McCoy, John, Treatment of conditions involving demyelination.
  1492. Margolis Ben Lewis ; Schlessinger Joseph, Treatment or diagnosis of diseases or conditions associated with a BLM domain.
  1493. Myers, Andrew G.; Hill, Nicholas E.; Svenda, Jakub; Yu, Robert T.; Smaltz, Daniel J.; Magauer, Thomas, Trioxacarcins and uses thereof.
  1494. Myers, Andrew G.; Smaltz, Daniel J.; Schumacher, Andreas, Trioxacarcins, trioxacarcin-antibody conjugates, and uses thereof.
  1495. Roth, David; He, Huaping, Tuberculosis nucleic acids, polypeptides and immunogenic compositions.
  1496. Ying-Fei Wei ; Jian Ni ; Reiner L. Gentz ; Steven M. Ruben, Tumor necrosis factor receptor 5.
  1497. Wei,Ying Fei; Gentz,Reiner; Ni,Jian; Ruben,Steven M, Tumor necrosis factor receptor-5.
  1498. Yu, Guo Liang; Ni, Jian; Rosen, Craig A.; Zhang, Jun, Tumor necrosis factor-gamma.
  1499. Yu, Guo-Liang; Ni, Jian; Rosen, Craig A.; Zhang, Jun, Tumor necrosis factor-gamma.
  1500. Yu, Guo-Liang; Ni, Jian; Rosen, Craig A.; Zhang, Jun, Tumor necrosis factor-gamma.
  1501. Hornbeck, Peter; Guo, Ailan; Gu, Ting-Lei; Rikova, Klarisa; Moritz, Albrecht; Farnsworth, Charles; Stokes, Matthew; Yu, Jian; Spek, Erik; Li, Yu; Possemato, Anthony; Cherry, Jessica; Goss, Valerie; Mitchell, Jeffrey; Rush, John; Michaud, Corinne, Tyrosine phosphorylation sites.
  1502. Godzik,Adam; Sikora,Sergey, Uncharacterized ORF3 in SARS-coronavirus is a cyclic-AMP-dependent kinase and a target for SARS therapy.
  1503. Glick, Gary D.; Matzger, Adam, Unsolvated benzodiazepine compositions and methods.
  1504. Parry, Graham; Mazar, Andrew P., Urokinase-type plasminogen activator receptor epitope, monoclonal antibodies derived therefrom and methods of use thereof.
  1505. Mueller, Bernhard K.; Macchi, Paolo; Bonhoeffer, Friedrich; Stahl, Bernd; Mann, Matthias; Andersen, Jens S.; Monnier, Philippe P., Use of RGM and its modulators.
  1506. Lucas, John; Briggs, Kristen, Use of adipsin/complement factor D in the treatment of metabolic related disorders.
  1507. Ni, Jian; Rosen, Craig A.; Gentz, Reiner L., Use of an antibody that binds human tumor necrosis factor receptor-like 2.
  1508. Ramakrishnan, Vanitha; Bhaskar, Vinay; Ho, Sun; Murray, Richard; Law, Debbie, Use of anti-α5β1 antibodies to inhibit cancer cell proliferation.
  1509. Bigler, Michael Eric; Cherwinski, Holly Marie; Phillips, Joseph H., Use of bispecific antibodies to regulate immune responses.
  1510. Wagner, George J.; Shepherd, Ryan W., Utility of phylloplanins as antibiotics, selective fungicides and for enhancing microbial resistance in crop plants.
  1511. S?llberg, Matti; Hultgren, Catharina, Vaccines containing ribavirin and methods of use thereof.
  1512. Sallberg, Matti; Hultgren, Catharina, Vaccines containing ribavirin and methods of use thereof.
  1513. S채llberg,Matti; Hultgren,Catharina, Vaccines containing ribavirin and methods of use thereof.
  1514. S?llberg,Matti; Hultgren,Catharina, Vaccines containing ribavirin and methods of use thereof.
  1515. S?llberg,Matti; Hultgren,Catharina, Vaccines containing ribavirin and methods of use thereof.
  1516. S?llberg,Matti; Hultgren,Catharina, Vaccines containing ribavirin and methods of use thereof.
  1517. Hartman, Jacob; Mendelovitz, Simona, Variant forms of urate oxidase and use thereof.
  1518. Hu,Yi, Variants of FAM3C.
  1519. Hj?lm,G?ran, Variants of the α1 subunit of human AMPK.
  1520. Hjälm,Göran, Variants of the alpha 1 subunit of human AMPK.
  1521. De Jong, Jan Cornelius; Fouchier, Ronaldus Adrianus Maria; Groen, Jan; Osterhaus, Albertus Dominicus Marcellinus Erasmus; Van Den Hoogen, Bernadetta Gerarda, Virus causing respiratory tract illness in susceptible mammals.
  1522. De Jong, Jan Cornelius; Fouchier, Ronaldus Adrianus Maria; Van Den Hoogen, Bernadetta Gerarda; Osterhaus, Albertus Dominicus Marcellinus Erasmus; Groen, Jan, Virus causing respiratory tract illness in susceptible mammals.
  1523. Pandey, Ravindra K.; Gryshuk, Amy; Goswami, Lalit; Potter, William; Oseroff, Allan, Water soluble tetrapyrollic photosensitizers for photodynamic therapy.
  1524. Pandey,Ravindra K.; Gryshuk,Amy; Goswami,Lalit; Potter,William; Oseroff,Allan, Water soluble tetrapyrollic photosensitizers for photodynamic therapy.
  1525. Bricker, Neal; Shankel, Stewart; Cain, Christopher D.; Mitchnick, Mark; Schmertzler, Michael, Xanthurenic acid derivative pharmaceutical compositions and methods related thereto.
  1526. Bricker, Neal; Shankel, Stewart; Cain, Christopher D.; Mitchnick, Mark; Schmertzler, Michael, Xanthurenic acid derivative pharmaceutical compositions and methods related thereto.
  1527. K. Dane Wittrup ; David M. Kranz ; Michele Keike ; Eric T. Boder, Yeast cell surface display of proteins and uses thereof.
  1528. Kieke Michele C. ; Wittrup K. Dane ; Boder Eric T. ; Kranz David M. ; Shusta Eric, Yeast cell surface display of proteins and uses thereof.
  1529. Wittrup K. Dane ; Kranz David M. ; Kieke Michele ; Boder Eric T., Yeast cell surface display of proteins and uses thereof.
  1530. Wittrup, K. Dane; Kranz, David M.; Kieke, Michele; Boder, Eric T., Yeast cell surface display of proteins and uses thereof.
  1531. Wittrup, K. Dane; Kranz, David M.; Kieke, Michele; Boder, Eric T., Yeast cell surface display of proteins and uses thereof.
  1532. Wittrup, K. Dane; Kranz, David M.; Kieke, Michele; Boder, Eric T., Yeast cell surface display of proteins and uses thereof.
  1533. Wittrup, K. Dane; Kranz, David M.; Kieke, Michele; Boder, Eric T., Yeast cell surface display of proteins and uses thereof.
  1534. Wittrup,K. Dane; Kranz,David M.; Kieke,Michele; Boder,Eric T., Yeast cell surface display of proteins and uses thereof.
  1535. Meinke, Andreas; Nagy, Eszter; Hanner, Markus; Dewasthaly, Shailesh; Stierschneider, Ulrike, antigens.
  1536. Pagano, Michele; Dehan, Elinor, β-TrCP1, β-TrCP2 and RSK1 or RSK2 inhibitors and methods for sensitizing target cells to apoptosis.
  1537. Shelton, Christopher Chad; Tian, Yuan; Li, Yueming, γ-Secretase substrates and methods of use.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로